id	sid	tid	token	lemma	pos
ajmpe-90	1	1	american	american	PROPN
ajmpe-90	1	2	journal	journal	PROPN
ajmpe-90	1	3	of	of	ADP
ajmpe-90	1	4	medical	medical	ADJ
ajmpe-90	1	5	and	and	CCONJ
ajmpe-90	1	6	physical	physical	ADJ
ajmpe-90	1	7	education	education	NOUN
ajmpe-90	1	8	vol.1	vol.1	PROPN
ajmpe-90	1	9	,	,	PUNCT
ajmpe-90	1	10	issue	issue	NOUN
ajmpe-90	1	11	1	1	NUM
ajmpe-90	1	12	;	;	PUNCT
ajmpe-90	1	13	july	july	PROPN
ajmpe-90	1	14	2023	2023	NUM
ajmpe-90	1	15	;	;	PUNCT
ajmpe-90	1	16	1252	1252	NUM
ajmpe-90	1	17	columbia	columbia	PROPN
ajmpe-90	1	18	rd	rd	PROPN
ajmpe-90	1	19	nw	nw	PROPN
ajmpe-90	1	20	,	,	PUNCT
ajmpe-90	1	21	washington	washington	PROPN
ajmpe-90	1	22	dc	dc	PROPN
ajmpe-90	1	23	,	,	PUNCT
ajmpe-90	1	24	united	united	PROPN
ajmpe-90	1	25	states	states	PROPN
ajmpe-90	1	26	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-90	1	27	;	;	PUNCT
ajmpe-90	1	28	mail	mail	NOUN
ajmpe-90	1	29	:	:	PUNCT
ajmpe-90	1	30	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-90	2	1	25	25	NUM
ajmpe-90	3	1	|	|	ADV
ajmpe-90	3	2	a	a	DET
ajmpe-90	3	3	m	m	NOUN
ajmpe-90	3	4	e	e	NOUN
ajmpe-90	3	5	r	r	NOUN
ajmpe-90	4	1	i	i	NOUN
ajmpe-90	4	2	c	c	VERB
ajmpe-90	4	3	a	a	DET
ajmpe-90	4	4	n	n	NOUN
ajmpe-90	5	1	j	j	NOUN
ajmpe-90	5	2	o	o	X
ajmpe-90	5	3	u	u	NOUN
ajmpe-90	5	4	r	r	NOUN
ajmpe-90	5	5	n	n	NOUN
ajmpe-90	5	6	a	a	DET
ajmpe-90	5	7	l	l	NOUN
ajmpe-90	5	8	o	o	X
ajmpe-90	6	1	f	f	X
ajmpe-90	6	2	m	m	NOUN
ajmpe-90	6	3	e	e	NOUN
ajmpe-90	7	1	d	d	NOUN
ajmpe-90	7	2	i	i	PRON
ajmpe-90	7	3	c	c	VERB
ajmpe-90	7	4	a	a	DET
ajmpe-90	7	5	l	l	NOUN
ajmpe-90	7	6	a	a	X
ajmpe-90	7	7	n	n	NOUN
ajmpe-90	8	1	d	d	NOUN
ajmpe-90	8	2	p	p	NOUN
ajmpe-90	8	3	h	h	NOUN
ajmpe-90	8	4	y	y	NOUN
ajmpe-90	8	5	s	s	VERB
ajmpe-90	9	1	i	i	INTJ
ajmpe-90	9	2	c	c	VERB
ajmpe-90	9	3	a	a	DET
ajmpe-90	9	4	l	l	NOUN
ajmpe-90	9	5	e	e	NOUN
ajmpe-90	9	6	d	d	X
ajmpe-90	9	7	u	u	X
ajmpe-90	9	8	c	c	PROPN
ajmpe-90	10	1	a	a	DET
ajmpe-90	10	2	t	t	NOUN
ajmpe-90	11	1	i	i	PRON
ajmpe-90	11	2	o	o	VERB
ajmpe-90	11	3	n	n	CCONJ
ajmpe-90	11	4	|	|	ADV
ajmpe-90	11	5	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	NUM
ajmpe-90	11	6	thyroid	thyroid	NOUN
ajmpe-90	11	7	function	function	NOUN
ajmpe-90	11	8	test	test	NOUN
ajmpe-90	11	9	evaluation	evaluation	NOUN
ajmpe-90	11	10	in	in	ADP
ajmpe-90	11	11	prostate	prostate	NOUN
ajmpe-90	11	12	cancer	cancer	NOUN
ajmpe-90	11	13	patients	patient	NOUN
ajmpe-90	11	14	in	in	ADP
ajmpe-90	11	15	khartoum	khartoum	PROPN
ajmpe-90	11	16	state	state	PROPN
ajmpe-90	11	17	abdallah	abdallah	PROPN
ajmpe-90	11	18	e.	e.	PROPN
ajmpe-90	11	19	ali1	ali1	PROPN
ajmpe-90	11	20	,	,	PUNCT
ajmpe-90	11	21	sejood	sejood	PROPN
ajmpe-90	11	22	e.	e.	PROPN
ajmpe-90	11	23	m.	m.	PROPN
ajmpe-90	11	24	abdalla1	abdalla1	PROPN
ajmpe-90	11	25	,	,	PUNCT
ajmpe-90	12	1	ibrahim	ibrahim	PROPN
ajmpe-90	12	2	a.	a.	PROPN
ajmpe-90	12	3	a.	a.	PROPN
ajmpe-90	12	4	karti	karti	PROPN
ajmpe-90	12	5	2	2	PROPN
ajmpe-90	12	6	and	and	CCONJ
ajmpe-90	12	7	haidar	haidar	PROPN
ajmpe-90	12	8	e.	e.	PROPN
ajmpe-90	12	9	saleh3	saleh3	PROPN
ajmpe-90	13	1	1university	1university	NUM
ajmpe-90	13	2	of	of	ADP
ajmpe-90	13	3	alzaeim	alzaeim	PROPN
ajmpe-90	13	4	al	al	PROPN
ajmpe-90	13	5	azhari	azhari	PROPN
ajmpe-90	13	6	faculty	faculty	NOUN
ajmpe-90	13	7	of	of	ADP
ajmpe-90	13	8	medical	medical	ADJ
ajmpe-90	13	9	laboratory	laboratory	NOUN
ajmpe-90	13	10	sciences	sciences	PROPN
ajmpe-90	13	11	,	,	PUNCT
ajmpe-90	13	12	department	department	NOUN
ajmpe-90	13	13	of	of	ADP
ajmpe-90	13	14	clinical	clinical	ADJ
ajmpe-90	13	15	chemistry	chemistry	NOUN
ajmpe-90	13	16	2alofoug	2alofoug	NUM
ajmpe-90	13	17	college	college	PROPN
ajmpe-90	13	18	of	of	ADP
ajmpe-90	13	19	science	science	PROPN
ajmpe-90	13	20	&	&	CCONJ
ajmpe-90	13	21	technology	technology	NOUN
ajmpe-90	13	22	,	,	PUNCT
ajmpe-90	13	23	program	program	NOUN
ajmpe-90	13	24	of	of	ADP
ajmpe-90	13	25	medicine	medicine	NOUN
ajmpe-90	13	26	,	,	PUNCT
ajmpe-90	13	27	khartoum	khartoum	PROPN
ajmpe-90	13	28	,	,	PUNCT
ajmpe-90	13	29	sudan	sudan	PROPN
ajmpe-90	13	30	.	.	PUNCT
ajmpe-90	14	1	3miami	3miami	NUM
ajmpe-90	14	2	university	university	NOUN
ajmpe-90	14	3	,	,	PUNCT
ajmpe-90	14	4	sylvester	sylvest	ADJ
ajmpe-90	14	5	comprehensive	comprehensive	ADJ
ajmpe-90	14	6	cancer	cancer	NOUN
ajmpe-90	14	7	center	center	NOUN
ajmpe-90	14	8	(	(	PUNCT
ajmpe-90	14	9	sccc	sccc	NOUN
ajmpe-90	14	10	)	)	PUNCT
ajmpe-90	14	11	clinical	clinical	ADJ
ajmpe-90	14	12	research	research	NOUN
ajmpe-90	14	13	laboratory	laboratory	PROPN
ajmpe-90	14	14	services	services	PROPN
ajmpe-90	14	15	miami	miami	PROPN
ajmpe-90	14	16	fl33136	fl33136	PROPN
ajmpe-90	14	17	usa	usa	PROPN
ajmpe-90	14	18	abstract	abstract	NOUN
ajmpe-90	14	19	:	:	PUNCT
ajmpe-90	14	20	introduction	introduction	NOUN
ajmpe-90	14	21	:	:	PUNCT
ajmpe-90	14	22	thyroid	thyroid	NOUN
ajmpe-90	14	23	hormones	hormone	NOUN
ajmpe-90	14	24	(	(	PUNCT
ajmpe-90	14	25	th	th	X
ajmpe-90	14	26	)	)	PUNCT
ajmpe-90	14	27	are	be	AUX
ajmpe-90	14	28	key	key	ADJ
ajmpe-90	14	29	regulators	regulator	NOUN
ajmpe-90	14	30	of	of	ADP
ajmpe-90	14	31	essential	essential	ADJ
ajmpe-90	14	32	cellular	cellular	ADJ
ajmpe-90	14	33	processes	process	NOUN
ajmpe-90	14	34	,	,	PUNCT
ajmpe-90	14	35	including	include	VERB
ajmpe-90	14	36	proliferation	proliferation	NOUN
ajmpe-90	14	37	,	,	PUNCT
ajmpe-90	14	38	differentiation	differentiation	NOUN
ajmpe-90	14	39	,	,	PUNCT
ajmpe-90	14	40	apoptosis	apoptosis	NOUN
ajmpe-90	14	41	,	,	PUNCT
ajmpe-90	14	42	and	and	CCONJ
ajmpe-90	14	43	metabolism	metabolism	NOUN
ajmpe-90	14	44	.	.	PUNCT
ajmpe-90	15	1	thyroid	thyroid	NOUN
ajmpe-90	15	2	hormones	hormone	NOUN
ajmpe-90	15	3	have	have	VERB
ajmpe-90	15	4	an	an	DET
ajmpe-90	15	5	important	important	ADJ
ajmpe-90	15	6	role	role	NOUN
ajmpe-90	15	7	in	in	ADP
ajmpe-90	15	8	the	the	DET
ajmpe-90	15	9	development	development	NOUN
ajmpe-90	15	10	of	of	ADP
ajmpe-90	15	11	prostate	prostate	NOUN
ajmpe-90	15	12	cancer	cancer	NOUN
ajmpe-90	15	13	.	.	PUNCT
ajmpe-90	16	1	so	so	ADV
ajmpe-90	16	2	this	this	DET
ajmpe-90	16	3	study	study	NOUN
ajmpe-90	16	4	aims	aim	VERB
ajmpe-90	16	5	to	to	PART
ajmpe-90	16	6	assess	assess	VERB
ajmpe-90	16	7	thyroid	thyroid	NOUN
ajmpe-90	16	8	function	function	NOUN
ajmpe-90	16	9	tests	test	NOUN
ajmpe-90	16	10	among	among	ADP
ajmpe-90	16	11	prostatic	prostatic	ADJ
ajmpe-90	16	12	cancer	cancer	NOUN
ajmpe-90	16	13	patients	patient	NOUN
ajmpe-90	16	14	.	.	PUNCT
ajmpe-90	17	1	methods	method	NOUN
ajmpe-90	17	2	:	:	PUNCT
ajmpe-90	17	3	total	total	ADJ
ajmpe-90	17	4	group	group	PROPN
ajmpe-90	17	5	study100	study100	PROPN
ajmpe-90	17	6	,	,	PUNCT
ajmpe-90	17	7	fifty	fifty	NUM
ajmpe-90	17	8	prostatic	prostatic	ADJ
ajmpe-90	17	9	cancer	cancer	NOUN
ajmpe-90	17	10	patients	patient	NOUN
ajmpe-90	17	11	as	as	ADP
ajmpe-90	17	12	a	a	DET
ajmpe-90	17	13	case	case	NOUN
ajmpe-90	17	14	study	study	NOUN
ajmpe-90	17	15	and	and	CCONJ
ajmpe-90	17	16	50	50	NUM
ajmpe-90	17	17	healthy	healthy	ADJ
ajmpe-90	17	18	men	man	NOUN
ajmpe-90	17	19	as	as	ADP
ajmpe-90	17	20	the	the	DET
ajmpe-90	17	21	control	control	NOUN
ajmpe-90	17	22	group	group	NOUN
ajmpe-90	17	23	,	,	PUNCT
ajmpe-90	17	24	blood	blood	NOUN
ajmpe-90	17	25	samples	sample	NOUN
ajmpe-90	17	26	were	be	AUX
ajmpe-90	17	27	collected	collect	VERB
ajmpe-90	17	28	for	for	ADP
ajmpe-90	17	29	measurement	measurement	NOUN
ajmpe-90	17	30	for	for	ADP
ajmpe-90	17	31	thyroid	thyroid	NOUN
ajmpe-90	17	32	function	function	NOUN
ajmpe-90	17	33	test	test	NOUN
ajmpe-90	17	34	and	and	CCONJ
ajmpe-90	17	35	prostate	prostate	NOUN
ajmpe-90	17	36	antigen	antigen	ADV
ajmpe-90	17	37	by	by	ADP
ajmpe-90	17	38	tosoh	tosoh	ADJ
ajmpe-90	17	39	tm	tm	PRON
ajmpe-90	17	40	device	device	NOUN
ajmpe-90	17	41	(	(	PUNCT
ajmpe-90	17	42	china	china	PROPN
ajmpe-90	17	43	)	)	PUNCT
ajmpe-90	17	44	and	and	CCONJ
ajmpe-90	17	45	enzyme	enzyme	NOUN
ajmpe-90	17	46	-	-	PUNCT
ajmpe-90	17	47	linked	link	VERB
ajmpe-90	17	48	immune	immune	ADJ
ajmpe-90	17	49	sorbent	sorbent	NOUN
ajmpe-90	17	50	assay	assay	NOUN
ajmpe-90	17	51	(	(	PUNCT
ajmpe-90	17	52	elisa	elisa	NOUN
ajmpe-90	17	53	)	)	PUNCT
ajmpe-90	17	54	fortress	fortress	NOUN
ajmpe-90	17	55	tm	tm	PROPN
ajmpe-90	17	56	.	.	PROPN
ajmpe-90	17	57	results	result	NOUN
ajmpe-90	17	58	:	:	PUNCT
ajmpe-90	17	59	statistical	statistical	ADJ
ajmpe-90	17	60	analysis	analysis	NOUN
ajmpe-90	17	61	of	of	ADP
ajmpe-90	17	62	test	test	NOUN
ajmpe-90	17	63	results	result	NOUN
ajmpe-90	17	64	of	of	ADP
ajmpe-90	17	65	the	the	DET
ajmpe-90	17	66	case	case	NOUN
ajmpe-90	17	67	study	study	NOUN
ajmpe-90	17	68	:	:	PUNCT
ajmpe-90	17	69	the	the	DET
ajmpe-90	17	70	mean	mean	NOUN
ajmpe-90	17	71	and	and	CCONJ
ajmpe-90	17	72	sd±	sd±	ADJ
ajmpe-90	17	73	psa=	psa=	NOUN
ajmpe-90	17	74	(	(	PUNCT
ajmpe-90	17	75	31.8	31.8	NUM
ajmpe-90	17	76	±	±	NUM
ajmpe-90	17	77	12.5	12.5	NUM
ajmpe-90	17	78	)	)	PUNCT
ajmpe-90	17	79	,	,	PUNCT
ajmpe-90	17	80	t3	t3	NOUN
ajmpe-90	17	81	=	=	PUNCT
ajmpe-90	17	82	(	(	PUNCT
ajmpe-90	17	83	3.3	3.3	NUM
ajmpe-90	17	84	±	±	NUM
ajmpe-90	17	85	1.3	1.3	NUM
ajmpe-90	17	86	)	)	PUNCT
ajmpe-90	17	87	,	,	PUNCT
ajmpe-90	17	88	t4	t4	PROPN
ajmpe-90	17	89	=	=	PROPN
ajmpe-90	17	90	(	(	PUNCT
ajmpe-90	17	91	119.58	119.58	NUM
ajmpe-90	17	92	±	±	NUM
ajmpe-90	17	93	46.21	46.21	NUM
ajmpe-90	17	94	)	)	PUNCT
ajmpe-90	17	95	and	and	CCONJ
ajmpe-90	17	96	tsh	tsh	NOUN
ajmpe-90	17	97	=(	=(	NOUN
ajmpe-90	17	98	4.6	4.6	NUM
ajmpe-90	17	99	±	±	NUM
ajmpe-90	17	100	3.4	3.4	NUM
ajmpe-90	17	101	)	)	PUNCT
ajmpe-90	17	102	.	.	PUNCT
ajmpe-90	18	1	for	for	ADP
ajmpe-90	18	2	each	each	DET
ajmpe-90	18	3	p	p	NOUN
ajmpe-90	18	4	-	-	PUNCT
ajmpe-90	18	5	value	value	NOUN
ajmpe-90	18	6	0.0001	0.0001	NUM
ajmpe-90	18	7	when	when	SCONJ
ajmpe-90	18	8	compared	compare	VERB
ajmpe-90	18	9	to	to	ADP
ajmpe-90	18	10	the	the	DET
ajmpe-90	18	11	control	control	NOUN
ajmpe-90	18	12	group	group	NOUN
ajmpe-90	18	13	,	,	PUNCT
ajmpe-90	18	14	the	the	DET
ajmpe-90	18	15	frequency	frequency	NOUN
ajmpe-90	18	16	of	of	ADP
ajmpe-90	18	17	thyroid	thyroid	NOUN
ajmpe-90	18	18	disorders	disorder	NOUN
ajmpe-90	18	19	among	among	ADP
ajmpe-90	18	20	case	case	NOUN
ajmpe-90	18	21	study	study	NOUN
ajmpe-90	18	22	participants	participant	NOUN
ajmpe-90	18	23	is	be	AUX
ajmpe-90	18	24	hyperthyroidism	hyperthyroidism	NOUN
ajmpe-90	18	25	(	(	PUNCT
ajmpe-90	18	26	33	33	NUM
ajmpe-90	18	27	=	=	SYM
ajmpe-90	18	28	66	66	NUM
ajmpe-90	18	29	%	%	NOUN
ajmpe-90	18	30	)	)	PUNCT
ajmpe-90	18	31	,	,	PUNCT
ajmpe-90	18	32	normal	normal	ADJ
ajmpe-90	18	33	(	(	PUNCT
ajmpe-90	18	34	14	14	NUM
ajmpe-90	18	35	=	=	SYM
ajmpe-90	18	36	28	28	NUM
ajmpe-90	18	37	%	%	NOUN
ajmpe-90	18	38	)	)	PUNCT
ajmpe-90	18	39	,	,	PUNCT
ajmpe-90	18	40	and	and	CCONJ
ajmpe-90	18	41	hypothyroidism	hypothyroidism	NOUN
ajmpe-90	18	42	(	(	PUNCT
ajmpe-90	18	43	3	3	NUM
ajmpe-90	18	44	=	=	SYM
ajmpe-90	18	45	6	6	NUM
ajmpe-90	18	46	%	%	NOUN
ajmpe-90	18	47	)	)	PUNCT
ajmpe-90	18	48	.	.	PUNCT
ajmpe-90	19	1	conclusion	conclusion	NOUN
ajmpe-90	19	2	:	:	PUNCT
ajmpe-90	19	3	hyperthyroidism	hyperthyroidism	NOUN
ajmpe-90	19	4	is	be	AUX
ajmpe-90	19	5	the	the	DET
ajmpe-90	19	6	most	most	ADV
ajmpe-90	19	7	common	common	ADJ
ajmpe-90	19	8	thyroid	thyroid	NOUN
ajmpe-90	19	9	disorder	disorder	NOUN
ajmpe-90	19	10	among	among	ADP
ajmpe-90	19	11	patients	patient	NOUN
ajmpe-90	19	12	with	with	ADP
ajmpe-90	19	13	prostatic	prostatic	ADJ
ajmpe-90	19	14	cancer	cancer	NOUN
ajmpe-90	19	15	.	.	PUNCT
ajmpe-90	20	1	keywords	keyword	NOUN
ajmpe-90	20	2	:	:	PUNCT
ajmpe-90	20	3	prostate	prostate	NOUN
ajmpe-90	20	4	cancer	cancer	NOUN
ajmpe-90	20	5	,	,	PUNCT
ajmpe-90	20	6	thyroid	thyroid	NOUN
ajmpe-90	20	7	hormones	hormone	NOUN
ajmpe-90	20	8	,	,	PUNCT
ajmpe-90	20	9	t3	t3	PROPN
ajmpe-90	20	10	,	,	PUNCT
ajmpe-90	20	11	t4	t4	PROPN
ajmpe-90	20	12	,	,	PUNCT
ajmpe-90	20	13	tsh	tsh	NOUN
ajmpe-90	20	14	,	,	PUNCT
ajmpe-90	20	15	and	and	CCONJ
ajmpe-90	20	16	prostate	prostate	NOUN
ajmpe-90	20	17	antigen	antigen	ADJ
ajmpe-90	20	18	.	.	PUNCT
ajmpe-90	21	1	introduction	introduction	NOUN
ajmpe-90	21	2	prostate	prostate	NOUN
ajmpe-90	21	3	cancer	cancer	NOUN
ajmpe-90	21	4	develops	develop	VERB
ajmpe-90	21	5	when	when	SCONJ
ajmpe-90	21	6	the	the	DET
ajmpe-90	21	7	rates	rate	NOUN
ajmpe-90	21	8	of	of	ADP
ajmpe-90	21	9	cell	cell	NOUN
ajmpe-90	21	10	division	division	NOUN
ajmpe-90	21	11	exceed	exceed	VERB
ajmpe-90	21	12	those	those	PRON
ajmpe-90	21	13	of	of	ADP
ajmpe-90	21	14	cell	cell	NOUN
ajmpe-90	21	15	death	death	NOUN
ajmpe-90	21	16	,	,	PUNCT
ajmpe-90	21	17	leading	lead	VERB
ajmpe-90	21	18	to	to	ADP
ajmpe-90	21	19	uncontrolled	uncontrolled	ADJ
ajmpe-90	21	20	tumor	tumor	NOUN
ajmpe-90	21	21	growth	growth	NOUN
ajmpe-90	21	22	.	.	PUNCT
ajmpe-90	22	1	following	follow	VERB
ajmpe-90	22	2	the	the	DET
ajmpe-90	22	3	initial	initial	ADJ
ajmpe-90	22	4	transformation	transformation	NOUN
ajmpe-90	22	5	event	event	NOUN
ajmpe-90	22	6	,	,	PUNCT
ajmpe-90	22	7	further	further	ADJ
ajmpe-90	22	8	mutations	mutation	NOUN
ajmpe-90	22	9	of	of	ADP
ajmpe-90	22	10	a	a	DET
ajmpe-90	22	11	multitude	multitude	NOUN
ajmpe-90	22	12	of	of	ADP
ajmpe-90	22	13	genes	gene	NOUN
ajmpe-90	22	14	,	,	PUNCT
ajmpe-90	22	15	including	include	VERB
ajmpe-90	22	16	the	the	DET
ajmpe-90	22	17	genes	gene	NOUN
ajmpe-90	22	18	for	for	ADP
ajmpe-90	22	19	retinoblastoma	retinoblastoma	NOUN
ajmpe-90	22	20	,	,	PUNCT
ajmpe-90	22	21	can	can	AUX
ajmpe-90	22	22	lead	lead	VERB
ajmpe-90	22	23	to	to	ADP
ajmpe-90	22	24	tumor	tumor	NOUN
ajmpe-90	22	25	progression	progression	NOUN
ajmpe-90	22	26	and	and	CCONJ
ajmpe-90	22	27	metastasis	metastasis	NOUN
ajmpe-90	22	28	.	.	PUNCT
ajmpe-90	23	1	most	most	ADJ
ajmpe-90	23	2	prostate	prostate	NOUN
ajmpe-90	23	3	cancers	cancer	NOUN
ajmpe-90	23	4	are	be	AUX
ajmpe-90	23	5	adenocarcinomas	adenocarcinoma	NOUN
ajmpe-90	24	1	[	[	X
ajmpe-90	24	2	1,2,3	1,2,3	NUM
ajmpe-90	24	3	]	]	PUNCT
ajmpe-90	24	4	.	.	PUNCT
ajmpe-90	25	1	triiodothyronine	triiodothyronine	PROPN
ajmpe-90	25	2	(	(	PUNCT
ajmpe-90	25	3	t3	t3	PROPN
ajmpe-90	25	4	)	)	PUNCT
ajmpe-90	25	5	and	and	CCONJ
ajmpe-90	25	6	its	its	PRON
ajmpe-90	25	7	prohormone	prohormone	NOUN
ajmpe-90	25	8	thyroxine	thyroxine	NOUN
ajmpe-90	25	9	(	(	PUNCT
ajmpe-90	25	10	t4	t4	PROPN
ajmpe-90	25	11	)	)	PUNCT
ajmpe-90	25	12	are	be	AUX
ajmpe-90	25	13	hypothesized	hypothesize	VERB
ajmpe-90	25	14	to	to	PART
ajmpe-90	25	15	promote	promote	VERB
ajmpe-90	25	16	carcinogenesis	carcinogenesis	NOUN
ajmpe-90	25	17	through	through	ADP
ajmpe-90	25	18	their	their	PRON
ajmpe-90	25	19	important	important	ADJ
ajmpe-90	25	20	roles	role	NOUN
ajmpe-90	25	21	in	in	ADP
ajmpe-90	25	22	cell	cell	NOUN
ajmpe-90	25	23	differentiation	differentiation	NOUN
ajmpe-90	25	24	,	,	PUNCT
ajmpe-90	25	25	growth	growth	NOUN
ajmpe-90	25	26	,	,	PUNCT
ajmpe-90	25	27	and	and	CCONJ
ajmpe-90	25	28	metabolism	metabolism	NOUN
ajmpe-90	26	1	[	[	X
ajmpe-90	26	2	4	4	NUM
ajmpe-90	26	3	]	]	PUNCT
ajmpe-90	26	4	.	.	PUNCT
ajmpe-90	27	1	the	the	DET
ajmpe-90	27	2	hormones	hormone	NOUN
ajmpe-90	27	3	also	also	ADV
ajmpe-90	27	4	promote	promote	VERB
ajmpe-90	27	5	tumor	tumor	NOUN
ajmpe-90	27	6	-	-	PUNCT
ajmpe-90	27	7	induced	induce	VERB
ajmpe-90	27	8	angiogenesis	angiogenesis	NOUN
ajmpe-90	27	9	[	[	X
ajmpe-90	27	10	5	5	NUM
ajmpe-90	27	11	]	]	PUNCT
ajmpe-90	27	12	,	,	PUNCT
ajmpe-90	27	13	and	and	CCONJ
ajmpe-90	27	14	have	have	AUX
ajmpe-90	27	15	been	be	AUX
ajmpe-90	27	16	shown	show	VERB
ajmpe-90	27	17	to	to	PART
ajmpe-90	27	18	increase	increase	VERB
ajmpe-90	27	19	prostate	prostate	NOUN
ajmpe-90	27	20	cancer	cancer	NOUN
ajmpe-90	27	21	cell	cell	NOUN
ajmpe-90	27	22	proliferation	proliferation	NOUN
ajmpe-90	27	23	in	in	ADP
ajmpe-90	27	24	vitro	vitro	X
ajmpe-90	28	1	[	[	PUNCT
ajmpe-90	28	2	6,7	6,7	NUM
ajmpe-90	28	3	]	]	PUNCT
ajmpe-90	28	4	.	.	PUNCT
ajmpe-90	29	1	thyroid	thyroid	NOUN
ajmpe-90	29	2	-	-	PUNCT
ajmpe-90	29	3	stimulating	stimulate	VERB
ajmpe-90	29	4	hormone	hormone	NOUN
ajmpe-90	29	5	(	(	PUNCT
ajmpe-90	29	6	tsh	tsh	NOUN
ajmpe-90	29	7	)	)	PUNCT
ajmpe-90	29	8	is	be	AUX
ajmpe-90	29	9	produced	produce	VERB
ajmpe-90	29	10	by	by	ADP
ajmpe-90	29	11	the	the	DET
ajmpe-90	29	12	anterior	anterior	ADJ
ajmpe-90	29	13	pituitary	pituitary	ADJ
ajmpe-90	29	14	gland	gland	NOUN
ajmpe-90	29	15	to	to	PART
ajmpe-90	29	16	regulate	regulate	VERB
ajmpe-90	29	17	t4	t4	PROPN
ajmpe-90	29	18	secretion	secretion	NOUN
ajmpe-90	29	19	from	from	ADP
ajmpe-90	29	20	the	the	DET
ajmpe-90	29	21	thyroid	thyroid	NOUN
ajmpe-90	29	22	and	and	CCONJ
ajmpe-90	29	23	is	be	AUX
ajmpe-90	29	24	an	an	DET
ajmpe-90	29	25	important	important	ADJ
ajmpe-90	29	26	laboratory	laboratory	NOUN
ajmpe-90	29	27	measure	measure	NOUN
ajmpe-90	29	28	for	for	ADP
ajmpe-90	29	29	determining	determine	VERB
ajmpe-90	29	30	thyroid	thyroid	NOUN
ajmpe-90	29	31	status	status	NOUN
ajmpe-90	29	32	[	[	X
ajmpe-90	29	33	8	8	NUM
ajmpe-90	29	34	]	]	PUNCT
ajmpe-90	29	35	.	.	PUNCT
ajmpe-90	30	1	in	in	ADP
ajmpe-90	30	2	individuals	individual	NOUN
ajmpe-90	30	3	with	with	ADP
ajmpe-90	30	4	normal	normal	ADJ
ajmpe-90	30	5	thyroid	thyroid	NOUN
ajmpe-90	30	6	function	function	NOUN
ajmpe-90	30	7	,	,	PUNCT
ajmpe-90	30	8	t4	t4	PROPN
ajmpe-90	30	9	and	and	CCONJ
ajmpe-90	30	10	tsh	tsh	PROPN
ajmpe-90	30	11	act	act	NOUN
ajmpe-90	30	12	in	in	ADP
ajmpe-90	30	13	a	a	DET
ajmpe-90	30	14	negative	negative	ADJ
ajmpe-90	30	15	feedback	feedback	NOUN
ajmpe-90	30	16	loop	loop	NOUN
ajmpe-90	30	17	[	[	X
ajmpe-90	30	18	5	5	NUM
ajmpe-90	30	19	]	]	PUNCT
ajmpe-90	30	20	;	;	PUNCT
ajmpe-90	30	21	thus	thus	ADV
ajmpe-90	30	22	,	,	PUNCT
ajmpe-90	30	23	a	a	DET
ajmpe-90	30	24	hypothyroid	hypothyroid	ADJ
ajmpe-90	30	25	state	state	NOUN
ajmpe-90	30	26	is	be	AUX
ajmpe-90	30	27	defined	define	VERB
ajmpe-90	30	28	as	as	ADP
ajmpe-90	30	29	having	have	VERB
ajmpe-90	30	30	low	low	ADJ
ajmpe-90	30	31	t4	t4	PROPN
ajmpe-90	30	32	but	but	CCONJ
ajmpe-90	30	33	high	high	ADJ
ajmpe-90	30	34	tsh	tsh	NOUN
ajmpe-90	30	35	,	,	PUNCT
ajmpe-90	30	36	and	and	CCONJ
ajmpe-90	30	37	hyperthyroid	hyperthyroid	NOUN
ajmpe-90	30	38	status	status	NOUN
ajmpe-90	30	39	is	be	AUX
ajmpe-90	30	40	defined	define	VERB
ajmpe-90	30	41	as	as	ADP
ajmpe-90	30	42	having	have	VERB
ajmpe-90	30	43	high	high	ADJ
ajmpe-90	30	44	t4	t4	PROPN
ajmpe-90	30	45	but	but	CCONJ
ajmpe-90	30	46	low	low	ADJ
ajmpe-90	30	47	tsh	tsh	NOUN
ajmpe-90	31	1	[	[	X
ajmpe-90	31	2	9	9	NUM
ajmpe-90	31	3	]	]	PUNCT
ajmpe-90	31	4	.	.	PUNCT
ajmpe-90	32	1	it	it	PRON
ajmpe-90	32	2	is	be	AUX
ajmpe-90	32	3	hypothesized	hypothesize	VERB
ajmpe-90	32	4	that	that	SCONJ
ajmpe-90	32	5	hypothyroid	hypothyroid	ADJ
ajmpe-90	32	6	men	man	NOUN
ajmpe-90	32	7	may	may	AUX
ajmpe-90	32	8	be	be	AUX
ajmpe-90	32	9	at	at	ADP
ajmpe-90	32	10	a	a	DET
ajmpe-90	32	11	decreased	decrease	VERB
ajmpe-90	32	12	risk	risk	NOUN
ajmpe-90	32	13	of	of	ADP
ajmpe-90	32	14	prostate	prostate	NOUN
ajmpe-90	32	15	cancer	cancer	NOUN
ajmpe-90	32	16	,	,	PUNCT
ajmpe-90	32	17	whereas	whereas	SCONJ
ajmpe-90	32	18	hyperthyroid	hyperthyroid	NOUN
ajmpe-90	32	19	men	man	NOUN
ajmpe-90	32	20	may	may	AUX
ajmpe-90	32	21	have	have	VERB
ajmpe-90	32	22	an	an	DET
ajmpe-90	32	23	increased	increase	VERB
ajmpe-90	32	24	risk	risk	NOUN
ajmpe-90	32	25	.	.	PUNCT
ajmpe-90	33	1	serum	serum	NOUN
ajmpe-90	33	2	prostate	prostate	NOUN
ajmpe-90	33	3	-	-	PUNCT
ajmpe-90	33	4	specific	specific	ADJ
ajmpe-90	33	5	antigen	antigen	NOUN
ajmpe-90	33	6	(	(	PUNCT
ajmpe-90	33	7	psa	psa	NOUN
ajmpe-90	33	8	)	)	PUNCT
ajmpe-90	33	9	measurement	measurement	NOUN
ajmpe-90	33	10	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-90	33	11	american	american	PROPN
ajmpe-90	33	12	journal	journal	PROPN
ajmpe-90	33	13	of	of	ADP
ajmpe-90	33	14	medical	medical	ADJ
ajmpe-90	33	15	and	and	CCONJ
ajmpe-90	33	16	physical	physical	ADJ
ajmpe-90	33	17	education	education	NOUN
ajmpe-90	33	18	vol.1	vol.1	PROPN
ajmpe-90	33	19	,	,	PUNCT
ajmpe-90	33	20	issue	issue	NOUN
ajmpe-90	33	21	1	1	NUM
ajmpe-90	33	22	;	;	PUNCT
ajmpe-90	33	23	july	july	PROPN
ajmpe-90	33	24	2023	2023	NUM
ajmpe-90	33	25	;	;	PUNCT
ajmpe-90	33	26	1252	1252	NUM
ajmpe-90	33	27	columbia	columbia	PROPN
ajmpe-90	33	28	rd	rd	PROPN
ajmpe-90	33	29	nw	nw	PROPN
ajmpe-90	33	30	,	,	PUNCT
ajmpe-90	33	31	washington	washington	PROPN
ajmpe-90	33	32	dc	dc	PROPN
ajmpe-90	33	33	,	,	PUNCT
ajmpe-90	33	34	united	united	PROPN
ajmpe-90	33	35	states	states	PROPN
ajmpe-90	33	36	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-90	33	37	;	;	PUNCT
ajmpe-90	33	38	mail	mail	NOUN
ajmpe-90	33	39	:	:	PUNCT
ajmpe-90	33	40	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-90	34	1	26	26	NUM
ajmpe-90	35	1	|	|	ADV
ajmpe-90	35	2	a	a	DET
ajmpe-90	35	3	m	m	NOUN
ajmpe-90	35	4	e	e	NOUN
ajmpe-90	35	5	r	r	NOUN
ajmpe-90	36	1	i	i	NOUN
ajmpe-90	36	2	c	c	VERB
ajmpe-90	36	3	a	a	DET
ajmpe-90	36	4	n	n	NOUN
ajmpe-90	37	1	j	j	NOUN
ajmpe-90	37	2	o	o	X
ajmpe-90	37	3	u	u	NOUN
ajmpe-90	37	4	r	r	NOUN
ajmpe-90	37	5	n	n	NOUN
ajmpe-90	37	6	a	a	DET
ajmpe-90	37	7	l	l	NOUN
ajmpe-90	37	8	o	o	X
ajmpe-90	38	1	f	f	X
ajmpe-90	38	2	m	m	NOUN
ajmpe-90	38	3	e	e	NOUN
ajmpe-90	39	1	d	d	NOUN
ajmpe-90	39	2	i	i	PRON
ajmpe-90	39	3	c	c	VERB
ajmpe-90	39	4	a	a	DET
ajmpe-90	39	5	l	l	NOUN
ajmpe-90	39	6	a	a	X
ajmpe-90	39	7	n	n	NOUN
ajmpe-90	40	1	d	d	NOUN
ajmpe-90	40	2	p	p	NOUN
ajmpe-90	40	3	h	h	NOUN
ajmpe-90	40	4	y	y	NOUN
ajmpe-90	40	5	s	s	VERB
ajmpe-90	41	1	i	i	INTJ
ajmpe-90	41	2	c	c	VERB
ajmpe-90	41	3	a	a	DET
ajmpe-90	41	4	l	l	NOUN
ajmpe-90	41	5	e	e	NOUN
ajmpe-90	41	6	d	d	X
ajmpe-90	41	7	u	u	X
ajmpe-90	41	8	c	c	PROPN
ajmpe-90	42	1	a	a	DET
ajmpe-90	42	2	t	t	NOUN
ajmpe-90	43	1	i	i	PRON
ajmpe-90	43	2	o	o	VERB
ajmpe-90	44	1	n	n	CCONJ
ajmpe-90	44	2	|	|	ADV
ajmpe-90	44	3	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	NOUN
ajmpe-90	44	4	has	have	AUX
ajmpe-90	44	5	been	be	AUX
ajmpe-90	44	6	widely	widely	ADV
ajmpe-90	44	7	used	use	VERB
ajmpe-90	44	8	in	in	ADP
ajmpe-90	44	9	screening	screen	VERB
ajmpe-90	44	10	(	(	PUNCT
ajmpe-90	44	11	early	early	ADJ
ajmpe-90	44	12	detection	detection	NOUN
ajmpe-90	44	13	)	)	PUNCT
ajmpe-90	44	14	,	,	PUNCT
ajmpe-90	44	15	diagnosis	diagnosis	NOUN
ajmpe-90	44	16	,	,	PUNCT
ajmpe-90	44	17	and	and	CCONJ
ajmpe-90	44	18	monitoring	monitor	VERB
ajmpe-90	44	19	treatment	treatment	NOUN
ajmpe-90	44	20	response	response	NOUN
ajmpe-90	44	21	in	in	ADP
ajmpe-90	44	22	various	various	ADJ
ajmpe-90	44	23	stages	stage	NOUN
ajmpe-90	44	24	of	of	ADP
ajmpe-90	44	25	prostate	prostate	NOUN
ajmpe-90	44	26	cancer	cancer	NOUN
ajmpe-90	44	27	(	(	PUNCT
ajmpe-90	44	28	pca	pca	PROPN
ajmpe-90	44	29	)	)	PUNCT
ajmpe-90	45	1	[	[	X
ajmpe-90	45	2	4	4	NUM
ajmpe-90	45	3	]	]	PUNCT
ajmpe-90	45	4	.	.	PUNCT
ajmpe-90	46	1	a	a	DET
ajmpe-90	46	2	major	major	ADJ
ajmpe-90	46	3	disadvantage	disadvantage	NOUN
ajmpe-90	46	4	of	of	ADP
ajmpe-90	46	5	psa	psa	NOUN
ajmpe-90	46	6	-	-	PUNCT
ajmpe-90	46	7	based	base	VERB
ajmpe-90	46	8	pca	pca	NOUN
ajmpe-90	46	9	detection	detection	NOUN
ajmpe-90	46	10	is	be	AUX
ajmpe-90	46	11	the	the	DET
ajmpe-90	46	12	considerable	considerable	ADJ
ajmpe-90	46	13	number	number	NOUN
ajmpe-90	46	14	of	of	ADP
ajmpe-90	46	15	false	false	ADJ
ajmpe-90	46	16	positive	positive	ADJ
ajmpe-90	46	17	results	result	NOUN
ajmpe-90	46	18	that	that	PRON
ajmpe-90	46	19	occur	occur	VERB
ajmpe-90	46	20	;	;	PUNCT
ajmpe-90	46	21	many	many	ADJ
ajmpe-90	46	22	patients	patient	NOUN
ajmpe-90	46	23	undergo	undergo	VERB
ajmpe-90	46	24	unnecessary	unnecessary	ADJ
ajmpe-90	46	25	prostate	prostate	NOUN
ajmpe-90	46	26	biopsy	biopsy	NOUN
ajmpe-90	46	27	procedures	procedure	NOUN
ajmpe-90	46	28	due	due	ADP
ajmpe-90	46	29	to	to	ADP
ajmpe-90	46	30	the	the	DET
ajmpe-90	46	31	false	false	ADJ
ajmpe-90	46	32	positive	positive	ADJ
ajmpe-90	46	33	elevation	elevation	NOUN
ajmpe-90	46	34	in	in	ADP
ajmpe-90	46	35	the	the	DET
ajmpe-90	46	36	serum	serum	NOUN
ajmpe-90	46	37	psa	psa	NOUN
ajmpe-90	46	38	level	level	NOUN
ajmpe-90	46	39	.	.	PUNCT
ajmpe-90	47	1	various	various	ADJ
ajmpe-90	47	2	diagnostic	diagnostic	ADJ
ajmpe-90	47	3	and	and	CCONJ
ajmpe-90	47	4	therapeutic	therapeutic	ADJ
ajmpe-90	47	5	procedures	procedure	NOUN
ajmpe-90	47	6	,	,	PUNCT
ajmpe-90	47	7	as	as	ADV
ajmpe-90	47	8	well	well	ADV
ajmpe-90	47	9	as	as	ADP
ajmpe-90	47	10	benign	benign	ADJ
ajmpe-90	47	11	and	and	CCONJ
ajmpe-90	47	12	physiologic	physiologic	ADJ
ajmpe-90	47	13	conditions	condition	NOUN
ajmpe-90	47	14	,	,	PUNCT
ajmpe-90	47	15	have	have	AUX
ajmpe-90	47	16	been	be	AUX
ajmpe-90	47	17	shown	show	VERB
ajmpe-90	47	18	to	to	PART
ajmpe-90	47	19	increase	increase	VERB
ajmpe-90	47	20	serum	serum	NOUN
ajmpe-90	47	21	psa	psa	NOUN
ajmpe-90	47	22	concentrations	concentration	NOUN
ajmpe-90	47	23	(	(	PUNCT
ajmpe-90	47	24	2	2	NUM
ajmpe-90	47	25	-	-	SYM
ajmpe-90	47	26	7	7	NUM
ajmpe-90	47	27	)	)	PUNCT
ajmpe-90	48	1	[	[	X
ajmpe-90	48	2	10	10	NUM
ajmpe-90	48	3	]	]	PUNCT
ajmpe-90	48	4	.	.	PUNCT
ajmpe-90	49	1	the	the	DET
ajmpe-90	49	2	close	close	ADJ
ajmpe-90	49	3	relationship	relationship	NOUN
ajmpe-90	49	4	between	between	ADP
ajmpe-90	49	5	the	the	DET
ajmpe-90	49	6	prostate	prostate	NOUN
ajmpe-90	49	7	and	and	CCONJ
ajmpe-90	49	8	thyroid	thyroid	NOUN
ajmpe-90	49	9	gland	gland	NOUN
ajmpe-90	49	10	although	although	SCONJ
ajmpe-90	49	11	it	it	PRON
ajmpe-90	49	12	is	be	AUX
ajmpe-90	49	13	very	very	ADV
ajmpe-90	49	14	well	well	ADV
ajmpe-90	49	15	known	know	VERB
ajmpe-90	49	16	that	that	SCONJ
ajmpe-90	49	17	thyroid	thyroid	NOUN
ajmpe-90	49	18	hormone	hormone	NOUN
ajmpe-90	49	19	regulates	regulate	VERB
ajmpe-90	49	20	thyrotropin	thyrotropin	NOUN
ajmpe-90	49	21	-	-	PUNCT
ajmpe-90	49	22	releasing	release	VERB
ajmpe-90	49	23	hormone	hormone	NOUN
ajmpe-90	49	24	levels	level	NOUN
ajmpe-90	49	25	in	in	ADP
ajmpe-90	49	26	the	the	DET
ajmpe-90	49	27	male	male	ADJ
ajmpe-90	49	28	reproductive	reproductive	ADJ
ajmpe-90	49	29	system	system	NOUN
ajmpe-90	49	30	,	,	PUNCT
ajmpe-90	49	31	including	include	VERB
ajmpe-90	49	32	the	the	DET
ajmpe-90	49	33	prostate	prostate	NOUN
ajmpe-90	49	34	,	,	PUNCT
ajmpe-90	49	35	the	the	DET
ajmpe-90	49	36	direct	direct	ADJ
ajmpe-90	49	37	effect	effect	NOUN
ajmpe-90	49	38	of	of	ADP
ajmpe-90	49	39	thyroid	thyroid	NOUN
ajmpe-90	49	40	hormones	hormone	NOUN
ajmpe-90	49	41	on	on	ADP
ajmpe-90	49	42	the	the	DET
ajmpe-90	49	43	prostate	prostate	NOUN
ajmpe-90	49	44	is	be	AUX
ajmpe-90	49	45	still	still	ADV
ajmpe-90	49	46	unclear	unclear	ADJ
ajmpe-90	49	47	.	.	PUNCT
ajmpe-90	50	1	evaluated	evaluate	VERB
ajmpe-90	50	2	the	the	DET
ajmpe-90	50	3	relationship	relationship	NOUN
ajmpe-90	50	4	between	between	ADP
ajmpe-90	50	5	serum	serum	NOUN
ajmpe-90	50	6	t3	t3	PROPN
ajmpe-90	50	7	levels	level	NOUN
ajmpe-90	50	8	and	and	CCONJ
ajmpe-90	50	9	risk	risk	NOUN
ajmpe-90	50	10	of	of	ADP
ajmpe-90	50	11	recurrence	recurrence	NOUN
ajmpe-90	50	12	in	in	ADP
ajmpe-90	50	13	patients	patient	NOUN
ajmpe-90	50	14	treated	treat	VERB
ajmpe-90	50	15	for	for	ADP
ajmpe-90	50	16	localized	localized	ADJ
ajmpe-90	50	17	prostate	prostate	NOUN
ajmpe-90	50	18	cancer[11	cancer[11	NOUN
ajmpe-90	50	19	]	]	PUNCT
ajmpe-90	50	20	.	.	PUNCT
ajmpe-90	51	1	materials	material	NOUN
ajmpe-90	51	2	and	and	CCONJ
ajmpe-90	51	3	methods	method	NOUN
ajmpe-90	51	4	:	:	PUNCT
ajmpe-90	51	5	study	study	NOUN
ajmpe-90	51	6	group	group	PROPN
ajmpe-90	51	7	a	a	DET
ajmpe-90	51	8	cross	cross	ADJ
ajmpe-90	51	9	-	-	ADJ
ajmpe-90	51	10	sectional	sectional	ADJ
ajmpe-90	51	11	study	study	NOUN
ajmpe-90	51	12	was	be	AUX
ajmpe-90	51	13	conducted	conduct	VERB
ajmpe-90	51	14	at	at	ADP
ajmpe-90	51	15	khartoum	khartoum	PROPN
ajmpe-90	51	16	oncology	oncology	NOUN
ajmpe-90	51	17	and	and	CCONJ
ajmpe-90	51	18	isotopic	isotopic	ADJ
ajmpe-90	51	19	treatment	treatment	NOUN
ajmpe-90	51	20	hospital	hospital	NOUN
ajmpe-90	51	21	during	during	ADP
ajmpe-90	51	22	the	the	DET
ajmpe-90	51	23	period	period	NOUN
ajmpe-90	51	24	from	from	ADP
ajmpe-90	51	25	september	september	PROPN
ajmpe-90	51	26	to	to	ADP
ajmpe-90	51	27	november	november	PROPN
ajmpe-90	51	28	2021	2021	NUM
ajmpe-90	51	29	.fifty	.fifty	NUM
ajmpe-90	51	30	patients	patient	NOUN
ajmpe-90	51	31	were	be	AUX
ajmpe-90	51	32	diagnosed	diagnose	VERB
ajmpe-90	51	33	with	with	ADP
ajmpe-90	51	34	prostatic	prostatic	ADJ
ajmpe-90	51	35	cancer	cancer	NOUN
ajmpe-90	51	36	aged	age	VERB
ajmpe-90	51	37	from	from	ADP
ajmpe-90	51	38	2666	2666	NUM
ajmpe-90	51	39	years	year	NOUN
ajmpe-90	51	40	as	as	ADP
ajmpe-90	51	41	case	case	NOUN
ajmpe-90	51	42	and	and	CCONJ
ajmpe-90	51	43	fifty	fifty	NUM
ajmpe-90	51	44	healthy	healthy	ADJ
ajmpe-90	51	45	men	man	NOUN
ajmpe-90	51	46	as	as	ADP
ajmpe-90	51	47	control	control	NOUN
ajmpe-90	51	48	.	.	PUNCT
ajmpe-90	52	1	inclusion	inclusion	NOUN
ajmpe-90	52	2	criteria	criterion	NOUN
ajmpe-90	52	3	and	and	CCONJ
ajmpe-90	52	4	exclusion	exclusion	NOUN
ajmpe-90	52	5	criteria	criterion	NOUN
ajmpe-90	52	6	:	:	PUNCT
ajmpe-90	52	7	men	man	NOUN
ajmpe-90	52	8	with	with	ADP
ajmpe-90	52	9	prostatic	prostatic	ADJ
ajmpe-90	52	10	cancer	cancer	NOUN
ajmpe-90	52	11	were	be	AUX
ajmpe-90	52	12	involved	involve	VERB
ajmpe-90	52	13	in	in	ADP
ajmpe-90	52	14	the	the	DET
ajmpe-90	52	15	study	study	NOUN
ajmpe-90	52	16	and	and	CCONJ
ajmpe-90	52	17	other	other	ADJ
ajmpe-90	52	18	types	type	NOUN
ajmpe-90	52	19	of	of	ADP
ajmpe-90	52	20	cancer	cancer	NOUN
ajmpe-90	52	21	patients	patient	NOUN
ajmpe-90	52	22	did	do	AUX
ajmpe-90	52	23	not	not	PART
ajmpe-90	52	24	be	be	AUX
ajmpe-90	52	25	part	part	NOUN
ajmpe-90	52	26	of	of	ADP
ajmpe-90	52	27	this	this	DET
ajmpe-90	52	28	study	study	NOUN
ajmpe-90	52	29	.	.	PUNCT
ajmpe-90	53	1	ethical	ethical	ADJ
ajmpe-90	53	2	consideration	consideration	NOUN
ajmpe-90	53	3	:	:	PUNCT
ajmpe-90	53	4	the	the	DET
ajmpe-90	53	5	study	study	NOUN
ajmpe-90	53	6	was	be	AUX
ajmpe-90	53	7	revised	revise	VERB
ajmpe-90	53	8	and	and	CCONJ
ajmpe-90	53	9	ethically	ethically	ADV
ajmpe-90	53	10	approved	approve	VERB
ajmpe-90	53	11	by	by	ADP
ajmpe-90	53	12	the	the	DET
ajmpe-90	53	13	ethical	ethical	ADJ
ajmpe-90	53	14	and	and	CCONJ
ajmpe-90	53	15	scientific	scientific	ADJ
ajmpe-90	53	16	committee	committee	NOUN
ajmpe-90	53	17	of	of	ADP
ajmpe-90	53	18	the	the	DET
ajmpe-90	53	19	faculty	faculty	NOUN
ajmpe-90	53	20	of	of	ADP
ajmpe-90	53	21	medical	medical	ADJ
ajmpe-90	53	22	laboratory	laboratory	NOUN
ajmpe-90	53	23	sciences	sciences	PROPN
ajmpe-90	53	24	,	,	PUNCT
ajmpe-90	53	25	university	university	NOUN
ajmpe-90	53	26	of	of	ADP
ajmpe-90	53	27	alzaiem	alzaiem	NOUN
ajmpe-90	53	28	alazhari	alazhari	NOUN
ajmpe-90	53	29	.	.	PUNCT
ajmpe-90	54	1	samples	sample	NOUN
ajmpe-90	54	2	were	be	AUX
ajmpe-90	54	3	taken	take	VERB
ajmpe-90	54	4	with	with	ADP
ajmpe-90	54	5	verbal	verbal	ADJ
ajmpe-90	54	6	consent	consent	NOUN
ajmpe-90	54	7	from	from	ADP
ajmpe-90	54	8	patients	patient	NOUN
ajmpe-90	54	9	or	or	CCONJ
ajmpe-90	54	10	their	their	PRON
ajmpe-90	54	11	relatives	relative	NOUN
ajmpe-90	54	12	.	.	PUNCT
ajmpe-90	55	1	data	datum	NOUN
ajmpe-90	55	2	collection	collection	NOUN
ajmpe-90	55	3	data	datum	NOUN
ajmpe-90	55	4	collected	collect	VERB
ajmpe-90	55	5	through	through	ADP
ajmpe-90	55	6	a	a	DET
ajmpe-90	55	7	direct	direct	ADJ
ajmpe-90	55	8	interview	interview	NOUN
ajmpe-90	55	9	questionnaire	questionnaire	NOUN
ajmpe-90	55	10	was	be	AUX
ajmpe-90	55	11	used	use	VERB
ajmpe-90	55	12	to	to	PART
ajmpe-90	55	13	collect	collect	VERB
ajmpe-90	55	14	data	datum	NOUN
ajmpe-90	55	15	.	.	PUNCT
ajmpe-90	56	1	well	well	ADV
ajmpe-90	56	2	-	-	PUNCT
ajmpe-90	56	3	constructed	construct	VERB
ajmpe-90	56	4	questionnaires	questionnaire	NOUN
ajmpe-90	56	5	such	such	ADJ
ajmpe-90	56	6	as	as	ADP
ajmpe-90	56	7	age	age	NOUN
ajmpe-90	56	8	,	,	PUNCT
ajmpe-90	56	9	gender	gender	NOUN
ajmpe-90	56	10	,	,	PUNCT
ajmpe-90	56	11	and	and	CCONJ
ajmpe-90	56	12	duration	duration	NOUN
ajmpe-90	56	13	of	of	ADP
ajmpe-90	56	14	the	the	DET
ajmpe-90	56	15	disease	disease	NOUN
ajmpe-90	56	16	.	.	PUNCT
ajmpe-90	57	1	collection	collection	NOUN
ajmpe-90	57	2	of	of	ADP
ajmpe-90	57	3	specimens	specimen	NOUN
ajmpe-90	57	4	:	:	PUNCT
ajmpe-90	57	5	venous	venous	ADJ
ajmpe-90	57	6	blood	blood	NOUN
ajmpe-90	57	7	samples	sample	NOUN
ajmpe-90	57	8	were	be	AUX
ajmpe-90	57	9	collected	collect	VERB
ajmpe-90	57	10	by	by	ADP
ajmpe-90	57	11	using	use	VERB
ajmpe-90	57	12	sterile	sterile	ADJ
ajmpe-90	57	13	,	,	PUNCT
ajmpe-90	57	14	dry	dry	ADJ
ajmpe-90	57	15	,	,	PUNCT
ajmpe-90	57	16	plastic	plastic	ADJ
ajmpe-90	57	17	syringes	syrinx	NOUN
ajmpe-90	57	18	and	and	CCONJ
ajmpe-90	57	19	a	a	DET
ajmpe-90	57	20	tourniquet	tourniquet	NOUN
ajmpe-90	57	21	to	to	PART
ajmpe-90	57	22	make	make	VERB
ajmpe-90	57	23	the	the	DET
ajmpe-90	57	24	veins	vein	NOUN
ajmpe-90	57	25	more	more	ADV
ajmpe-90	57	26	prominent	prominent	ADJ
ajmpe-90	57	27	.	.	PUNCT
ajmpe-90	58	1	the	the	DET
ajmpe-90	58	2	puncture	puncture	NOUN
ajmpe-90	58	3	sites	site	NOUN
ajmpe-90	58	4	are	be	AUX
ajmpe-90	58	5	cleaned	clean	VERB
ajmpe-90	58	6	with	with	ADP
ajmpe-90	58	7	70	70	NUM
ajmpe-90	58	8	%	%	NOUN
ajmpe-90	58	9	ethanol	ethanol	NOUN
ajmpe-90	58	10	and	and	CCONJ
ajmpe-90	58	11	5	5	NUM
ajmpe-90	58	12	ml	ml	NOUN
ajmpe-90	58	13	of	of	ADP
ajmpe-90	58	14	blood	blood	NOUN
ajmpe-90	58	15	is	be	AUX
ajmpe-90	58	16	collected	collect	VERB
ajmpe-90	58	17	in	in	ADP
ajmpe-90	58	18	lithium	lithium	NOUN
ajmpe-90	58	19	heparin	heparin	ADJ
ajmpe-90	58	20	containers	container	NOUN
ajmpe-90	58	21	.	.	PUNCT
ajmpe-90	59	1	the	the	DET
ajmpe-90	59	2	lithium	lithium	NOUN
ajmpe-90	59	3	heparin	heparin	ADJ
ajmpe-90	59	4	blood	blood	NOUN
ajmpe-90	59	5	sample	sample	NOUN
ajmpe-90	59	6	was	be	AUX
ajmpe-90	59	7	centrifuged	centrifuge	VERB
ajmpe-90	59	8	at	at	ADP
ajmpe-90	59	9	4000	4000	NUM
ajmpe-90	59	10	rpm	rpm	NOUN
ajmpe-90	59	11	to	to	PART
ajmpe-90	59	12	obtain	obtain	VERB
ajmpe-90	59	13	the	the	DET
ajmpe-90	59	14	plasma	plasma	NOUN
ajmpe-90	59	15	and	and	CCONJ
ajmpe-90	59	16	then	then	ADV
ajmpe-90	59	17	stored	store	VERB
ajmpe-90	59	18	at	at	ADP
ajmpe-90	59	19	(	(	PUNCT
ajmpe-90	59	20	-4	-4	INTJ
ajmpe-90	59	21	c	c	X
ajmpe-90	59	22	)	)	PUNCT
ajmpe-90	59	23	until	until	ADP
ajmpe-90	59	24	the	the	DET
ajmpe-90	59	25	analysis	analysis	NOUN
ajmpe-90	59	26	.	.	PUNCT
ajmpe-90	60	1	measurement	measurement	NOUN
ajmpe-90	60	2	of	of	ADP
ajmpe-90	60	3	biochemical	biochemical	ADJ
ajmpe-90	60	4	parameters	parameter	NOUN
ajmpe-90	60	5	:	:	PUNCT
ajmpe-90	60	6	whole	whole	ADJ
ajmpe-90	60	7	blood	blood	NOUN
ajmpe-90	60	8	samples	sample	NOUN
ajmpe-90	60	9	were	be	AUX
ajmpe-90	60	10	collected	collect	VERB
ajmpe-90	60	11	in	in	ADP
ajmpe-90	60	12	heparinized	heparinize	VERB
ajmpe-90	60	13	blood	blood	NOUN
ajmpe-90	60	14	containers	container	NOUN
ajmpe-90	60	15	,	,	PUNCT
ajmpe-90	60	16	and	and	CCONJ
ajmpe-90	60	17	plasma	plasma	NOUN
ajmpe-90	60	18	was	be	AUX
ajmpe-90	60	19	used	use	VERB
ajmpe-90	60	20	for	for	ADP
ajmpe-90	60	21	measurement	measurement	NOUN
ajmpe-90	60	22	of	of	ADP
ajmpe-90	60	23	thyroid	thyroid	NOUN
ajmpe-90	60	24	function	function	NOUN
ajmpe-90	60	25	test	test	PROPN
ajmpe-90	60	26	t3	t3	PROPN
ajmpe-90	60	27	,	,	PUNCT
ajmpe-90	60	28	t4	t4	PROPN
ajmpe-90	60	29	,	,	PUNCT
ajmpe-90	60	30	tsh	tsh	NOUN
ajmpe-90	60	31	,	,	PUNCT
ajmpe-90	60	32	and	and	CCONJ
ajmpe-90	60	33	prostate	prostate	NOUN
ajmpe-90	60	34	antigen	antigen	ADV
ajmpe-90	60	35	by	by	ADP
ajmpe-90	60	36	tosoh	tosoh	ADJ
ajmpe-90	60	37	tm	tm	PRON
ajmpe-90	60	38	device	device	NOUN
ajmpe-90	60	39	(	(	PUNCT
ajmpe-90	60	40	china	china	PROPN
ajmpe-90	60	41	)	)	PUNCT
ajmpe-90	60	42	and	and	CCONJ
ajmpe-90	60	43	enzyme	enzyme	NOUN
ajmpe-90	60	44	-	-	PUNCT
ajmpe-90	60	45	linked	link	VERB
ajmpe-90	60	46	immune	immune	ADJ
ajmpe-90	60	47	sorbent	sorbent	NOUN
ajmpe-90	60	48	assay	assay	NOUN
ajmpe-90	60	49	(	(	PUNCT
ajmpe-90	60	50	elisa	elisa	NOUN
ajmpe-90	60	51	)	)	PUNCT
ajmpe-90	60	52	fortress	fortress	NOUN
ajmpe-90	60	53	tm	tm	NOUN
ajmpe-90	60	54	,	,	PUNCT
ajmpe-90	60	55	thyroid	thyroid	NOUN
ajmpe-90	60	56	function	function	NOUN
ajmpe-90	60	57	tests	test	NOUN
ajmpe-90	60	58	are	be	AUX
ajmpe-90	60	59	designed	design	VERB
ajmpe-90	60	60	to	to	PART
ajmpe-90	60	61	distinguish	distinguish	VERB
ajmpe-90	60	62	hyperthyroidism	hyperthyroidism	NOUN
ajmpe-90	60	63	and	and	CCONJ
ajmpe-90	60	64	hypothyroidism	hypothyroidism	NOUN
ajmpe-90	60	65	from	from	ADP
ajmpe-90	60	66	the	the	DET
ajmpe-90	60	67	euthyroid	euthyroid	PROPN
ajmpe-90	60	68	state	state	NOUN
ajmpe-90	60	69	.	.	PUNCT
ajmpe-90	61	1	to	to	PART
ajmpe-90	61	2	accomplish	accomplish	VERB
ajmpe-90	61	3	direct	direct	ADJ
ajmpe-90	61	4	measurements	measurement	NOUN
ajmpe-90	61	5	of	of	ADP
ajmpe-90	61	6	the	the	DET
ajmpe-90	61	7	plasma	plasma	NOUN
ajmpe-90	61	8	level	level	NOUN
ajmpe-90	61	9	of	of	ADP
ajmpe-90	61	10	hormones	hormone	NOUN
ajmpe-90	61	11	,	,	PUNCT
ajmpe-90	61	12	the	the	DET
ajmpe-90	61	13	tsh	tsh	PROPN
ajmpe-90	61	14	elisa	elisa	PROPN
ajmpe-90	61	15	test	test	NOUN
ajmpe-90	61	16	on	on	ADP
ajmpe-90	61	17	the	the	DET
ajmpe-90	61	18	principle	principle	NOUN
ajmpe-90	61	19	of	of	ADP
ajmpe-90	61	20	solid	solid	ADJ
ajmpe-90	61	21	phase	phase	NOUN
ajmpe-90	61	22	enzyme	enzyme	NOUN
ajmpe-90	61	23	-	-	PUNCT
ajmpe-90	61	24	linked	link	VERB
ajmpe-90	61	25	immunosorbent	immunosorbent	NOUN
ajmpe-90	61	26	assay	assay	PROPN
ajmpe-90	61	27	,	,	PUNCT
ajmpe-90	61	28	the	the	DET
ajmpe-90	61	29	assay	assay	NOUN
ajmpe-90	61	30	system	system	NOUN
ajmpe-90	61	31	utilizes	utilize	VERB
ajmpe-90	61	32	a	a	DET
ajmpe-90	61	33	unique	unique	ADJ
ajmpe-90	61	34	monoclonal	monoclonal	NOUN
ajmpe-90	61	35	antibody	antibody	NOUN
ajmpe-90	61	36	directed	direct	VERB
ajmpe-90	61	37	against	against	ADP
ajmpe-90	61	38	a	a	DET
ajmpe-90	61	39	distinct	distinct	ADJ
ajmpe-90	61	40	antigen	antigen	NOUN
ajmpe-90	61	41	determinant	determinant	ADJ
ajmpe-90	61	42	on	on	ADP
ajmpe-90	61	43	the	the	DET
ajmpe-90	61	44	intact	intact	ADJ
ajmpe-90	61	45	tsh	tsh	NOUN
ajmpe-90	61	46	molecule	molecule	NOUN
ajmpe-90	61	47	.	.	PUNCT
ajmpe-90	62	1	normal	normal	ADJ
ajmpe-90	62	2	rang	ring	VERB
ajmpe-90	62	3	:	:	PUNCT
ajmpe-90	62	4	t3	t3	PROPN
ajmpe-90	62	5	(	(	PUNCT
ajmpe-90	62	6	1.3_3.1	1.3_3.1	NUM
ajmpe-90	62	7	nmol	nmol	NOUN
ajmpe-90	62	8	/	/	SYM
ajmpe-90	62	9	l	l	NOUN
ajmpe-90	62	10	)	)	PUNCT
ajmpe-90	62	11	t4(63_141	t4(63_141	X
ajmpe-90	62	12	nmol	nmol	PROPN
ajmpe-90	62	13	/	/	SYM
ajmpe-90	62	14	l	l	NOUN
ajmpe-90	62	15	)	)	PUNCT
ajmpe-90	62	16	tsh	tsh	NOUN
ajmpe-90	62	17	(	(	PUNCT
ajmpe-90	62	18	0.5_5	0.5_5	PROPN
ajmpe-90	62	19	nmol	nmol	PROPN
ajmpe-90	62	20	/	/	SYM
ajmpe-90	62	21	l	l	NOUN
ajmpe-90	62	22	)	)	PUNCT
ajmpe-90	62	23	psa	psa	VERB
ajmpe-90	62	24	:	:	PUNCT
ajmpe-90	62	25	normal	normal	ADJ
ajmpe-90	62	26	(	(	PUNCT
ajmpe-90	62	27	0_4	0_4	NOUN
ajmpe-90	62	28	)	)	PUNCT
ajmpe-90	62	29	border(4_10	border(4_10	NOUN
ajmpe-90	62	30	)	)	PUNCT
ajmpe-90	62	31	susicious	susicious	ADJ
ajmpe-90	62	32	>	>	ADP
ajmpe-90	62	33	10	10	NUM
ajmpe-90	62	34	.	.	PUNCT
ajmpe-90	63	1	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-90	63	2	american	american	PROPN
ajmpe-90	63	3	journal	journal	PROPN
ajmpe-90	63	4	of	of	ADP
ajmpe-90	63	5	medical	medical	ADJ
ajmpe-90	63	6	and	and	CCONJ
ajmpe-90	63	7	physical	physical	ADJ
ajmpe-90	63	8	education	education	NOUN
ajmpe-90	63	9	vol.1	vol.1	PROPN
ajmpe-90	63	10	,	,	PUNCT
ajmpe-90	63	11	issue	issue	NOUN
ajmpe-90	63	12	1	1	NUM
ajmpe-90	63	13	;	;	PUNCT
ajmpe-90	63	14	july	july	PROPN
ajmpe-90	63	15	2023	2023	NUM
ajmpe-90	63	16	;	;	PUNCT
ajmpe-90	63	17	1252	1252	NUM
ajmpe-90	63	18	columbia	columbia	PROPN
ajmpe-90	63	19	rd	rd	PROPN
ajmpe-90	63	20	nw	nw	PROPN
ajmpe-90	63	21	,	,	PUNCT
ajmpe-90	63	22	washington	washington	PROPN
ajmpe-90	63	23	dc	dc	PROPN
ajmpe-90	63	24	,	,	PUNCT
ajmpe-90	63	25	united	united	PROPN
ajmpe-90	63	26	states	states	PROPN
ajmpe-90	63	27	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-90	63	28	;	;	PUNCT
ajmpe-90	63	29	mail	mail	NOUN
ajmpe-90	63	30	:	:	PUNCT
ajmpe-90	63	31	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-90	64	1	27	27	NUM
ajmpe-90	65	1	|	|	ADV
ajmpe-90	65	2	a	a	DET
ajmpe-90	65	3	m	m	NOUN
ajmpe-90	65	4	e	e	NOUN
ajmpe-90	65	5	r	r	NOUN
ajmpe-90	66	1	i	i	NOUN
ajmpe-90	66	2	c	c	VERB
ajmpe-90	66	3	a	a	DET
ajmpe-90	66	4	n	n	NOUN
ajmpe-90	67	1	j	j	NOUN
ajmpe-90	67	2	o	o	X
ajmpe-90	67	3	u	u	NOUN
ajmpe-90	67	4	r	r	NOUN
ajmpe-90	67	5	n	n	NOUN
ajmpe-90	67	6	a	a	DET
ajmpe-90	67	7	l	l	NOUN
ajmpe-90	67	8	o	o	X
ajmpe-90	68	1	f	f	X
ajmpe-90	68	2	m	m	NOUN
ajmpe-90	68	3	e	e	NOUN
ajmpe-90	69	1	d	d	NOUN
ajmpe-90	69	2	i	i	PRON
ajmpe-90	69	3	c	c	VERB
ajmpe-90	69	4	a	a	DET
ajmpe-90	69	5	l	l	NOUN
ajmpe-90	69	6	a	a	X
ajmpe-90	69	7	n	n	NOUN
ajmpe-90	70	1	d	d	NOUN
ajmpe-90	70	2	p	p	NOUN
ajmpe-90	70	3	h	h	NOUN
ajmpe-90	70	4	y	y	NOUN
ajmpe-90	70	5	s	s	VERB
ajmpe-90	71	1	i	i	INTJ
ajmpe-90	71	2	c	c	VERB
ajmpe-90	71	3	a	a	DET
ajmpe-90	71	4	l	l	NOUN
ajmpe-90	71	5	e	e	NOUN
ajmpe-90	71	6	d	d	X
ajmpe-90	71	7	u	u	X
ajmpe-90	71	8	c	c	PROPN
ajmpe-90	72	1	a	a	DET
ajmpe-90	72	2	t	t	NOUN
ajmpe-90	73	1	i	i	PRON
ajmpe-90	73	2	o	o	VERB
ajmpe-90	73	3	n	n	CCONJ
ajmpe-90	73	4	|	|	ADV
ajmpe-90	73	5	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	NUM
ajmpe-90	73	6	data	datum	NOUN
ajmpe-90	73	7	analysis	analysis	NOUN
ajmpe-90	73	8	the	the	DET
ajmpe-90	73	9	statistical	statistical	ADJ
ajmpe-90	73	10	analysis	analysis	NOUN
ajmpe-90	73	11	of	of	ADP
ajmpe-90	73	12	the	the	DET
ajmpe-90	73	13	results	result	NOUN
ajmpe-90	73	14	was	be	AUX
ajmpe-90	73	15	performed	perform	VERB
ajmpe-90	73	16	by	by	ADP
ajmpe-90	73	17	using	use	VERB
ajmpe-90	73	18	the	the	DET
ajmpe-90	73	19	statistical	statistical	ADJ
ajmpe-90	73	20	package	package	NOUN
ajmpe-90	73	21	for	for	ADP
ajmpe-90	73	22	social	social	ADJ
ajmpe-90	73	23	sciences	science	NOUN
ajmpe-90	73	24	(	(	PUNCT
ajmpe-90	73	25	spss	spss	PROPN
ajmpe-90	73	26	)	)	PUNCT
ajmpe-90	73	27	version	version	NOUN
ajmpe-90	73	28	15.0	15.0	NUM
ajmpe-90	73	29	for	for	ADP
ajmpe-90	73	30	windows	window	NOUN
ajmpe-90	73	31	version	version	NOUN
ajmpe-90	73	32	10	10	NUM
ajmpe-90	73	33	using	use	VERB
ajmpe-90	73	34	a	a	DET
ajmpe-90	73	35	t	t	NOUN
ajmpe-90	73	36	-	-	PUNCT
ajmpe-90	73	37	test	test	NOUN
ajmpe-90	73	38	for	for	ADP
ajmpe-90	73	39	testing	testing	NOUN
ajmpe-90	73	40	difference	difference	NOUN
ajmpe-90	73	41	significance	significance	NOUN
ajmpe-90	73	42	and	and	CCONJ
ajmpe-90	73	43	a	a	DET
ajmpe-90	73	44	pearson	pearson	NOUN
ajmpe-90	73	45	correlation	correlation	NOUN
ajmpe-90	73	46	test	test	NOUN
ajmpe-90	73	47	(	(	PUNCT
ajmpe-90	73	48	r	r	NOUN
ajmpe-90	73	49	-	-	PUNCT
ajmpe-90	73	50	value	value	NOUN
ajmpe-90	73	51	as	as	ADP
ajmpe-90	73	52	the	the	DET
ajmpe-90	73	53	coefficient	coefficient	NOUN
ajmpe-90	73	54	)	)	PUNCT
ajmpe-90	73	55	.	.	PUNCT
ajmpe-90	74	1	a	a	DET
ajmpe-90	74	2	p.	p.	NOUN
ajmpe-90	74	3	value	value	NOUN
ajmpe-90	74	4	of	of	ADP
ajmpe-90	74	5	0.05	0.05	NUM
ajmpe-90	74	6	was	be	AUX
ajmpe-90	74	7	considered	consider	VERB
ajmpe-90	74	8	statistically	statistically	ADV
ajmpe-90	74	9	significant	significant	ADJ
ajmpe-90	74	10	.	.	PUNCT
ajmpe-90	75	1	results	result	VERB
ajmpe-90	75	2	this	this	DET
ajmpe-90	75	3	case	case	NOUN
ajmpe-90	75	4	-	-	PUNCT
ajmpe-90	75	5	control	control	NOUN
ajmpe-90	75	6	study	study	NOUN
ajmpe-90	75	7	involved	involve	VERB
ajmpe-90	75	8	50	50	NUM
ajmpe-90	75	9	professionally	professionally	ADV
ajmpe-90	75	10	diagnosed	diagnose	VERB
ajmpe-90	75	11	patients	patient	NOUN
ajmpe-90	75	12	with	with	ADP
ajmpe-90	75	13	prostatic	prostatic	ADJ
ajmpe-90	75	14	cancer	cancer	NOUN
ajmpe-90	75	15	set	set	VERB
ajmpe-90	75	16	as	as	ADP
ajmpe-90	75	17	the	the	DET
ajmpe-90	75	18	case	case	NOUN
ajmpe-90	75	19	group	group	NOUN
ajmpe-90	75	20	.	.	PUNCT
ajmpe-90	76	1	measuring	measure	VERB
ajmpe-90	76	2	psa	psa	NOUN
ajmpe-90	76	3	as	as	ADV
ajmpe-90	76	4	well	well	ADV
ajmpe-90	76	5	as	as	ADP
ajmpe-90	76	6	tft	tft	ADV
ajmpe-90	76	7	among	among	ADP
ajmpe-90	76	8	case	case	NOUN
ajmpe-90	76	9	and	and	CCONJ
ajmpe-90	76	10	control	control	NOUN
ajmpe-90	76	11	groups	group	NOUN
ajmpe-90	76	12	,	,	PUNCT
ajmpe-90	76	13	showed	show	VERB
ajmpe-90	76	14	an	an	DET
ajmpe-90	76	15	elevation	elevation	NOUN
ajmpe-90	76	16	of	of	ADP
ajmpe-90	76	17	each	each	DET
ajmpe-90	76	18	parameter	parameter	NOUN
ajmpe-90	76	19	(	(	PUNCT
ajmpe-90	76	20	t3	t3	PROPN
ajmpe-90	76	21	,	,	PUNCT
ajmpe-90	76	22	t4	t4	PROPN
ajmpe-90	76	23	,	,	PUNCT
ajmpe-90	76	24	tsh	tsh	NOUN
ajmpe-90	76	25	,	,	PUNCT
ajmpe-90	76	26	and	and	CCONJ
ajmpe-90	76	27	psa	psa	VERB
ajmpe-90	76	28	)	)	PUNCT
ajmpe-90	76	29	among	among	ADP
ajmpe-90	76	30	case	case	NOUN
ajmpe-90	76	31	than	than	ADP
ajmpe-90	76	32	the	the	DET
ajmpe-90	76	33	control	control	NOUN
ajmpe-90	76	34	group	group	NOUN
ajmpe-90	76	35	,	,	PUNCT
ajmpe-90	76	36	giving	give	VERB
ajmpe-90	76	37	significant	significant	ADJ
ajmpe-90	76	38	differences	difference	NOUN
ajmpe-90	76	39	when	when	SCONJ
ajmpe-90	76	40	both	both	DET
ajmpe-90	76	41	groups	group	NOUN
ajmpe-90	76	42	;	;	PUNCT
ajmpe-90	76	43	data	datum	NOUN
ajmpe-90	76	44	compared	compare	VERB
ajmpe-90	76	45	as	as	ADP
ajmpe-90	76	46	the	the	DET
ajmpe-90	76	47	p	p	NOUN
ajmpe-90	76	48	-	-	PUNCT
ajmpe-90	76	49	value	value	NOUN
ajmpe-90	76	50	for	for	ADP
ajmpe-90	76	51	each	each	DET
ajmpe-90	76	52	<	<	X
ajmpe-90	76	53	0.000	0.000	NUM
ajmpe-90	76	54	as	as	ADP
ajmpe-90	76	55	in	in	ADP
ajmpe-90	76	56	table	table	NOUN
ajmpe-90	76	57	1	1	NUM
ajmpe-90	76	58	.	.	PUNCT
ajmpe-90	77	1	in	in	ADP
ajmpe-90	77	2	this	this	DET
ajmpe-90	77	3	case	case	NOUN
ajmpe-90	77	4	their	their	PRON
ajmpe-90	77	5	age	age	NOUN
ajmpe-90	77	6	mean+	mean+	NOUN
ajmpe-90	77	7	sd	sd	NOUN
ajmpe-90	77	8	was	be	AUX
ajmpe-90	77	9	66.5	66.5	NUM
ajmpe-90	77	10	+	+	NOUN
ajmpe-90	77	11	6.52	6.52	NUM
ajmpe-90	77	12	years	year	NOUN
ajmpe-90	77	13	,	,	PUNCT
ajmpe-90	77	14	parallel	parallel	ADJ
ajmpe-90	77	15	with	with	ADP
ajmpe-90	77	16	a	a	DET
ajmpe-90	77	17	healthy	healthy	ADJ
ajmpe-90	77	18	group	group	NOUN
ajmpe-90	77	19	of	of	ADP
ajmpe-90	77	20	men	man	NOUN
ajmpe-90	77	21	set	set	VERB
ajmpe-90	77	22	as	as	ADP
ajmpe-90	77	23	the	the	DET
ajmpe-90	77	24	control	control	NOUN
ajmpe-90	77	25	group	group	NOUN
ajmpe-90	77	26	,	,	PUNCT
ajmpe-90	77	27	their	their	PRON
ajmpe-90	77	28	age	age	NOUN
ajmpe-90	77	29	’s	’s	PART
ajmpe-90	77	30	mean	mean	NOUN
ajmpe-90	77	31	sd	sd	NOUN
ajmpe-90	77	32	was	be	AUX
ajmpe-90	77	33	,	,	PUNCT
ajmpe-90	77	34	patients	patient	NOUN
ajmpe-90	77	35	were	be	AUX
ajmpe-90	77	36	recruited	recruit	VERB
ajmpe-90	77	37	from	from	ADP
ajmpe-90	77	38	khartoum	khartoum	PROPN
ajmpe-90	77	39	oncology	oncology	NOUN
ajmpe-90	77	40	hospital	hospital	NOUN
ajmpe-90	77	41	,	,	PUNCT
ajmpe-90	77	42	the	the	DET
ajmpe-90	77	43	majority	majority	NOUN
ajmpe-90	77	44	of	of	ADP
ajmpe-90	77	45	them	they	PRON
ajmpe-90	77	46	from	from	ADP
ajmpe-90	77	47	west	west	PROPN
ajmpe-90	77	48	origin	origin	PROPN
ajmpe-90	77	49	56	56	NUM
ajmpe-90	77	50	%	%	NOUN
ajmpe-90	77	51	,	,	PUNCT
ajmpe-90	77	52	then	then	ADV
ajmpe-90	77	53	middle	middle	ADJ
ajmpe-90	77	54	22	22	NUM
ajmpe-90	77	55	%	%	NOUN
ajmpe-90	77	56	,	,	PUNCT
ajmpe-90	77	57	then	then	ADV
ajmpe-90	77	58	northern	northern	ADJ
ajmpe-90	77	59	origin	origin	NOUN
ajmpe-90	77	60	18	18	NUM
ajmpe-90	77	61	%	%	NOUN
ajmpe-90	77	62	and	and	CCONJ
ajmpe-90	77	63	lesser	less	ADJ
ajmpe-90	77	64	from	from	ADP
ajmpe-90	77	65	south4	south4	NOUN
ajmpe-90	77	66	%	%	NOUN
ajmpe-90	77	67	.	.	PUNCT
ajmpe-90	78	1	pearson	pearson	PROPN
ajmpe-90	78	2	's	's	PART
ajmpe-90	78	3	correlation	correlation	NOUN
ajmpe-90	78	4	showed	show	VERB
ajmpe-90	78	5	a	a	DET
ajmpe-90	78	6	negative	negative	ADJ
ajmpe-90	78	7	correlation	correlation	NOUN
ajmpe-90	78	8	between	between	ADP
ajmpe-90	78	9	all	all	DET
ajmpe-90	78	10	measured	measured	ADJ
ajmpe-90	78	11	parameters	parameter	NOUN
ajmpe-90	78	12	(	(	PUNCT
ajmpe-90	78	13	t3	t3	PROPN
ajmpe-90	78	14	,	,	PUNCT
ajmpe-90	78	15	t4	t4	PROPN
ajmpe-90	78	16	,	,	PUNCT
ajmpe-90	78	17	tsh	tsh	NOUN
ajmpe-90	78	18	,	,	PUNCT
ajmpe-90	78	19	and	and	CCONJ
ajmpe-90	78	20	psa	psa	VERB
ajmpe-90	78	21	)	)	PUNCT
ajmpe-90	78	22	with	with	ADP
ajmpe-90	78	23	the	the	DET
ajmpe-90	78	24	age	age	NOUN
ajmpe-90	78	25	of	of	ADP
ajmpe-90	78	26	patients	patient	NOUN
ajmpe-90	78	27	and	and	CCONJ
ajmpe-90	78	28	duration	duration	NOUN
ajmpe-90	78	29	of	of	ADP
ajmpe-90	78	30	the	the	DET
ajmpe-90	78	31	disease	disease	NOUN
ajmpe-90	78	32	,	,	PUNCT
ajmpe-90	78	33	only	only	ADV
ajmpe-90	78	34	significant	significant	ADJ
ajmpe-90	78	35	difference	difference	NOUN
ajmpe-90	78	36	was	be	AUX
ajmpe-90	78	37	obtained	obtain	VERB
ajmpe-90	78	38	with	with	ADP
ajmpe-90	78	39	tsh	tsh	NOUN
ajmpe-90	78	40	with	with	ADP
ajmpe-90	78	41	duration	duration	NOUN
ajmpe-90	78	42	p	p	NOUN
ajmpe-90	78	43	value	value	NOUN
ajmpe-90	78	44	<	<	NOUN
ajmpe-90	78	45	0.05	0.05	NUM
ajmpe-90	78	46	as	as	ADP
ajmpe-90	78	47	in	in	ADP
ajmpe-90	78	48	table	table	NOUN
ajmpe-90	78	49	2	2	NUM
ajmpe-90	78	50	.	.	PUNCT
ajmpe-90	79	1	the	the	DET
ajmpe-90	79	2	correlation	correlation	NOUN
ajmpe-90	79	3	of	of	ADP
ajmpe-90	79	4	psa	psa	NOUN
ajmpe-90	79	5	and	and	CCONJ
ajmpe-90	79	6	tft	tft	ADJ
ajmpe-90	79	7	positive	positive	ADJ
ajmpe-90	79	8	correlation	correlation	NOUN
ajmpe-90	79	9	with	with	ADP
ajmpe-90	79	10	t3	t3	PROPN
ajmpe-90	79	11	and	and	CCONJ
ajmpe-90	79	12	tsh	tsh	NOUN
ajmpe-90	79	13	,	,	PUNCT
ajmpe-90	79	14	giving	give	VERB
ajmpe-90	79	15	a	a	DET
ajmpe-90	79	16	significant	significant	ADJ
ajmpe-90	79	17	difference	difference	NOUN
ajmpe-90	79	18	,	,	PUNCT
ajmpe-90	79	19	while	while	SCONJ
ajmpe-90	79	20	a	a	DET
ajmpe-90	79	21	negative	negative	ADJ
ajmpe-90	79	22	correlation	correlation	NOUN
ajmpe-90	79	23	was	be	AUX
ajmpe-90	79	24	obtained	obtain	VERB
ajmpe-90	79	25	with	with	ADP
ajmpe-90	79	26	t4	t4	PROPN
ajmpe-90	79	27	with	with	ADP
ajmpe-90	79	28	no	no	DET
ajmpe-90	79	29	significant	significant	ADJ
ajmpe-90	79	30	difference	difference	NOUN
ajmpe-90	79	31	as	as	ADP
ajmpe-90	79	32	in	in	ADP
ajmpe-90	79	33	table	table	NOUN
ajmpe-90	79	34	3	3	NUM
ajmpe-90	79	35	-	-	SYM
ajmpe-90	79	36	3	3	NUM
ajmpe-90	79	37	and	and	CCONJ
ajmpe-90	79	38	figures	figure	NOUN
ajmpe-90	79	39	2	2	NUM
ajmpe-90	79	40	,	,	PUNCT
ajmpe-90	79	41	3	3	NUM
ajmpe-90	79	42	respectively	respectively	ADV
ajmpe-90	79	43	,	,	PUNCT
ajmpe-90	79	44	and	and	CCONJ
ajmpe-90	79	45	4	4	X
ajmpe-90	79	46	.	.	PUNCT
ajmpe-90	80	1	most	most	ADJ
ajmpe-90	80	2	of	of	ADP
ajmpe-90	80	3	the	the	DET
ajmpe-90	80	4	patients	patient	NOUN
ajmpe-90	80	5	are	be	AUX
ajmpe-90	80	6	secondary	secondary	ADJ
ajmpe-90	80	7	hyperthyroidism	hyperthyroidism	NOUN
ajmpe-90	80	8	66	66	NUM
ajmpe-90	80	9	%	%	NOUN
ajmpe-90	80	10	this	this	PRON
ajmpe-90	80	11	may	may	AUX
ajmpe-90	80	12	be	be	AUX
ajmpe-90	80	13	due	due	ADJ
ajmpe-90	80	14	to	to	ADP
ajmpe-90	80	15	decreased	decrease	VERB
ajmpe-90	80	16	production	production	NOUN
ajmpe-90	80	17	of	of	ADP
ajmpe-90	80	18	tsh	tsh	NOUN
ajmpe-90	80	19	from	from	ADP
ajmpe-90	80	20	the	the	DET
ajmpe-90	80	21	pituitary	pituitary	ADJ
ajmpe-90	80	22	gland	gland	NOUN
ajmpe-90	80	23	or	or	CCONJ
ajmpe-90	80	24	tsh	tsh	ADV
ajmpe-90	80	25	-	-	PUNCT
ajmpe-90	80	26	secreting	secrete	VERB
ajmpe-90	80	27	tumor	tumor	NOUN
ajmpe-90	80	28	,	,	PUNCT
ajmpe-90	80	29	or	or	CCONJ
ajmpe-90	80	30	more	more	ADV
ajmpe-90	80	31	rarely	rarely	ADV
ajmpe-90	80	32	from	from	ADP
ajmpe-90	80	33	the	the	DET
ajmpe-90	80	34	overproduction	overproduction	NOUN
ajmpe-90	80	35	of	of	ADP
ajmpe-90	80	36	trh	trh	NOUN
ajmpe-90	80	37	from	from	ADP
ajmpe-90	80	38	the	the	DET
ajmpe-90	80	39	hypothalamus	hypothalamus	PROPN
ajmpe-90	80	40	or	or	CCONJ
ajmpe-90	80	41	thyrotropin	thyrotropin	NOUN
ajmpe-90	80	42	-	-	PUNCT
ajmpe-90	80	43	releasing	release	VERB
ajmpe-90	80	44	hormone	hormone	NOUN
ajmpe-90	80	45	and	and	CCONJ
ajmpe-90	80	46	other	other	ADJ
ajmpe-90	80	47	patients	patient	NOUN
ajmpe-90	80	48	are	be	AUX
ajmpe-90	80	49	28	28	NUM
ajmpe-90	80	50	%	%	NOUN
ajmpe-90	80	51	normal	normal	ADJ
ajmpe-90	80	52	and	and	CCONJ
ajmpe-90	80	53	3	3	NUM
ajmpe-90	80	54	%	%	NOUN
ajmpe-90	80	55	are	be	AUX
ajmpe-90	80	56	hypothyroidisms	hypothyroidism	NOUN
ajmpe-90	80	57	as	as	ADP
ajmpe-90	80	58	in	in	ADP
ajmpe-90	80	59	figure	figure	NOUN
ajmpe-90	80	60	1	1	NUM
ajmpe-90	80	61	and	and	CCONJ
ajmpe-90	80	62	in	in	ADP
ajmpe-90	80	63	table	table	NOUN
ajmpe-90	80	64	4	4	NUM
ajmpe-90	80	65	the	the	DET
ajmpe-90	80	66	comparison	comparison	NOUN
ajmpe-90	80	67	of	of	ADP
ajmpe-90	80	68	mean	mean	ADJ
ajmpe-90	80	69	levels	level	NOUN
ajmpe-90	80	70	of	of	ADP
ajmpe-90	80	71	tfts	tft	NOUN
ajmpe-90	80	72	and	and	CCONJ
ajmpe-90	80	73	psa	psa	VERB
ajmpe-90	80	74	and	and	CCONJ
ajmpe-90	80	75	p	p	NOUN
ajmpe-90	80	76	value	value	NOUN
ajmpe-90	80	77	in	in	ADP
ajmpe-90	80	78	hyperthyroidism	hyperthyroidism	NOUN
ajmpe-90	80	79	patients	patient	NOUN
ajmpe-90	80	80	table	table	VERB
ajmpe-90	80	81	1	1	NUM
ajmpe-90	80	82	:	:	PUNCT
ajmpe-90	80	83	comparison	comparison	NOUN
ajmpe-90	80	84	of	of	ADP
ajmpe-90	80	85	mean	mean	ADJ
ajmpe-90	80	86	levels	level	NOUN
ajmpe-90	80	87	of	of	ADP
ajmpe-90	80	88	tfts	tft	NOUN
ajmpe-90	80	89	and	and	CCONJ
ajmpe-90	80	90	psa	psa	VERB
ajmpe-90	80	91	among	among	ADP
ajmpe-90	80	92	study	study	NOUN
ajmpe-90	80	93	groups	group	NOUN
ajmpe-90	80	94	case	case	NOUN
ajmpe-90	80	95	group	group	NOUN
ajmpe-90	80	96	n=50	n=50	PROPN
ajmpe-90	80	97	control	control	NOUN
ajmpe-90	80	98	group	group	NOUN
ajmpe-90	80	99	n=50	n=50	ADJ
ajmpe-90	80	100	p	p	NOUN
ajmpe-90	80	101	-	-	PUNCT
ajmpe-90	80	102	value	value	NOUN
ajmpe-90	80	103	t3	t3	PROPN
ajmpe-90	80	104	nmol	nmol	PROPN
ajmpe-90	80	105	/	/	SYM
ajmpe-90	80	106	l	l	NOUN
ajmpe-90	80	107	3.3	3.3	NUM
ajmpe-90	80	108	±	±	NUM
ajmpe-90	80	109	1.3	1.3	NUM
ajmpe-90	80	110	1.6	1.6	NUM
ajmpe-90	80	111	±	±	NUM
ajmpe-90	80	112	0.67	0.67	NUM
ajmpe-90	80	113	0.000	0.000	NUM
ajmpe-90	80	114	t4nmol	t4nmol	NUM
ajmpe-90	80	115	/	/	SYM
ajmpe-90	80	116	l	l	NOUN
ajmpe-90	80	117	119.58	119.58	NUM
ajmpe-90	80	118	±	±	NUM
ajmpe-90	80	119	46.21	46.21	NUM
ajmpe-90	80	120	101.6	101.6	NUM
ajmpe-90	80	121	±	±	NUM
ajmpe-90	80	122	17.95	17.95	NUM
ajmpe-90	80	123	0.045	0.045	NUM
ajmpe-90	80	124	tsh	tsh	PROPN
ajmpe-90	80	125	nmol	nmol	PROPN
ajmpe-90	80	126	/	/	SYM
ajmpe-90	80	127	l	l	NOUN
ajmpe-90	80	128	4.6	4.6	NUM
ajmpe-90	80	129	±	±	NUM
ajmpe-90	80	130	3.4	3.4	NUM
ajmpe-90	80	131	1.7	1.7	NUM
ajmpe-90	80	132	±	±	NUM
ajmpe-90	80	133	0.7	0.7	NUM
ajmpe-90	80	134	0.000	0.000	NUM
ajmpe-90	80	135	psa	psa	NOUN
ajmpe-90	80	136	nmol	nmol	PROPN
ajmpe-90	80	137	/	/	SYM
ajmpe-90	80	138	l	l	PROPN
ajmpe-90	80	139	31.8	31.8	NUM
ajmpe-90	80	140	±	±	NUM
ajmpe-90	80	141	12.5	12.5	NUM
ajmpe-90	80	142	1.85	1.85	NUM
ajmpe-90	80	143	±	±	NUM
ajmpe-90	80	144	2.1	2.1	NUM
ajmpe-90	80	145	0.000	0.000	NUM
ajmpe-90	80	146	table	table	NOUN
ajmpe-90	80	147	2	2	NUM
ajmpe-90	80	148	:	:	PUNCT
ajmpe-90	80	149	correlation	correlation	NOUN
ajmpe-90	80	150	of	of	ADP
ajmpe-90	80	151	age	age	NOUN
ajmpe-90	80	152	and	and	CCONJ
ajmpe-90	80	153	duration	duration	NOUN
ajmpe-90	80	154	of	of	ADP
ajmpe-90	80	155	disease	disease	NOUN
ajmpe-90	80	156	with	with	ADP
ajmpe-90	80	157	tfts	tft	NOUN
ajmpe-90	80	158	and	and	CCONJ
ajmpe-90	80	159	psa	psa	VERB
ajmpe-90	80	160	parameters	parameter	NOUN
ajmpe-90	80	161	values	value	NOUN
ajmpe-90	80	162	age	age	NOUN
ajmpe-90	80	163	duration	duration	NOUN
ajmpe-90	80	164	t3	t3	PROPN
ajmpe-90	80	165	r	r	PROPN
ajmpe-90	80	166	-0.033	-0.033	PROPN
ajmpe-90	80	167	-0.117	-0.117	PROPN
ajmpe-90	80	168	p	p	NOUN
ajmpe-90	80	169	0.819	0.819	NUM
ajmpe-90	80	170	0.418	0.418	NUM
ajmpe-90	80	171	t4	t4	PROPN
ajmpe-90	80	172	r	r	NOUN
ajmpe-90	80	173	-0.092	-0.092	PUNCT
ajmpe-90	80	174	-0.024	-0.024	PUNCT
ajmpe-90	80	175	p	p	X
ajmpe-90	80	176	0.526	0.526	NUM
ajmpe-90	80	177	0.870	0.870	NUM
ajmpe-90	80	178	tsh	tsh	NOUN
ajmpe-90	80	179	r	r	NOUN
ajmpe-90	80	180	-0.051	-0.051	NOUN
ajmpe-90	80	181	-0.317	-0.317	PROPN
ajmpe-90	80	182	*	*	SYM
ajmpe-90	80	183	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-90	80	184	american	american	PROPN
ajmpe-90	80	185	journal	journal	PROPN
ajmpe-90	80	186	of	of	ADP
ajmpe-90	80	187	medical	medical	ADJ
ajmpe-90	80	188	and	and	CCONJ
ajmpe-90	80	189	physical	physical	ADJ
ajmpe-90	80	190	education	education	NOUN
ajmpe-90	80	191	vol.1	vol.1	PROPN
ajmpe-90	80	192	,	,	PUNCT
ajmpe-90	80	193	issue	issue	NOUN
ajmpe-90	80	194	1	1	NUM
ajmpe-90	80	195	;	;	PUNCT
ajmpe-90	80	196	july	july	PROPN
ajmpe-90	80	197	2023	2023	NUM
ajmpe-90	80	198	;	;	PUNCT
ajmpe-90	80	199	1252	1252	NUM
ajmpe-90	80	200	columbia	columbia	PROPN
ajmpe-90	80	201	rd	rd	PROPN
ajmpe-90	80	202	nw	nw	PROPN
ajmpe-90	80	203	,	,	PUNCT
ajmpe-90	80	204	washington	washington	PROPN
ajmpe-90	80	205	dc	dc	PROPN
ajmpe-90	80	206	,	,	PUNCT
ajmpe-90	80	207	united	united	PROPN
ajmpe-90	80	208	states	states	PROPN
ajmpe-90	80	209	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-90	80	210	;	;	PUNCT
ajmpe-90	80	211	mail	mail	NOUN
ajmpe-90	80	212	:	:	PUNCT
ajmpe-90	80	213	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-90	81	1	28	28	NUM
ajmpe-90	82	1	|	|	ADV
ajmpe-90	82	2	a	a	DET
ajmpe-90	82	3	m	m	NOUN
ajmpe-90	82	4	e	e	NOUN
ajmpe-90	82	5	r	r	NOUN
ajmpe-90	83	1	i	i	NOUN
ajmpe-90	83	2	c	c	VERB
ajmpe-90	83	3	a	a	DET
ajmpe-90	83	4	n	n	NOUN
ajmpe-90	84	1	j	j	NOUN
ajmpe-90	84	2	o	o	X
ajmpe-90	84	3	u	u	NOUN
ajmpe-90	84	4	r	r	NOUN
ajmpe-90	84	5	n	n	NOUN
ajmpe-90	84	6	a	a	DET
ajmpe-90	84	7	l	l	NOUN
ajmpe-90	84	8	o	o	X
ajmpe-90	85	1	f	f	X
ajmpe-90	85	2	m	m	NOUN
ajmpe-90	85	3	e	e	NOUN
ajmpe-90	86	1	d	d	NOUN
ajmpe-90	86	2	i	i	PRON
ajmpe-90	86	3	c	c	VERB
ajmpe-90	86	4	a	a	DET
ajmpe-90	86	5	l	l	NOUN
ajmpe-90	86	6	a	a	X
ajmpe-90	86	7	n	n	NOUN
ajmpe-90	87	1	d	d	NOUN
ajmpe-90	87	2	p	p	NOUN
ajmpe-90	87	3	h	h	NOUN
ajmpe-90	87	4	y	y	NOUN
ajmpe-90	87	5	s	s	VERB
ajmpe-90	88	1	i	i	INTJ
ajmpe-90	88	2	c	c	VERB
ajmpe-90	88	3	a	a	DET
ajmpe-90	88	4	l	l	NOUN
ajmpe-90	88	5	e	e	NOUN
ajmpe-90	88	6	d	d	X
ajmpe-90	88	7	u	u	X
ajmpe-90	88	8	c	c	PROPN
ajmpe-90	89	1	a	a	DET
ajmpe-90	89	2	t	t	NOUN
ajmpe-90	90	1	i	i	PRON
ajmpe-90	90	2	o	o	VERB
ajmpe-90	91	1	n	n	CCONJ
ajmpe-90	91	2	|	|	ADV
ajmpe-90	91	3	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-90	91	4	p	p	NOUN
ajmpe-90	91	5	0.725	0.725	NUM
ajmpe-90	91	6	0.025	0.025	NUM
ajmpe-90	91	7	psa	psa	NOUN
ajmpe-90	91	8	r	r	NOUN
ajmpe-90	91	9	-0.109	-0.109	NUM
ajmpe-90	91	10	-0.259	-0.259	NOUN
ajmpe-90	91	11	p	p	VERB
ajmpe-90	91	12	0.452	0.452	NUM
ajmpe-90	91	13	0.070	0.070	NUM
ajmpe-90	91	14	r	r	NOUN
ajmpe-90	91	15	=	=	SYM
ajmpe-90	91	16	pearson	pearson	PROPN
ajmpe-90	91	17	’s	’s	PART
ajmpe-90	91	18	correlation	correlation	NOUN
ajmpe-90	91	19	between	between	ADP
ajmpe-90	91	20	1	1	NUM
ajmpe-90	91	21	and	and	CCONJ
ajmpe-90	91	22	-1	-1	NOUN
ajmpe-90	91	23	.	.	PUNCT
ajmpe-90	92	1	table	table	NOUN
ajmpe-90	92	2	3	3	NUM
ajmpe-90	92	3	:	:	PUNCT
ajmpe-90	92	4	correlation	correlation	NOUN
ajmpe-90	92	5	of	of	ADP
ajmpe-90	92	6	psa	psa	NOUN
ajmpe-90	92	7	with	with	ADP
ajmpe-90	92	8	tfts	tft	NOUN
ajmpe-90	92	9	variable	variable	ADJ
ajmpe-90	92	10	t3	t3	PROPN
ajmpe-90	92	11	t4	t4	PROPN
ajmpe-90	92	12	tsh	tsh	PROPN
ajmpe-90	92	13	psa	psa	PROPN
ajmpe-90	92	14	person	person	NOUN
ajmpe-90	92	15	correlation	correlation	NOUN
ajmpe-90	92	16	0.343	0.343	NUM
ajmpe-90	92	17	-0.033	-0.033	NUM
ajmpe-90	92	18	0.280	0.280	NUM
ajmpe-90	92	19	p	p	ADJ
ajmpe-90	92	20	-	-	PUNCT
ajmpe-90	92	21	value	value	NOUN
ajmpe-90	92	22	0.007	0.007	NUM
ajmpe-90	92	23	0.803	0.803	NUM
ajmpe-90	92	24	0.029	0.029	NUM
ajmpe-90	92	25	table	table	NOUN
ajmpe-90	92	26	4	4	NUM
ajmpe-90	92	27	:	:	PUNCT
ajmpe-90	92	28	comparison	comparison	NOUN
ajmpe-90	92	29	of	of	ADP
ajmpe-90	92	30	mean	mean	ADJ
ajmpe-90	92	31	levels	level	NOUN
ajmpe-90	92	32	of	of	ADP
ajmpe-90	92	33	tfts	tft	NOUN
ajmpe-90	92	34	and	and	CCONJ
ajmpe-90	92	35	psa	psa	VERB
ajmpe-90	92	36	and	and	CCONJ
ajmpe-90	92	37	p	p	NOUN
ajmpe-90	92	38	value	value	NOUN
ajmpe-90	92	39	in	in	ADP
ajmpe-90	92	40	hyperthyroidism	hyperthyroidism	NOUN
ajmpe-90	92	41	patients	patient	NOUN
ajmpe-90	92	42	variable	variable	ADJ
ajmpe-90	92	43	hyperthyroidism	hyperthyroidism	NOUN
ajmpe-90	92	44	n=33	n=33	NOUN
ajmpe-90	92	45	control	control	PROPN
ajmpe-90	92	46	group	group	PROPN
ajmpe-90	92	47	n=50	n=50	ADJ
ajmpe-90	92	48	p	p	NOUN
ajmpe-90	92	49	-	-	PUNCT
ajmpe-90	92	50	value	value	NOUN
ajmpe-90	92	51	t3	t3	NOUN
ajmpe-90	92	52	3.1	3.1	NUM
ajmpe-90	92	53	±	±	NUM
ajmpe-90	92	54	1.0	1.0	NUM
ajmpe-90	92	55	1.6	1.6	NUM
ajmpe-90	92	56	±	±	NUM
ajmpe-90	92	57	0.67	0.67	NUM
ajmpe-90	92	58	0.000	0.000	NUM
ajmpe-90	92	59	t4	t4	PROPN
ajmpe-90	92	60	39.8	39.8	NUM
ajmpe-90	92	61	±	±	NUM
ajmpe-90	92	62	15.4	15.4	NUM
ajmpe-90	92	63	101.6	101.6	NUM
ajmpe-90	92	64	±	±	NUM
ajmpe-90	92	65	17.95	17.95	NUM
ajmpe-90	92	66	0.000	0.000	NUM
ajmpe-90	92	67	tsh	tsh	NOUN
ajmpe-90	92	68	0.4	0.4	NUM
ajmpe-90	92	69	±	±	NUM
ajmpe-90	92	70	0.1	0.1	NUM
ajmpe-90	92	71	1.7	1.7	NUM
ajmpe-90	92	72	±	±	NUM
ajmpe-90	92	73	0.7	0.7	NUM
ajmpe-90	92	74	0.000	0.000	NUM
ajmpe-90	92	75	psa	psa	VERB
ajmpe-90	92	76	12.3	12.3	NUM
ajmpe-90	92	77	±	±	NUM
ajmpe-90	92	78	10.4	10.4	NUM
ajmpe-90	92	79	1.85	1.85	NUM
ajmpe-90	92	80	±	±	NUM
ajmpe-90	92	81	2.1	2.1	NUM
ajmpe-90	92	82	0.000	0.000	NUM
ajmpe-90	92	83	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-90	92	84	american	american	PROPN
ajmpe-90	92	85	journal	journal	PROPN
ajmpe-90	92	86	of	of	ADP
ajmpe-90	92	87	medical	medical	ADJ
ajmpe-90	92	88	and	and	CCONJ
ajmpe-90	92	89	physical	physical	ADJ
ajmpe-90	92	90	education	education	NOUN
ajmpe-90	92	91	vol.1	vol.1	PROPN
ajmpe-90	92	92	,	,	PUNCT
ajmpe-90	92	93	issue	issue	NOUN
ajmpe-90	92	94	1	1	NUM
ajmpe-90	92	95	;	;	PUNCT
ajmpe-90	92	96	july	july	PROPN
ajmpe-90	92	97	2023	2023	NUM
ajmpe-90	92	98	;	;	PUNCT
ajmpe-90	92	99	1252	1252	NUM
ajmpe-90	92	100	columbia	columbia	PROPN
ajmpe-90	92	101	rd	rd	PROPN
ajmpe-90	92	102	nw	nw	PROPN
ajmpe-90	92	103	,	,	PUNCT
ajmpe-90	92	104	washington	washington	PROPN
ajmpe-90	92	105	dc	dc	PROPN
ajmpe-90	92	106	,	,	PUNCT
ajmpe-90	92	107	united	united	PROPN
ajmpe-90	92	108	states	states	PROPN
ajmpe-90	92	109	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-90	92	110	;	;	PUNCT
ajmpe-90	92	111	mail	mail	NOUN
ajmpe-90	92	112	:	:	PUNCT
ajmpe-90	92	113	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-90	92	114	29	29	NUM
ajmpe-90	93	1	|	|	ADV
ajmpe-90	93	2	a	a	DET
ajmpe-90	93	3	m	m	NOUN
ajmpe-90	93	4	e	e	NOUN
ajmpe-90	93	5	r	r	NOUN
ajmpe-90	93	6	i	i	NOUN
ajmpe-90	93	7	c	c	VERB
ajmpe-90	93	8	a	a	DET
ajmpe-90	93	9	n	n	NOUN
ajmpe-90	94	1	j	j	NOUN
ajmpe-90	94	2	o	o	X
ajmpe-90	94	3	u	u	NOUN
ajmpe-90	94	4	r	r	NOUN
ajmpe-90	94	5	n	n	NOUN
ajmpe-90	94	6	a	a	DET
ajmpe-90	94	7	l	l	NOUN
ajmpe-90	94	8	o	o	X
ajmpe-90	95	1	f	f	X
ajmpe-90	95	2	m	m	NOUN
ajmpe-90	95	3	e	e	NOUN
ajmpe-90	96	1	d	d	NOUN
ajmpe-90	96	2	i	i	PRON
ajmpe-90	96	3	c	c	VERB
ajmpe-90	96	4	a	a	DET
ajmpe-90	96	5	l	l	NOUN
ajmpe-90	96	6	a	a	X
ajmpe-90	96	7	n	n	NOUN
ajmpe-90	97	1	d	d	NOUN
ajmpe-90	97	2	p	p	NOUN
ajmpe-90	97	3	h	h	NOUN
ajmpe-90	97	4	y	y	NOUN
ajmpe-90	97	5	s	s	VERB
ajmpe-90	98	1	i	i	INTJ
ajmpe-90	98	2	c	c	VERB
ajmpe-90	98	3	a	a	DET
ajmpe-90	98	4	l	l	NOUN
ajmpe-90	98	5	e	e	NOUN
ajmpe-90	98	6	d	d	X
ajmpe-90	98	7	u	u	X
ajmpe-90	98	8	c	c	PROPN
ajmpe-90	99	1	a	a	DET
ajmpe-90	99	2	t	t	NOUN
ajmpe-90	100	1	i	i	PRON
ajmpe-90	100	2	o	o	VERB
ajmpe-90	100	3	n	n	CCONJ
ajmpe-90	100	4	|	|	ADV
ajmpe-90	100	5	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	NUM
ajmpe-90	100	6	figure	figure	NOUN
ajmpe-90	100	7	2	2	NUM
ajmpe-90	100	8	:	:	PUNCT
ajmpe-90	100	9	correlation	correlation	NOUN
ajmpe-90	100	10	between	between	ADP
ajmpe-90	100	11	psa	psa	NOUN
ajmpe-90	100	12	and	and	CCONJ
ajmpe-90	100	13	t3	t3	NOUN
ajmpe-90	100	14	among	among	ADP
ajmpe-90	100	15	case	case	NOUN
ajmpe-90	100	16	studies	study	NOUN
ajmpe-90	100	17	(	(	PUNCT
ajmpe-90	100	18	p.	p.	NOUN
ajmpe-90	100	19	value=0.007	value=0.007	NUM
ajmpe-90	100	20	,	,	PUNCT
ajmpe-90	100	21	r=0.34	r=0.34	NOUN
ajmpe-90	100	22	)	)	PUNCT
ajmpe-90	100	23	figure	figure	NOUN
ajmpe-90	100	24	3	3	NUM
ajmpe-90	100	25	:	:	PUNCT
ajmpe-90	100	26	correlation	correlation	NOUN
ajmpe-90	100	27	between	between	ADP
ajmpe-90	100	28	psa	psa	NOUN
ajmpe-90	100	29	and	and	CCONJ
ajmpe-90	100	30	tsh	tsh	NOUN
ajmpe-90	100	31	among	among	ADP
ajmpe-90	100	32	case	case	NOUN
ajmpe-90	100	33	studies	study	NOUN
ajmpe-90	100	34	(	(	PUNCT
ajmpe-90	100	35	p.	p.	NOUN
ajmpe-90	100	36	value=0.029	value=0.029	NOUN
ajmpe-90	100	37	,	,	PUNCT
ajmpe-90	100	38	r=0.282	r=0.282	NOUN
ajmpe-90	100	39	)	)	PUNCT
ajmpe-90	100	40	figure	figure	NOUN
ajmpe-90	100	41	1	1	NUM
ajmpe-90	100	42	:	:	PUNCT
ajmpe-90	100	43	frequency	frequency	NOUN
ajmpe-90	100	44	of	of	ADP
ajmpe-90	100	45	thyroid	thyroid	NOUN
ajmpe-90	100	46	disorders	disorder	NOUN
ajmpe-90	100	47	among	among	ADP
ajmpe-90	100	48	case	case	NOUN
ajmpe-90	100	49	group	group	NOUN
ajmpe-90	100	50	\	\	PROPN
ajmpe-90	100	51	66	66	NUM
ajmpe-90	100	52	%	%	NOUN
ajmpe-90	100	53	%	%	NOUN
ajmpe-90	100	54	28	28	NUM
ajmpe-90	100	55	%	%	NOUN
ajmpe-90	100	56	6	6	NUM
ajmpe-90	100	57	sales	sale	NOUN
ajmpe-90	100	58	hyperthyroidism	hyperthyroidism	NOUN
ajmpe-90	100	59	normal	normal	ADJ
ajmpe-90	100	60	hyporthyrodism	hyporthyrodism	NOUN
ajmpe-90	100	61	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-90	100	62	american	american	PROPN
ajmpe-90	100	63	journal	journal	PROPN
ajmpe-90	100	64	of	of	ADP
ajmpe-90	100	65	medical	medical	ADJ
ajmpe-90	100	66	and	and	CCONJ
ajmpe-90	100	67	physical	physical	ADJ
ajmpe-90	100	68	education	education	NOUN
ajmpe-90	100	69	vol.1	vol.1	PROPN
ajmpe-90	100	70	,	,	PUNCT
ajmpe-90	100	71	issue	issue	NOUN
ajmpe-90	100	72	1	1	NUM
ajmpe-90	100	73	;	;	PUNCT
ajmpe-90	100	74	july	july	PROPN
ajmpe-90	100	75	2023	2023	NUM
ajmpe-90	100	76	;	;	PUNCT
ajmpe-90	100	77	1252	1252	NUM
ajmpe-90	100	78	columbia	columbia	PROPN
ajmpe-90	100	79	rd	rd	PROPN
ajmpe-90	100	80	nw	nw	PROPN
ajmpe-90	100	81	,	,	PUNCT
ajmpe-90	100	82	washington	washington	PROPN
ajmpe-90	100	83	dc	dc	PROPN
ajmpe-90	100	84	,	,	PUNCT
ajmpe-90	100	85	united	united	PROPN
ajmpe-90	100	86	states	states	PROPN
ajmpe-90	100	87	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-90	100	88	;	;	PUNCT
ajmpe-90	100	89	mail	mail	NOUN
ajmpe-90	100	90	:	:	PUNCT
ajmpe-90	100	91	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-90	101	1	30	30	NUM
ajmpe-90	102	1	|	|	ADV
ajmpe-90	102	2	a	a	DET
ajmpe-90	102	3	m	m	NOUN
ajmpe-90	102	4	e	e	NOUN
ajmpe-90	102	5	r	r	NOUN
ajmpe-90	103	1	i	i	NOUN
ajmpe-90	103	2	c	c	VERB
ajmpe-90	103	3	a	a	DET
ajmpe-90	103	4	n	n	NOUN
ajmpe-90	104	1	j	j	NOUN
ajmpe-90	104	2	o	o	X
ajmpe-90	104	3	u	u	NOUN
ajmpe-90	104	4	r	r	NOUN
ajmpe-90	104	5	n	n	NOUN
ajmpe-90	104	6	a	a	DET
ajmpe-90	104	7	l	l	NOUN
ajmpe-90	104	8	o	o	X
ajmpe-90	105	1	f	f	X
ajmpe-90	105	2	m	m	NOUN
ajmpe-90	105	3	e	e	NOUN
ajmpe-90	106	1	d	d	NOUN
ajmpe-90	106	2	i	i	PRON
ajmpe-90	106	3	c	c	VERB
ajmpe-90	106	4	a	a	DET
ajmpe-90	106	5	l	l	NOUN
ajmpe-90	106	6	a	a	X
ajmpe-90	106	7	n	n	NOUN
ajmpe-90	107	1	d	d	NOUN
ajmpe-90	107	2	p	p	NOUN
ajmpe-90	107	3	h	h	NOUN
ajmpe-90	107	4	y	y	NOUN
ajmpe-90	107	5	s	s	VERB
ajmpe-90	108	1	i	i	INTJ
ajmpe-90	108	2	c	c	VERB
ajmpe-90	108	3	a	a	DET
ajmpe-90	108	4	l	l	NOUN
ajmpe-90	108	5	e	e	NOUN
ajmpe-90	108	6	d	d	X
ajmpe-90	108	7	u	u	X
ajmpe-90	108	8	c	c	PROPN
ajmpe-90	109	1	a	a	DET
ajmpe-90	109	2	t	t	NOUN
ajmpe-90	110	1	i	i	PRON
ajmpe-90	110	2	o	o	VERB
ajmpe-90	110	3	n	n	CCONJ
ajmpe-90	110	4	|	|	ADV
ajmpe-90	110	5	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	NUM
ajmpe-90	110	6	figure	figure	NOUN
ajmpe-90	110	7	4	4	NUM
ajmpe-90	110	8	:	:	PUNCT
ajmpe-90	110	9	correlation	correlation	NOUN
ajmpe-90	110	10	between	between	ADP
ajmpe-90	110	11	t4	t4	PROPN
ajmpe-90	110	12	and	and	CCONJ
ajmpe-90	110	13	psa	psa	VERB
ajmpe-90	110	14	among	among	ADP
ajmpe-90	110	15	case	case	NOUN
ajmpe-90	110	16	studies	study	NOUN
ajmpe-90	110	17	(	(	PUNCT
ajmpe-90	110	18	p.	p.	NOUN
ajmpe-90	110	19	value=0.803	value=0.803	NOUN
ajmpe-90	110	20	,	,	PUNCT
ajmpe-90	110	21	r=0.001	r=0.001	NOUN
ajmpe-90	110	22	)	)	PUNCT
ajmpe-90	110	23	discussion	discussion	NOUN
ajmpe-90	110	24	prostate	prostate	NOUN
ajmpe-90	110	25	cancer	cancer	NOUN
ajmpe-90	110	26	develops	develop	VERB
ajmpe-90	110	27	when	when	SCONJ
ajmpe-90	110	28	the	the	DET
ajmpe-90	110	29	rates	rate	NOUN
ajmpe-90	110	30	of	of	ADP
ajmpe-90	110	31	cell	cell	NOUN
ajmpe-90	110	32	division	division	NOUN
ajmpe-90	110	33	exceed	exceed	VERB
ajmpe-90	110	34	those	those	PRON
ajmpe-90	110	35	of	of	ADP
ajmpe-90	110	36	cell	cell	NOUN
ajmpe-90	110	37	death	death	NOUN
ajmpe-90	110	38	,	,	PUNCT
ajmpe-90	110	39	leading	lead	VERB
ajmpe-90	110	40	to	to	ADP
ajmpe-90	110	41	uncontrolled	uncontrolled	ADJ
ajmpe-90	110	42	tumor	tumor	NOUN
ajmpe-90	110	43	growth	growth	NOUN
ajmpe-90	110	44	.	.	PUNCT
ajmpe-90	111	1	following	follow	VERB
ajmpe-90	111	2	the	the	DET
ajmpe-90	111	3	initial	initial	ADJ
ajmpe-90	111	4	transformation	transformation	NOUN
ajmpe-90	111	5	event	event	NOUN
ajmpe-90	111	6	,	,	PUNCT
ajmpe-90	111	7	a	a	DET
ajmpe-90	111	8	variety	variety	NOUN
ajmpe-90	111	9	of	of	ADP
ajmpe-90	111	10	genes	gene	NOUN
ajmpe-90	111	11	,	,	PUNCT
ajmpe-90	111	12	including	include	VERB
ajmpe-90	111	13	those	those	PRON
ajmpe-90	111	14	for	for	ADP
ajmpe-90	111	15	retinoblastoma	retinoblastoma	NOUN
ajmpe-90	111	16	,	,	PUNCT
ajmpe-90	111	17	can	can	AUX
ajmpe-90	111	18	undergo	undergo	VERB
ajmpe-90	111	19	further	further	ADJ
ajmpe-90	111	20	alterations	alteration	NOUN
ajmpe-90	111	21	that	that	PRON
ajmpe-90	111	22	cause	cause	VERB
ajmpe-90	111	23	tumor	tumor	NOUN
ajmpe-90	111	24	growth	growth	NOUN
ajmpe-90	111	25	and	and	CCONJ
ajmpe-90	111	26	metastasis	metastasis	NOUN
ajmpe-90	111	27	.	.	PUNCT
ajmpe-90	112	1	adenocarcinomas	adenocarcinoma	NOUN
ajmpe-90	112	2	are	be	AUX
ajmpe-90	112	3	the	the	DET
ajmpe-90	112	4	primary	primary	ADJ
ajmpe-90	112	5	kind	kind	NOUN
ajmpe-90	112	6	of	of	ADP
ajmpe-90	112	7	prostate	prostate	NOUN
ajmpe-90	112	8	cancer	cancer	NOUN
ajmpe-90	112	9	.	.	PUNCT
ajmpe-90	113	1	when	when	SCONJ
ajmpe-90	113	2	psa	psa	VERB
ajmpe-90	113	3	expression	expression	NOUN
ajmpe-90	113	4	was	be	AUX
ajmpe-90	113	5	thought	think	VERB
ajmpe-90	113	6	to	to	PART
ajmpe-90	113	7	be	be	AUX
ajmpe-90	113	8	unique	unique	ADJ
ajmpe-90	113	9	to	to	ADP
ajmpe-90	113	10	the	the	DET
ajmpe-90	113	11	prostate	prostate	NOUN
ajmpe-90	113	12	gland	gland	NOUN
ajmpe-90	113	13	and	and	CCONJ
ajmpe-90	113	14	was	be	AUX
ajmpe-90	113	15	thought	think	VERB
ajmpe-90	113	16	to	to	PART
ajmpe-90	113	17	be	be	AUX
ajmpe-90	113	18	raised	raise	VERB
ajmpe-90	113	19	in	in	ADP
ajmpe-90	113	20	benign	benign	ADJ
ajmpe-90	113	21	situations	situation	NOUN
ajmpe-90	113	22	,	,	PUNCT
ajmpe-90	113	23	the	the	DET
ajmpe-90	113	24	blood	blood	NOUN
ajmpe-90	113	25	psa	psa	NOUN
ajmpe-90	113	26	was	be	AUX
ajmpe-90	113	27	the	the	DET
ajmpe-90	113	28	most	most	ADV
ajmpe-90	113	29	significant	significant	ADJ
ajmpe-90	113	30	biochemical	biochemical	ADJ
ajmpe-90	113	31	tumor	tumor	NOUN
ajmpe-90	113	32	marker	marker	NOUN
ajmpe-90	113	33	utilized	utilize	VERB
ajmpe-90	113	34	in	in	ADP
ajmpe-90	113	35	the	the	DET
ajmpe-90	113	36	screening	screening	NOUN
ajmpe-90	113	37	,	,	PUNCT
ajmpe-90	113	38	diagnosis	diagnosis	NOUN
ajmpe-90	113	39	,	,	PUNCT
ajmpe-90	113	40	and	and	CCONJ
ajmpe-90	113	41	monitoring	monitoring	NOUN
ajmpe-90	113	42	of	of	ADP
ajmpe-90	113	43	patients	patient	NOUN
ajmpe-90	113	44	with	with	ADP
ajmpe-90	113	45	prostate	prostate	NOUN
ajmpe-90	113	46	malignancies	malignancy	NOUN
ajmpe-90	113	47	.	.	PUNCT
ajmpe-90	114	1	regardless	regardless	ADV
ajmpe-90	114	2	of	of	ADP
ajmpe-90	114	3	the	the	DET
ajmpe-90	114	4	fact	fact	NOUN
ajmpe-90	114	5	that	that	SCONJ
ajmpe-90	114	6	it	it	PRON
ajmpe-90	114	7	is	be	AUX
ajmpe-90	114	8	generally	generally	ADV
ajmpe-90	114	9	known	know	VERB
ajmpe-90	114	10	that	that	SCONJ
ajmpe-90	114	11	thyroid	thyroid	NOUN
ajmpe-90	114	12	hormone	hormone	NOUN
ajmpe-90	114	13	modulates	modulate	VERB
ajmpe-90	114	14	the	the	DET
ajmpe-90	114	15	levels	level	NOUN
ajmpe-90	114	16	of	of	ADP
ajmpe-90	114	17	thyrotropin	thyrotropin	NOUN
ajmpe-90	114	18	-	-	PUNCT
ajmpe-90	114	19	releasing	release	VERB
ajmpe-90	114	20	hormone	hormone	NOUN
ajmpe-90	114	21	throughout	throughout	ADP
ajmpe-90	114	22	the	the	DET
ajmpe-90	114	23	male	male	ADJ
ajmpe-90	114	24	reproductive	reproductive	ADJ
ajmpe-90	114	25	system	system	NOUN
ajmpe-90	114	26	,	,	PUNCT
ajmpe-90	114	27	including	include	VERB
ajmpe-90	114	28	the	the	DET
ajmpe-90	114	29	prostate	prostate	NOUN
ajmpe-90	114	30	,	,	PUNCT
ajmpe-90	114	31	it	it	PRON
ajmpe-90	114	32	is	be	AUX
ajmpe-90	114	33	still	still	ADV
ajmpe-90	114	34	unclear	unclear	ADJ
ajmpe-90	114	35	how	how	SCONJ
ajmpe-90	114	36	thyroid	thyroid	NOUN
ajmpe-90	114	37	hormones	hormone	NOUN
ajmpe-90	114	38	directly	directly	ADV
ajmpe-90	114	39	affect	affect	VERB
ajmpe-90	114	40	the	the	DET
ajmpe-90	114	41	prostate	prostate	NOUN
ajmpe-90	114	42	.	.	PUNCT
ajmpe-90	115	1	in	in	ADP
ajmpe-90	115	2	patients	patient	NOUN
ajmpe-90	115	3	receiving	receive	VERB
ajmpe-90	115	4	treatment	treatment	NOUN
ajmpe-90	115	5	for	for	ADP
ajmpe-90	115	6	locally	locally	ADV
ajmpe-90	115	7	advanced	advanced	ADJ
ajmpe-90	115	8	prostate	prostate	NOUN
ajmpe-90	115	9	cancer	cancer	NOUN
ajmpe-90	115	10	,	,	PUNCT
ajmpe-90	115	11	they	they	PRON
ajmpe-90	115	12	assessed	assess	VERB
ajmpe-90	115	13	the	the	DET
ajmpe-90	115	14	connection	connection	NOUN
ajmpe-90	115	15	between	between	ADP
ajmpe-90	115	16	serum	serum	NOUN
ajmpe-90	115	17	t3	t3	PROPN
ajmpe-90	115	18	levels	level	NOUN
ajmpe-90	115	19	and	and	CCONJ
ajmpe-90	115	20	the	the	DET
ajmpe-90	115	21	probability	probability	NOUN
ajmpe-90	115	22	of	of	ADP
ajmpe-90	115	23	recurrence[12	recurrence[12	NOUN
ajmpe-90	115	24	]	]	PUNCT
ajmpe-90	115	25	.	.	PUNCT
ajmpe-90	116	1	nearly	nearly	ADV
ajmpe-90	116	2	every	every	PRON
ajmpe-90	116	3	tissue	tissue	NOUN
ajmpe-90	116	4	in	in	ADP
ajmpe-90	116	5	the	the	DET
ajmpe-90	116	6	body	body	NOUN
ajmpe-90	116	7	develops	develop	VERB
ajmpe-90	116	8	,	,	PUNCT
ajmpe-90	116	9	differentiates	differentiate	NOUN
ajmpe-90	116	10	,	,	PUNCT
ajmpe-90	116	11	and	and	CCONJ
ajmpe-90	116	12	grows	grow	VERB
ajmpe-90	116	13	in	in	ADP
ajmpe-90	116	14	response	response	NOUN
ajmpe-90	116	15	to	to	PART
ajmpe-90	116	16	thyroid	thyroid	VERB
ajmpe-90	116	17	hormones	hormone	NOUN
ajmpe-90	116	18	[	[	X
ajmpe-90	116	19	13	13	NUM
ajmpe-90	116	20	]	]	PUNCT
ajmpe-90	116	21	.	.	PUNCT
ajmpe-90	117	1	according	accord	VERB
ajmpe-90	117	2	to	to	ADP
ajmpe-90	117	3	bilek	bilek	PROPN
ajmpe-90	117	4	et	et	PROPN
ajmpe-90	117	5	al	al	PROPN
ajmpe-90	117	6	.	.	PUNCT
ajmpe-90	118	1	[	[	X
ajmpe-90	118	2	14	14	NUM
ajmpe-90	118	3	]	]	PUNCT
ajmpe-90	118	4	,	,	PUNCT
ajmpe-90	118	5	the	the	DET
ajmpe-90	118	6	thyroid	thyroid	NOUN
ajmpe-90	118	7	gland	gland	NOUN
ajmpe-90	118	8	and	and	CCONJ
ajmpe-90	118	9	the	the	DET
ajmpe-90	118	10	rat	rat	NOUN
ajmpe-90	118	11	ventral	ventral	ADJ
ajmpe-90	118	12	prostate	prostate	NOUN
ajmpe-90	118	13	have	have	VERB
ajmpe-90	118	14	a	a	DET
ajmpe-90	118	15	close	close	ADJ
ajmpe-90	118	16	association	association	NOUN
ajmpe-90	118	17	.	.	PUNCT
ajmpe-90	119	1	the	the	DET
ajmpe-90	119	2	direct	direct	ADJ
ajmpe-90	119	3	impact	impact	NOUN
ajmpe-90	119	4	of	of	ADP
ajmpe-90	119	5	thyroid	thyroid	NOUN
ajmpe-90	119	6	hormones	hormone	NOUN
ajmpe-90	119	7	on	on	ADP
ajmpe-90	119	8	the	the	DET
ajmpe-90	119	9	prostate	prostate	NOUN
ajmpe-90	119	10	is	be	AUX
ajmpe-90	119	11	still	still	ADV
ajmpe-90	119	12	unknown	unknown	ADJ
ajmpe-90	119	13	,	,	PUNCT
ajmpe-90	119	14	despite	despite	SCONJ
ajmpe-90	119	15	the	the	DET
ajmpe-90	119	16	fact	fact	NOUN
ajmpe-90	119	17	that	that	SCONJ
ajmpe-90	119	18	it	it	PRON
ajmpe-90	119	19	is	be	AUX
ajmpe-90	119	20	widely	widely	ADV
ajmpe-90	119	21	known	know	VERB
ajmpe-90	119	22	that	that	SCONJ
ajmpe-90	119	23	thyroid	thyroid	NOUN
ajmpe-90	119	24	hormone	hormone	NOUN
ajmpe-90	119	25	modulates	modulate	NOUN
ajmpe-90	119	26	thyrotropin	thyrotropin	NOUN
ajmpe-90	119	27	-	-	PUNCT
ajmpe-90	119	28	releasing	release	VERB
ajmpe-90	119	29	hormone	hormone	NOUN
ajmpe-90	119	30	levels	level	NOUN
ajmpe-90	119	31	in	in	ADP
ajmpe-90	119	32	the	the	DET
ajmpe-90	119	33	male	male	ADJ
ajmpe-90	119	34	reproductive	reproductive	ADJ
ajmpe-90	119	35	system	system	NOUN
ajmpe-90	119	36	,	,	PUNCT
ajmpe-90	119	37	including	include	VERB
ajmpe-90	119	38	the	the	DET
ajmpe-90	119	39	prostate	prostate	NOUN
ajmpe-90	119	40	[	[	X
ajmpe-90	119	41	15	15	NUM
ajmpe-90	119	42	]	]	PUNCT
ajmpe-90	119	43	.	.	PUNCT
ajmpe-90	120	1	in	in	ADP
ajmpe-90	120	2	patients	patient	NOUN
ajmpe-90	120	3	receiving	receive	VERB
ajmpe-90	120	4	treatment	treatment	NOUN
ajmpe-90	120	5	for	for	ADP
ajmpe-90	120	6	localized	localized	ADJ
ajmpe-90	120	7	pca	pca	NOUN
ajmpe-90	120	8	,	,	PUNCT
ajmpe-90	120	9	lehrer	lehrer	PROPN
ajmpe-90	120	10	et	et	PROPN
ajmpe-90	120	11	al	al	PROPN
ajmpe-90	120	12	.	.	PUNCT
ajmpe-90	121	1	[	[	X
ajmpe-90	121	2	16	16	NUM
ajmpe-90	121	3	]	]	PUNCT
ajmpe-90	121	4	examined	examine	VERB
ajmpe-90	121	5	the	the	DET
ajmpe-90	121	6	association	association	NOUN
ajmpe-90	121	7	between	between	ADP
ajmpe-90	121	8	serum	serum	PROPN
ajmpe-90	121	9	t3	t3	PROPN
ajmpe-90	121	10	levels	level	NOUN
ajmpe-90	121	11	and	and	CCONJ
ajmpe-90	121	12	the	the	DET
ajmpe-90	121	13	likelihood	likelihood	NOUN
ajmpe-90	121	14	of	of	ADP
ajmpe-90	121	15	recurrence	recurrence	NOUN
ajmpe-90	121	16	.	.	PUNCT
ajmpe-90	122	1	they	they	PRON
ajmpe-90	122	2	classified	classify	VERB
ajmpe-90	122	3	the	the	DET
ajmpe-90	122	4	68	68	NUM
ajmpe-90	122	5	individuals	individual	NOUN
ajmpe-90	122	6	in	in	ADP
ajmpe-90	122	7	their	their	PRON
ajmpe-90	122	8	study	study	NOUN
ajmpe-90	122	9	into	into	ADP
ajmpe-90	122	10	three	three	NUM
ajmpe-90	122	11	risks	risk	NOUN
ajmpe-90	122	12	identified	identify	VERB
ajmpe-90	122	13	,	,	PUNCT
ajmpe-90	122	14	moderate	moderate	ADJ
ajmpe-90	122	15	,	,	PUNCT
ajmpe-90	122	16	and	and	CCONJ
ajmpe-90	122	17	high	high	ADJ
ajmpe-90	122	18	risk	risk	NOUN
ajmpe-90	122	19	.	.	PUNCT
ajmpe-90	123	1	in	in	ADP
ajmpe-90	123	2	the	the	DET
ajmpe-90	123	3	present	present	ADJ
ajmpe-90	123	4	study	study	NOUN
ajmpe-90	123	5	patients	patient	NOUN
ajmpe-90	123	6	diagnosed	diagnose	VERB
ajmpe-90	123	7	with	with	ADP
ajmpe-90	123	8	prostatic	prostatic	ADJ
ajmpe-90	123	9	cancer	cancer	NOUN
ajmpe-90	123	10	were	be	AUX
ajmpe-90	123	11	set	set	VERB
ajmpe-90	123	12	as	as	ADP
ajmpe-90	123	13	case	case	NOUN
ajmpe-90	123	14	group	group	NOUN
ajmpe-90	123	15	,	,	PUNCT
ajmpe-90	123	16	measuring	measure	VERB
ajmpe-90	123	17	psa	psa	NOUN
ajmpe-90	123	18	as	as	ADV
ajmpe-90	123	19	well	well	ADV
ajmpe-90	123	20	as	as	ADP
ajmpe-90	123	21	tft	tft	ADV
ajmpe-90	123	22	among	among	ADP
ajmpe-90	123	23	case	case	NOUN
ajmpe-90	123	24	and	and	CCONJ
ajmpe-90	123	25	control	control	NOUN
ajmpe-90	123	26	groups	group	NOUN
ajmpe-90	123	27	,	,	PUNCT
ajmpe-90	123	28	showed	show	VERB
ajmpe-90	123	29	an	an	DET
ajmpe-90	123	30	elevation	elevation	NOUN
ajmpe-90	123	31	of	of	ADP
ajmpe-90	123	32	each	each	DET
ajmpe-90	123	33	parameter	parameter	NOUN
ajmpe-90	123	34	among	among	ADP
ajmpe-90	123	35	cases	case	NOUN
ajmpe-90	123	36	than	than	ADP
ajmpe-90	123	37	a	a	DET
ajmpe-90	123	38	control	control	NOUN
ajmpe-90	123	39	group	group	NOUN
ajmpe-90	123	40	,	,	PUNCT
ajmpe-90	123	41	giving	give	VERB
ajmpe-90	123	42	significant	significant	ADJ
ajmpe-90	123	43	difference	difference	NOUN
ajmpe-90	123	44	,	,	PUNCT
ajmpe-90	123	45	a	a	DET
ajmpe-90	123	46	suggests	suggest	VERB
ajmpe-90	123	47	that	that	SCONJ
ajmpe-90	123	48	secondary	secondary	ADJ
ajmpe-90	123	49	hyperthyroidism	hyperthyroidism	NOUN
ajmpe-90	123	50	increase	increase	VERB
ajmpe-90	123	51	the	the	DET
ajmpe-90	123	52	risk	risk	NOUN
ajmpe-90	123	53	of	of	ADP
ajmpe-90	123	54	prostatic	prostatic	ADJ
ajmpe-90	123	55	cancer	cancer	NOUN
ajmpe-90	123	56	.	.	PUNCT
ajmpe-90	124	1	a	a	DET
ajmpe-90	124	2	prospective	prospective	ADJ
ajmpe-90	124	3	cohort	cohort	NOUN
ajmpe-90	124	4	study	study	NOUN
ajmpe-90	124	5	of	of	ADP
ajmpe-90	124	6	a	a	DET
ajmpe-90	124	7	community	community	NOUN
ajmpe-90	124	8	-	-	PUNCT
ajmpe-90	124	9	dwelling	dwell	VERB
ajmpe-90	124	10	population	population	NOUN
ajmpe-90	124	11	in	in	ADP
ajmpe-90	124	12	western	western	ADJ
ajmpe-90	124	13	australia	australia	PROPN
ajmpe-90	124	14	between	between	ADP
ajmpe-90	124	15	the	the	DET
ajmpe-90	124	16	ages	age	NOUN
ajmpe-90	124	17	of	of	ADP
ajmpe-90	124	18	25	25	NUM
ajmpe-90	124	19	and	and	CCONJ
ajmpe-90	124	20	84	84	NUM
ajmpe-90	124	21	found	find	VERB
ajmpe-90	124	22	some	some	DET
ajmpe-90	124	23	agreement	agreement	NOUN
ajmpe-90	124	24	.	.	PUNCT
ajmpe-90	125	1	tests	test	NOUN
ajmpe-90	125	2	including	include	VERB
ajmpe-90	125	3	the	the	DET
ajmpe-90	125	4	tsh	tsh	NOUN
ajmpe-90	125	5	and	and	CCONJ
ajmpe-90	125	6	ft4	ft4	NOUN
ajmpe-90	125	7	were	be	AUX
ajmpe-90	125	8	performed	perform	VERB
ajmpe-90	125	9	on	on	ADP
ajmpe-90	125	10	the	the	DET
ajmpe-90	125	11	archived	archive	VERB
ajmpe-90	125	12	.	.	PUNCT
ajmpe-90	126	1	along	along	ADP
ajmpe-90	126	2	with	with	ADP
ajmpe-90	126	3	the	the	DET
ajmpe-90	126	4	41	41	NUM
ajmpe-90	126	5	prostate	prostate	NOUN
ajmpe-90	126	6	malignancies	malignancy	NOUN
ajmpe-90	126	7	,	,	PUNCT
ajmpe-90	126	8	other	other	ADJ
ajmpe-90	126	9	cancer	cancer	NOUN
ajmpe-90	126	10	kinds	kind	NOUN
ajmpe-90	126	11	were	be	AUX
ajmpe-90	126	12	also	also	ADV
ajmpe-90	126	13	included	include	VERB
ajmpe-90	126	14	.	.	PUNCT
ajmpe-90	127	1	a	a	DET
ajmpe-90	127	2	decreased	decrease	VERB
ajmpe-90	127	3	risk	risk	NOUN
ajmpe-90	127	4	of	of	ADP
ajmpe-90	127	5	prostate	prostate	NOUN
ajmpe-90	127	6	cancer	cancer	NOUN
ajmpe-90	127	7	was	be	AUX
ajmpe-90	127	8	linked	link	VERB
ajmpe-90	127	9	to	to	ADP
ajmpe-90	127	10	higher	high	ADJ
ajmpe-90	127	11	tsh	tsh	NOUN
ajmpe-90	127	12	(	(	PUNCT
ajmpe-90	127	13	p	p	NOUN
ajmpe-90	127	14	=	=	NOUN
ajmpe-90	127	15	0.005	0.005	NUM
ajmpe-90	127	16	)	)	PUNCT
ajmpe-90	127	17	.	.	PUNCT
ajmpe-90	128	1	similar	similar	ADJ
ajmpe-90	128	2	to	to	ADP
ajmpe-90	128	3	this	this	PRON
ajmpe-90	128	4	,	,	PUNCT
ajmpe-90	128	5	greater	great	ADJ
ajmpe-90	128	6	ft4	ft4	PROPN
ajmpe-90	128	7	was	be	AUX
ajmpe-90	128	8	linked	link	VERB
ajmpe-90	128	9	to	to	ADP
ajmpe-90	128	10	a	a	DET
ajmpe-90	128	11	higher	high	ADJ
ajmpe-90	128	12	risk	risk	NOUN
ajmpe-90	128	13	of	of	ADP
ajmpe-90	128	14	prostate	prostate	NOUN
ajmpe-90	128	15	cancer	cancer	NOUN
ajmpe-90	128	16	(	(	PUNCT
ajmpe-90	128	17	p	p	NOUN
ajmpe-90	128	18	=	=	NOUN
ajmpe-90	128	19	0.009	0.009	NUM
ajmpe-90	128	20	)	)	PUNCT
ajmpe-90	129	1	[	[	X
ajmpe-90	129	2	17	17	NUM
ajmpe-90	129	3	]	]	PUNCT
ajmpe-90	129	4	,	,	PUNCT
ajmpe-90	129	5	middle	middle	NOUN
ajmpe-90	129	6	-	-	PUNCT
ajmpe-90	129	7	aged	aged	ADJ
ajmpe-90	129	8	males	male	NOUN
ajmpe-90	129	9	with	with	ADP
ajmpe-90	129	10	benign	benign	ADJ
ajmpe-90	129	11	prostatic	prostatic	ADJ
ajmpe-90	129	12	hyperplasia	hyperplasia	NOUN
ajmpe-90	129	13	were	be	AUX
ajmpe-90	129	14	given	give	VERB
ajmpe-90	129	15	hormones	hormone	NOUN
ajmpe-90	129	16	.	.	PUNCT
ajmpe-90	130	1	levels	level	NOUN
ajmpe-90	130	2	of	of	ADP
ajmpe-90	130	3	free	free	ADJ
ajmpe-90	130	4	thyroxin	thyroxin	NOUN
ajmpe-90	130	5	(	(	PUNCT
ajmpe-90	130	6	ft4	ft4	NOUN
ajmpe-90	130	7	)	)	PUNCT
ajmpe-90	130	8	and	and	CCONJ
ajmpe-90	130	9	thyroid	thyroid	NOUN
ajmpe-90	130	10	-	-	PUNCT
ajmpe-90	130	11	stimulating	stimulate	VERB
ajmpe-90	130	12	hormone	hormone	NOUN
ajmpe-90	130	13	(	(	PUNCT
ajmpe-90	130	14	tsh	tsh	NOUN
ajmpe-90	130	15	)	)	PUNCT
ajmpe-90	130	16	were	be	AUX
ajmpe-90	130	17	assessed	assess	VERB
ajmpe-90	130	18	.	.	PUNCT
ajmpe-90	131	1	the	the	DET
ajmpe-90	131	2	ft4	ft4	PROPN
ajmpe-90	131	3	quartile	quartile	NOUN
ajmpe-90	131	4	had	have	VERB
ajmpe-90	131	5	a	a	DET
ajmpe-90	131	6	large	large	ADJ
ajmpe-90	131	7	increase	increase	NOUN
ajmpe-90	131	8	.	.	PUNCT
ajmpe-90	132	1	no	no	DET
ajmpe-90	132	2	statistically	statistically	ADV
ajmpe-90	132	3	significant	significant	ADJ
ajmpe-90	132	4	difference	difference	NOUN
ajmpe-90	132	5	was	be	AUX
ajmpe-90	132	6	seen	see	VERB
ajmpe-90	132	7	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-90	132	8	american	american	PROPN
ajmpe-90	132	9	journal	journal	PROPN
ajmpe-90	132	10	of	of	ADP
ajmpe-90	132	11	medical	medical	ADJ
ajmpe-90	132	12	and	and	CCONJ
ajmpe-90	132	13	physical	physical	ADJ
ajmpe-90	132	14	education	education	NOUN
ajmpe-90	132	15	vol.1	vol.1	PROPN
ajmpe-90	132	16	,	,	PUNCT
ajmpe-90	132	17	issue	issue	NOUN
ajmpe-90	132	18	1	1	NUM
ajmpe-90	132	19	;	;	PUNCT
ajmpe-90	132	20	july	july	PROPN
ajmpe-90	132	21	2023	2023	NUM
ajmpe-90	132	22	;	;	PUNCT
ajmpe-90	132	23	1252	1252	NUM
ajmpe-90	132	24	columbia	columbia	PROPN
ajmpe-90	132	25	rd	rd	PROPN
ajmpe-90	132	26	nw	nw	PROPN
ajmpe-90	132	27	,	,	PUNCT
ajmpe-90	132	28	washington	washington	PROPN
ajmpe-90	132	29	dc	dc	PROPN
ajmpe-90	132	30	,	,	PUNCT
ajmpe-90	132	31	united	united	PROPN
ajmpe-90	132	32	states	states	PROPN
ajmpe-90	132	33	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-90	132	34	;	;	PUNCT
ajmpe-90	132	35	mail	mail	NOUN
ajmpe-90	132	36	:	:	PUNCT
ajmpe-90	132	37	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-90	133	1	31	31	NUM
ajmpe-90	134	1	|	|	ADV
ajmpe-90	134	2	a	a	DET
ajmpe-90	134	3	m	m	NOUN
ajmpe-90	134	4	e	e	NOUN
ajmpe-90	134	5	r	r	NOUN
ajmpe-90	134	6	i	i	NOUN
ajmpe-90	134	7	c	c	VERB
ajmpe-90	134	8	a	a	DET
ajmpe-90	134	9	n	n	NOUN
ajmpe-90	135	1	j	j	NOUN
ajmpe-90	135	2	o	o	X
ajmpe-90	135	3	u	u	NOUN
ajmpe-90	135	4	r	r	NOUN
ajmpe-90	135	5	n	n	NOUN
ajmpe-90	135	6	a	a	DET
ajmpe-90	135	7	l	l	NOUN
ajmpe-90	135	8	o	o	X
ajmpe-90	136	1	f	f	X
ajmpe-90	136	2	m	m	NOUN
ajmpe-90	136	3	e	e	NOUN
ajmpe-90	137	1	d	d	NOUN
ajmpe-90	137	2	i	i	PRON
ajmpe-90	137	3	c	c	VERB
ajmpe-90	137	4	a	a	DET
ajmpe-90	137	5	l	l	NOUN
ajmpe-90	137	6	a	a	X
ajmpe-90	137	7	n	n	NOUN
ajmpe-90	138	1	d	d	NOUN
ajmpe-90	138	2	p	p	NOUN
ajmpe-90	138	3	h	h	NOUN
ajmpe-90	138	4	y	y	NOUN
ajmpe-90	138	5	s	s	VERB
ajmpe-90	139	1	i	i	INTJ
ajmpe-90	139	2	c	c	VERB
ajmpe-90	139	3	a	a	DET
ajmpe-90	139	4	l	l	NOUN
ajmpe-90	139	5	e	e	NOUN
ajmpe-90	139	6	d	d	X
ajmpe-90	139	7	u	u	X
ajmpe-90	139	8	c	c	PROPN
ajmpe-90	140	1	a	a	DET
ajmpe-90	140	2	t	t	NOUN
ajmpe-90	141	1	i	i	PRON
ajmpe-90	141	2	o	o	VERB
ajmpe-90	141	3	n	n	CCONJ
ajmpe-90	141	4	|	|	ADV
ajmpe-90	141	5	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-90	141	6	in	in	ADP
ajmpe-90	141	7	tsh	tsh	NOUN
ajmpe-90	141	8	[	[	X
ajmpe-90	141	9	18	18	NUM
ajmpe-90	141	10	]	]	PUNCT
ajmpe-90	141	11	.	.	PUNCT
ajmpe-90	142	1	in	in	ADP
ajmpe-90	142	2	previous	previous	ADJ
ajmpe-90	142	3	study	study	NOUN
ajmpe-90	142	4	,	,	PUNCT
ajmpe-90	142	5	thyroid	thyroid	NOUN
ajmpe-90	142	6	hormones	hormone	NOUN
ajmpe-90	142	7	were	be	AUX
ajmpe-90	142	8	found	find	VERB
ajmpe-90	142	9	related	relate	VERB
ajmpe-90	142	10	to	to	ADP
ajmpe-90	142	11	the	the	DET
ajmpe-90	142	12	pathophysiology	pathophysiology	NOUN
ajmpe-90	142	13	of	of	ADP
ajmpe-90	142	14	several	several	ADJ
ajmpe-90	142	15	cancer	cancer	NOUN
ajmpe-90	142	16	forms	form	NOUN
ajmpe-90	142	17	,	,	PUNCT
ajmpe-90	142	18	according	accord	VERB
ajmpe-90	142	19	to	to	ADP
ajmpe-90	142	20	study	study	NOUN
ajmpe-90	142	21	results	result	NOUN
ajmpe-90	142	22	,	,	PUNCT
ajmpe-90	142	23	results	result	NOUN
ajmpe-90	142	24	from	from	ADP
ajmpe-90	142	25	case	case	NOUN
ajmpe-90	142	26	-	-	PUNCT
ajmpe-90	142	27	control	control	NOUN
ajmpe-90	142	28	and	and	CCONJ
ajmpe-90	142	29	population	population	NOUN
ajmpe-90	142	30	-	-	PUNCT
ajmpe-90	142	31	based	base	VERB
ajmpe-90	142	32	studies	study	NOUN
ajmpe-90	142	33	are	be	AUX
ajmpe-90	142	34	inconclusive	inconclusive	ADJ
ajmpe-90	142	35	when	when	SCONJ
ajmpe-90	142	36	it	it	PRON
ajmpe-90	142	37	comes	come	VERB
ajmpe-90	142	38	to	to	ADP
ajmpe-90	142	39	the	the	DET
ajmpe-90	142	40	link	link	NOUN
ajmpe-90	142	41	between	between	ADP
ajmpe-90	142	42	thyroid	thyroid	NOUN
ajmpe-90	142	43	hormones	hormone	NOUN
ajmpe-90	142	44	and	and	CCONJ
ajmpe-90	142	45	cancer	cancer	NOUN
ajmpe-90	142	46	.	.	PUNCT
ajmpe-90	143	1	numerous	numerous	ADJ
ajmpe-90	143	2	pieces	piece	NOUN
ajmpe-90	143	3	of	of	ADP
ajmpe-90	143	4	evidence	evidence	NOUN
ajmpe-90	143	5	point	point	NOUN
ajmpe-90	143	6	to	to	ADP
ajmpe-90	143	7	an	an	DET
ajmpe-90	143	8	increased	increase	VERB
ajmpe-90	143	9	risk	risk	NOUN
ajmpe-90	143	10	of	of	ADP
ajmpe-90	143	11	various	various	ADJ
ajmpe-90	143	12	solid	solid	ADJ
ajmpe-90	143	13	tumors	tumor	NOUN
ajmpe-90	143	14	in	in	ADP
ajmpe-90	143	15	people	people	NOUN
ajmpe-90	143	16	with	with	ADP
ajmpe-90	143	17	asymptomatic	asymptomatic	ADJ
ajmpe-90	143	18	and	and	CCONJ
ajmpe-90	143	19	clinical	clinical	ADJ
ajmpe-90	143	20	hyperthyroidism[19	hyperthyroidism[19	NOUN
ajmpe-90	143	21	]	]	PUNCT
ajmpe-90	143	22	.	.	PUNCT
ajmpe-90	144	1	the	the	DET
ajmpe-90	144	2	results	result	NOUN
ajmpe-90	144	3	of	of	ADP
ajmpe-90	144	4	a	a	DET
ajmpe-90	144	5	study	study	NOUN
ajmpe-90	144	6	agreed	agree	VERB
ajmpe-90	144	7	that	that	SCONJ
ajmpe-90	144	8	there	there	PRON
ajmpe-90	144	9	is	be	VERB
ajmpe-90	144	10	a	a	DET
ajmpe-90	144	11	link	link	NOUN
ajmpe-90	144	12	between	between	ADP
ajmpe-90	144	13	thyroid	thyroid	NOUN
ajmpe-90	144	14	hormones	hormone	NOUN
ajmpe-90	144	15	and	and	CCONJ
ajmpe-90	144	16	prostate	prostate	NOUN
ajmpe-90	144	17	cancer	cancer	NOUN
ajmpe-90	144	18	case	case	NOUN
ajmpe-90	144	19	-	-	PUNCT
ajmpe-90	144	20	control	control	NOUN
ajmpe-90	144	21	20	20	NUM
ajmpe-90	144	22	]	]	PUNCT
ajmpe-90	144	23	.	.	PUNCT
ajmpe-90	145	1	the	the	DET
ajmpe-90	145	2	patients	patient	NOUN
ajmpe-90	145	3	in	in	ADP
ajmpe-90	145	4	this	this	DET
ajmpe-90	145	5	study	study	NOUN
ajmpe-90	145	6	were	be	AUX
ajmpe-90	145	7	56.7	56.7	NUM
ajmpe-90	145	8	years	year	NOUN
ajmpe-90	145	9	old	old	ADJ
ajmpe-90	145	10	on	on	ADP
ajmpe-90	145	11	average	average	ADJ
ajmpe-90	145	12	.	.	PUNCT
ajmpe-90	146	1	according	accord	VERB
ajmpe-90	146	2	to	to	ADP
ajmpe-90	146	3	our	our	PRON
ajmpe-90	146	4	research	research	NOUN
ajmpe-90	146	5	,	,	PUNCT
ajmpe-90	146	6	elevated	elevated	ADJ
ajmpe-90	146	7	serum	serum	NOUN
ajmpe-90	146	8	psa	psa	NOUN
ajmpe-90	146	9	levels	level	NOUN
ajmpe-90	146	10	were	be	AUX
ajmpe-90	146	11	related	relate	VERB
ajmpe-90	146	12	to	to	ADP
ajmpe-90	146	13	higher	high	ADJ
ajmpe-90	146	14	serum	serum	NOUN
ajmpe-90	146	15	tsh	tsh	PROPN
ajmpe-90	146	16	,	,	PUNCT
ajmpe-90	146	17	t3	t3	PROPN
ajmpe-90	146	18	,	,	PUNCT
ajmpe-90	146	19	and	and	CCONJ
ajmpe-90	146	20	t4	t4	PROPN
ajmpe-90	146	21	levels	level	NOUN
ajmpe-90	146	22	.	.	PUNCT
ajmpe-90	147	1	previous	previous	ADJ
ajmpe-90	147	2	research	research	NOUN
ajmpe-90	147	3	demonstrated	demonstrate	VERB
ajmpe-90	147	4	lower	low	ADJ
ajmpe-90	147	5	serum	serum	NOUN
ajmpe-90	147	6	tsh	tsh	NOUN
ajmpe-90	147	7	and	and	CCONJ
ajmpe-90	147	8	greater	great	ADJ
ajmpe-90	147	9	serum	serum	NOUN
ajmpe-90	147	10	t3	t3	PROPN
ajmpe-90	147	11	levels	level	NOUN
ajmpe-90	147	12	in	in	ADP
ajmpe-90	147	13	men	man	NOUN
ajmpe-90	147	14	with	with	ADP
ajmpe-90	147	15	benign	benign	ADJ
ajmpe-90	147	16	prostatic	prostatic	ADJ
ajmpe-90	147	17	hyperplasia	hyperplasia	NOUN
ajmpe-90	147	18	and	and	CCONJ
ajmpe-90	147	19	prostate	prostate	NOUN
ajmpe-90	147	20	cancer	cancer	NOUN
ajmpe-90	147	21	.	.	PUNCT
ajmpe-90	148	1	additionally	additionally	ADV
ajmpe-90	148	2	,	,	PUNCT
ajmpe-90	148	3	it	it	PRON
ajmpe-90	148	4	is	be	AUX
ajmpe-90	148	5	well	well	ADV
ajmpe-90	148	6	-	-	PUNCT
ajmpe-90	148	7	known	know	VERB
ajmpe-90	148	8	that	that	SCONJ
ajmpe-90	148	9	a	a	DET
ajmpe-90	148	10	number	number	NOUN
ajmpe-90	148	11	of	of	ADP
ajmpe-90	148	12	factors	factor	NOUN
ajmpe-90	148	13	can	can	AUX
ajmpe-90	148	14	affect	affect	VERB
ajmpe-90	148	15	psa	psa	VERB
ajmpe-90	148	16	,	,	PUNCT
ajmpe-90	148	17	the	the	DET
ajmpe-90	148	18	most	most	ADV
ajmpe-90	148	19	widely	widely	ADV
ajmpe-90	148	20	used	use	VERB
ajmpe-90	148	21	biomarker	biomarker	NOUN
ajmpe-90	148	22	for	for	ADP
ajmpe-90	148	23	the	the	DET
ajmpe-90	148	24	diagnosis	diagnosis	NOUN
ajmpe-90	148	25	of	of	ADP
ajmpe-90	148	26	prostate	prostate	NOUN
ajmpe-90	148	27	cancer	cancer	NOUN
ajmpe-90	148	28	[	[	X
ajmpe-90	148	29	21	21	NUM
ajmpe-90	148	30	]	]	PUNCT
ajmpe-90	148	31	.	.	PUNCT
ajmpe-90	149	1	increased	increase	VERB
ajmpe-90	149	2	t3	t3	PROPN
ajmpe-90	149	3	levels	level	NOUN
ajmpe-90	149	4	have	have	AUX
ajmpe-90	149	5	been	be	AUX
ajmpe-90	149	6	linked	link	VERB
ajmpe-90	149	7	to	to	ADP
ajmpe-90	149	8	a	a	DET
ajmpe-90	149	9	number	number	NOUN
ajmpe-90	149	10	of	of	ADP
ajmpe-90	149	11	markers	marker	NOUN
ajmpe-90	149	12	of	of	ADP
ajmpe-90	149	13	prostate	prostate	NOUN
ajmpe-90	149	14	cancer	cancer	NOUN
ajmpe-90	149	15	histopathological	histopathological	ADJ
ajmpe-90	149	16	aggressiveness	aggressiveness	NOUN
ajmpe-90	149	17	,	,	PUNCT
ajmpe-90	149	18	according	accord	VERB
ajmpe-90	149	19	to	to	ADP
ajmpe-90	149	20	a	a	DET
ajmpe-90	149	21	prior	prior	ADJ
ajmpe-90	149	22	study	study	NOUN
ajmpe-90	149	23	[	[	X
ajmpe-90	149	24	22	22	NUM
ajmpe-90	149	25	]	]	PUNCT
ajmpe-90	149	26	.	.	PUNCT
ajmpe-90	150	1	according	accord	VERB
ajmpe-90	150	2	to	to	ADP
ajmpe-90	150	3	new	new	ADJ
ajmpe-90	150	4	endocrinological	endocrinological	ADJ
ajmpe-90	150	5	guidelines	guideline	NOUN
ajmpe-90	150	6	[	[	X
ajmpe-90	150	7	23	23	NUM
ajmpe-90	150	8	]	]	PUNCT
ajmpe-90	150	9	,	,	PUNCT
ajmpe-90	150	10	men	man	NOUN
ajmpe-90	150	11	with	with	ADP
ajmpe-90	150	12	clinical	clinical	ADJ
ajmpe-90	150	13	or	or	CCONJ
ajmpe-90	150	14	subclinical	subclinical	ADJ
ajmpe-90	150	15	hypothyroid	hypothyroid	ADJ
ajmpe-90	150	16	status	status	NOUN
ajmpe-90	150	17	had	have	VERB
ajmpe-90	150	18	a	a	DET
ajmpe-90	150	19	lower	low	ADJ
ajmpe-90	150	20	chance	chance	NOUN
ajmpe-90	150	21	of	of	ADP
ajmpe-90	150	22	developing	develop	VERB
ajmpe-90	150	23	prostate	prostate	NOUN
ajmpe-90	150	24	cancer	cancer	NOUN
ajmpe-90	150	25	than	than	ADP
ajmpe-90	150	26	men	man	NOUN
ajmpe-90	150	27	with	with	ADP
ajmpe-90	150	28	normal	normal	ADJ
ajmpe-90	150	29	thyroid	thyroid	NOUN
ajmpe-90	150	30	function	function	NOUN
ajmpe-90	150	31	.	.	PUNCT
ajmpe-90	151	1	this	this	PRON
ajmpe-90	151	2	was	be	AUX
ajmpe-90	151	3	found	find	VERB
ajmpe-90	151	4	in	in	ADP
ajmpe-90	151	5	a	a	DET
ajmpe-90	151	6	previous	previous	ADJ
ajmpe-90	151	7	study	study	NOUN
ajmpe-90	151	8	.	.	PUNCT
ajmpe-90	152	1	similar	similar	ADJ
ajmpe-90	152	2	to	to	ADP
ajmpe-90	152	3	this	this	PRON
ajmpe-90	152	4	,	,	PUNCT
ajmpe-90	152	5	we	we	PRON
ajmpe-90	152	6	found	find	VERB
ajmpe-90	152	7	that	that	SCONJ
ajmpe-90	152	8	males	male	NOUN
ajmpe-90	152	9	with	with	ADP
ajmpe-90	152	10	the	the	DET
ajmpe-90	152	11	highest	high	ADJ
ajmpe-90	152	12	tsh	tsh	NOUN
ajmpe-90	152	13	levels	level	NOUN
ajmpe-90	152	14	(	(	PUNCT
ajmpe-90	152	15	which	which	PRON
ajmpe-90	152	16	indicate	indicate	VERB
ajmpe-90	152	17	a	a	DET
ajmpe-90	152	18	hypothyroid	hypothyroid	ADJ
ajmpe-90	152	19	state	state	NOUN
ajmpe-90	152	20	)	)	PUNCT
ajmpe-90	152	21	had	have	VERB
ajmpe-90	152	22	a	a	DET
ajmpe-90	152	23	decreased	decrease	VERB
ajmpe-90	152	24	risk	risk	NOUN
ajmpe-90	152	25	of	of	ADP
ajmpe-90	152	26	developing	develop	VERB
ajmpe-90	152	27	prostate	prostate	NOUN
ajmpe-90	152	28	cancer	cancer	NOUN
ajmpe-90	152	29	.	.	PUNCT
ajmpe-90	153	1	these	these	DET
ajmpe-90	153	2	results	result	NOUN
ajmpe-90	153	3	are	be	AUX
ajmpe-90	153	4	in	in	ADP
ajmpe-90	153	5	line	line	NOUN
ajmpe-90	153	6	with	with	ADP
ajmpe-90	153	7	earlier	early	ADJ
ajmpe-90	153	8	laboratory	laboratory	NOUN
ajmpe-90	153	9	and	and	CCONJ
ajmpe-90	153	10	epidemiologic	epidemiologic	ADJ
ajmpe-90	153	11	evidence	evidence	NOUN
ajmpe-90	153	12	that	that	PRON
ajmpe-90	153	13	thyroid	thyroid	NOUN
ajmpe-90	153	14	hormones	hormone	NOUN
ajmpe-90	153	15	affect	affect	VERB
ajmpe-90	153	16	the	the	DET
ajmpe-90	153	17	incidence	incidence	NOUN
ajmpe-90	153	18	of	of	ADP
ajmpe-90	153	19	prostate	prostate	NOUN
ajmpe-90	153	20	cancer	cancer	NOUN
ajmpe-90	153	21	[	[	X
ajmpe-90	153	22	24,25,26	24,25,26	NUM
ajmpe-90	153	23	-	-	SYM
ajmpe-90	153	24	29	29	NUM
ajmpe-90	153	25	]	]	PUNCT
ajmpe-90	153	26	.	.	PUNCT
ajmpe-90	154	1	another	another	DET
ajmpe-90	154	2	cross	cross	ADJ
ajmpe-90	154	3	-	-	ADJ
ajmpe-90	154	4	sectional	sectional	ADJ
ajmpe-90	154	5	investigation	investigation	NOUN
ajmpe-90	154	6	similarly	similarly	ADV
ajmpe-90	154	7	revealed	reveal	VERB
ajmpe-90	154	8	that	that	SCONJ
ajmpe-90	154	9	prostate	prostate	NOUN
ajmpe-90	154	10	cancer	cancer	NOUN
ajmpe-90	154	11	cases	case	NOUN
ajmpe-90	154	12	had	have	VERB
ajmpe-90	154	13	more	more	ADJ
ajmpe-90	154	14	circulating	circulate	VERB
ajmpe-90	154	15	t3	t3	NOUN
ajmpe-90	154	16	than	than	SCONJ
ajmpe-90	154	17	controls	control	NOUN
ajmpe-90	154	18	did	do	VERB
ajmpe-90	154	19	[	[	X
ajmpe-90	154	20	27	27	NUM
ajmpe-90	154	21	]	]	PUNCT
ajmpe-90	154	22	.	.	PUNCT
ajmpe-90	155	1	the	the	DET
ajmpe-90	155	2	association	association	NOUN
ajmpe-90	155	3	between	between	ADP
ajmpe-90	155	4	thyroid	thyroid	NOUN
ajmpe-90	155	5	hormones	hormone	NOUN
ajmpe-90	155	6	or	or	CCONJ
ajmpe-90	155	7	status	status	NOUN
ajmpe-90	155	8	and	and	CCONJ
ajmpe-90	155	9	the	the	DET
ajmpe-90	155	10	incidence	incidence	NOUN
ajmpe-90	155	11	of	of	ADP
ajmpe-90	155	12	prostate	prostate	NOUN
ajmpe-90	155	13	cancer	cancer	NOUN
ajmpe-90	155	14	was	be	AUX
ajmpe-90	155	15	only	only	ADV
ajmpe-90	155	16	explored	explore	VERB
ajmpe-90	155	17	in	in	ADP
ajmpe-90	155	18	two	two	NUM
ajmpe-90	155	19	prospective	prospective	ADJ
ajmpe-90	155	20	studies	study	NOUN
ajmpe-90	155	21	[	[	X
ajmpe-90	155	22	28,29	28,29	NUM
ajmpe-90	155	23	]	]	X
ajmpe-90	155	24	.	.	PUNCT
ajmpe-90	156	1	one	one	NUM
ajmpe-90	156	2	found	find	VERB
ajmpe-90	156	3	that	that	SCONJ
ajmpe-90	156	4	males	male	NOUN
ajmpe-90	156	5	who	who	PRON
ajmpe-90	156	6	self	self	NOUN
ajmpe-90	156	7	-	-	PUNCT
ajmpe-90	156	8	reported	report	VERB
ajmpe-90	156	9	having	have	VERB
ajmpe-90	156	10	thyroid	thyroid	NOUN
ajmpe-90	156	11	disease	disease	NOUN
ajmpe-90	156	12	had	have	VERB
ajmpe-90	156	13	a	a	DET
ajmpe-90	156	14	higher	high	ADJ
ajmpe-90	156	15	chance	chance	NOUN
ajmpe-90	156	16	of	of	ADP
ajmpe-90	156	17	developing	develop	VERB
ajmpe-90	156	18	prostate	prostate	NOUN
ajmpe-90	156	19	cancer	cancer	NOUN
ajmpe-90	156	20	[	[	X
ajmpe-90	156	21	28	28	NUM
ajmpe-90	156	22	]	]	PUNCT
ajmpe-90	156	23	,	,	PUNCT
ajmpe-90	156	24	but	but	CCONJ
ajmpe-90	156	25	this	this	DET
ajmpe-90	156	26	study	study	NOUN
ajmpe-90	156	27	did	do	AUX
ajmpe-90	156	28	not	not	PART
ajmpe-90	156	29	distinguish	distinguish	VERB
ajmpe-90	156	30	between	between	ADP
ajmpe-90	156	31	hypothyroid	hypothyroid	ADJ
ajmpe-90	156	32	and	and	CCONJ
ajmpe-90	156	33	hyperthyroid	hyperthyroid	NOUN
ajmpe-90	156	34	conditions	condition	NOUN
ajmpe-90	156	35	.	.	PUNCT
ajmpe-90	157	1	tsh	tsh	NOUN
ajmpe-90	157	2	concentration	concentration	NOUN
ajmpe-90	157	3	and	and	CCONJ
ajmpe-90	157	4	risk	risk	NOUN
ajmpe-90	157	5	were	be	AUX
ajmpe-90	157	6	found	find	VERB
ajmpe-90	157	7	to	to	PART
ajmpe-90	157	8	be	be	AUX
ajmpe-90	157	9	negatively	negatively	ADV
ajmpe-90	157	10	correlated	correlate	VERB
ajmpe-90	157	11	in	in	ADP
ajmpe-90	157	12	the	the	DET
ajmpe-90	157	13	one	one	NUM
ajmpe-90	157	14	study	study	NOUN
ajmpe-90	157	15	that	that	PRON
ajmpe-90	157	16	looked	look	VERB
ajmpe-90	157	17	at	at	ADP
ajmpe-90	157	18	circulating	circulate	VERB
ajmpe-90	157	19	thyroid	thyroid	NOUN
ajmpe-90	157	20	hormone	hormone	NOUN
ajmpe-90	157	21	levels	level	NOUN
ajmpe-90	157	22	and	and	CCONJ
ajmpe-90	157	23	prostate	prostate	NOUN
ajmpe-90	157	24	cancer	cancer	NOUN
ajmpe-90	157	25	(	(	PUNCT
ajmpe-90	157	26	advanced	advanced	ADJ
ajmpe-90	157	27	cases	case	NOUN
ajmpe-90	157	28	were	be	AUX
ajmpe-90	157	29	not	not	PART
ajmpe-90	157	30	looked	look	VERB
ajmpe-90	157	31	at	at	ADP
ajmpe-90	157	32	individually	individually	ADV
ajmpe-90	157	33	)	)	PUNCT
ajmpe-90	158	1	[	[	X
ajmpe-90	158	2	29	29	NUM
ajmpe-90	158	3	]	]	X
ajmpe-90	158	4	t4	t4	PROPN
ajmpe-90	158	5	and	and	CCONJ
ajmpe-90	158	6	tsh	tsh	NOUN
ajmpe-90	158	7	interact	interact	NOUN
ajmpe-90	158	8	negatively	negatively	ADV
ajmpe-90	158	9	in	in	ADP
ajmpe-90	158	10	individuals	individual	NOUN
ajmpe-90	158	11	who	who	PRON
ajmpe-90	158	12	have	have	VERB
ajmpe-90	158	13	normal	normal	ADJ
ajmpe-90	158	14	thyroid	thyroid	NOUN
ajmpe-90	158	15	function	function	NOUN
ajmpe-90	158	16	[	[	X
ajmpe-90	158	17	8	8	NUM
ajmpe-90	158	18	]	]	PUNCT
ajmpe-90	158	19	.	.	PUNCT
ajmpe-90	159	1	accordingly	accordingly	ADV
ajmpe-90	159	2	,	,	PUNCT
ajmpe-90	159	3	a	a	DET
ajmpe-90	159	4	hypothyroid	hypothyroid	ADJ
ajmpe-90	159	5	state	state	NOUN
ajmpe-90	159	6	is	be	AUX
ajmpe-90	159	7	characterized	characterize	VERB
ajmpe-90	159	8	by	by	ADP
ajmpe-90	159	9	low	low	ADJ
ajmpe-90	159	10	t4	t4	PROPN
ajmpe-90	159	11	and	and	CCONJ
ajmpe-90	159	12	high	high	ADJ
ajmpe-90	159	13	tsh	tsh	NOUN
ajmpe-90	159	14	,	,	PUNCT
ajmpe-90	159	15	and	and	CCONJ
ajmpe-90	159	16	a	a	DET
ajmpe-90	159	17	hyperthyroid	hyperthyroid	NOUN
ajmpe-90	159	18	state	state	NOUN
ajmpe-90	159	19	by	by	ADP
ajmpe-90	159	20	high	high	ADJ
ajmpe-90	159	21	t4	t4	PROPN
ajmpe-90	159	22	and	and	CCONJ
ajmpe-90	159	23	low	low	ADJ
ajmpe-90	159	24	tsh	tsh	NOUN
ajmpe-90	159	25	.	.	PUNCT
ajmpe-90	160	1	t4	t4	PROPN
ajmpe-90	160	2	and	and	CCONJ
ajmpe-90	160	3	t3	t3	PROPN
ajmpe-90	160	4	binding	bind	VERB
ajmpe-90	160	5	to	to	ADP
ajmpe-90	160	6	the	the	DET
ajmpe-90	160	7	plasma	plasma	NOUN
ajmpe-90	160	8	membrane	membrane	NOUN
ajmpe-90	160	9	receptor	receptor	NOUN
ajmpe-90	160	10	integrin	integrin	NOUN
ajmpe-90	160	11	avb3	avb3	PROPN
ajmpe-90	160	12	stimulates	stimulate	VERB
ajmpe-90	160	13	several	several	ADJ
ajmpe-90	160	14	pro	pro	ADJ
ajmpe-90	160	15	-	-	ADJ
ajmpe-90	160	16	carcinogenic	carcinogenic	ADJ
ajmpe-90	160	17	pathways	pathway	NOUN
ajmpe-90	160	18	,	,	PUNCT
ajmpe-90	160	19	including	include	VERB
ajmpe-90	160	20	pi-3k	pi-3k	NOUN
ajmpe-90	160	21	and	and	CCONJ
ajmpe-90	160	22	mapk	mapk	NOUN
ajmpe-90	160	23	/	/	SYM
ajmpe-90	160	24	erk1/2	erk1/2	PROPN
ajmpe-90	160	25	,	,	PUNCT
ajmpe-90	160	26	and	and	CCONJ
ajmpe-90	160	27	boosts	boost	VERB
ajmpe-90	160	28	cell	cell	NOUN
ajmpe-90	160	29	proliferation	proliferation	NOUN
ajmpe-90	160	30	and	and	CCONJ
ajmpe-90	160	31	angiogenesis	angiogenesis	NOUN
ajmpe-90	160	32	,	,	PUNCT
ajmpe-90	160	33	which	which	PRON
ajmpe-90	160	34	is	be	AUX
ajmpe-90	160	35	a	a	DET
ajmpe-90	160	36	well	well	ADV
ajmpe-90	160	37	-	-	PUNCT
ajmpe-90	160	38	known	know	VERB
ajmpe-90	160	39	biological	biological	ADJ
ajmpe-90	160	40	mechanism	mechanism	NOUN
ajmpe-90	160	41	via	via	ADP
ajmpe-90	160	42	which	which	PRON
ajmpe-90	160	43	this	this	PRON
ajmpe-90	160	44	may	may	AUX
ajmpe-90	160	45	occur	occur	VERB
ajmpe-90	160	46	[	[	X
ajmpe-90	160	47	5	5	NUM
ajmpe-90	160	48	]	]	PUNCT
ajmpe-90	160	49	.	.	PUNCT
ajmpe-90	161	1	importantly	importantly	ADV
ajmpe-90	161	2	,	,	PUNCT
ajmpe-90	161	3	integrin	integrin	PROPN
ajmpe-90	161	4	avb3	avb3	PROPN
ajmpe-90	161	5	has	have	AUX
ajmpe-90	161	6	been	be	AUX
ajmpe-90	161	7	linked	link	VERB
ajmpe-90	161	8	to	to	ADP
ajmpe-90	161	9	the	the	DET
ajmpe-90	161	10	spread	spread	NOUN
ajmpe-90	161	11	of	of	ADP
ajmpe-90	161	12	prostate	prostate	NOUN
ajmpe-90	161	13	cancer	cancer	NOUN
ajmpe-90	161	14	[	[	X
ajmpe-90	161	15	30	30	NUM
ajmpe-90	161	16	]	]	PUNCT
ajmpe-90	161	17	.	.	PUNCT
ajmpe-90	162	1	nearly	nearly	ADV
ajmpe-90	162	2	every	every	PRON
ajmpe-90	162	3	tissue	tissue	NOUN
ajmpe-90	162	4	in	in	ADP
ajmpe-90	162	5	the	the	DET
ajmpe-90	162	6	body	body	NOUN
ajmpe-90	162	7	develops	develop	VERB
ajmpe-90	162	8	,	,	PUNCT
ajmpe-90	162	9	differentiates	differentiate	NOUN
ajmpe-90	162	10	,	,	PUNCT
ajmpe-90	162	11	and	and	CCONJ
ajmpe-90	162	12	grows	grow	VERB
ajmpe-90	162	13	in	in	ADP
ajmpe-90	162	14	response	response	NOUN
ajmpe-90	162	15	to	to	PART
ajmpe-90	162	16	thyroid	thyroid	VERB
ajmpe-90	162	17	hormones	hormone	NOUN
ajmpe-90	162	18	[	[	X
ajmpe-90	162	19	13	13	NUM
ajmpe-90	162	20	]	]	PUNCT
ajmpe-90	162	21	.	.	PUNCT
ajmpe-90	163	1	according	accord	VERB
ajmpe-90	163	2	to	to	ADP
ajmpe-90	163	3	bilek	bilek	PROPN
ajmpe-90	163	4	et	et	PROPN
ajmpe-90	163	5	al	al	PROPN
ajmpe-90	163	6	.	.	PUNCT
ajmpe-90	164	1	[	[	X
ajmpe-90	164	2	14	14	NUM
ajmpe-90	164	3	]	]	PUNCT
ajmpe-90	164	4	,	,	PUNCT
ajmpe-90	164	5	the	the	DET
ajmpe-90	164	6	thyroid	thyroid	NOUN
ajmpe-90	164	7	gland	gland	NOUN
ajmpe-90	164	8	and	and	CCONJ
ajmpe-90	164	9	the	the	DET
ajmpe-90	164	10	rat	rat	NOUN
ajmpe-90	164	11	ventral	ventral	ADJ
ajmpe-90	164	12	prostate	prostate	NOUN
ajmpe-90	164	13	have	have	VERB
ajmpe-90	164	14	a	a	DET
ajmpe-90	164	15	close	close	ADJ
ajmpe-90	164	16	association	association	NOUN
ajmpe-90	164	17	.	.	PUNCT
ajmpe-90	165	1	the	the	DET
ajmpe-90	165	2	direct	direct	ADJ
ajmpe-90	165	3	impact	impact	NOUN
ajmpe-90	165	4	of	of	ADP
ajmpe-90	165	5	thyroid	thyroid	NOUN
ajmpe-90	165	6	hormones	hormone	NOUN
ajmpe-90	165	7	on	on	ADP
ajmpe-90	165	8	the	the	DET
ajmpe-90	165	9	prostate	prostate	NOUN
ajmpe-90	165	10	is	be	AUX
ajmpe-90	165	11	still	still	ADV
ajmpe-90	165	12	unknown	unknown	ADJ
ajmpe-90	165	13	,	,	PUNCT
ajmpe-90	165	14	despite	despite	SCONJ
ajmpe-90	165	15	the	the	DET
ajmpe-90	165	16	fact	fact	NOUN
ajmpe-90	165	17	that	that	SCONJ
ajmpe-90	165	18	it	it	PRON
ajmpe-90	165	19	is	be	AUX
ajmpe-90	165	20	widely	widely	ADV
ajmpe-90	165	21	known	know	VERB
ajmpe-90	165	22	that	that	SCONJ
ajmpe-90	165	23	thyroid	thyroid	NOUN
ajmpe-90	165	24	hormone	hormone	NOUN
ajmpe-90	165	25	modulates	modulate	NOUN
ajmpe-90	165	26	thyrotropin	thyrotropin	NOUN
ajmpe-90	165	27	-	-	PUNCT
ajmpe-90	165	28	releasing	release	VERB
ajmpe-90	165	29	hormone	hormone	NOUN
ajmpe-90	165	30	levels	level	NOUN
ajmpe-90	165	31	in	in	ADP
ajmpe-90	165	32	the	the	DET
ajmpe-90	165	33	male	male	ADJ
ajmpe-90	165	34	reproductive	reproductive	ADJ
ajmpe-90	165	35	system	system	NOUN
ajmpe-90	165	36	,	,	PUNCT
ajmpe-90	165	37	including	include	VERB
ajmpe-90	165	38	the	the	DET
ajmpe-90	165	39	prostate	prostate	NOUN
ajmpe-90	165	40	[	[	X
ajmpe-90	165	41	15	15	NUM
ajmpe-90	165	42	]	]	PUNCT
ajmpe-90	165	43	.	.	PUNCT
ajmpe-90	166	1	2001	2001	NUM
ajmpe-90	166	2	saw	see	VERB
ajmpe-90	166	3	lehrer	lehrer	PROPN
ajmpe-90	166	4	et	et	PROPN
ajmpe-90	166	5	al	al	PROPN
ajmpe-90	166	6	.	.	PUNCT
ajmpe-90	167	1	it	it	PRON
ajmpe-90	167	2	is	be	AUX
ajmpe-90	167	3	hypothesized	hypothesize	VERB
ajmpe-90	167	4	that	that	SCONJ
ajmpe-90	167	5	hypothyroid	hypothyroid	ADJ
ajmpe-90	167	6	men	man	NOUN
ajmpe-90	167	7	may	may	AUX
ajmpe-90	167	8	be	be	AUX
ajmpe-90	167	9	at	at	ADP
ajmpe-90	167	10	a	a	DET
ajmpe-90	167	11	decreased	decrease	VERB
ajmpe-90	167	12	risk	risk	NOUN
ajmpe-90	167	13	of	of	ADP
ajmpe-90	167	14	prostate	prostate	NOUN
ajmpe-90	167	15	cancer	cancer	NOUN
ajmpe-90	167	16	,	,	PUNCT
ajmpe-90	167	17	whereas	whereas	SCONJ
ajmpe-90	167	18	hyperthyroid	hyperthyroid	NOUN
ajmpe-90	167	19	men	man	NOUN
ajmpe-90	167	20	may	may	AUX
ajmpe-90	167	21	have	have	VERB
ajmpe-90	167	22	an	an	DET
ajmpe-90	167	23	increased	increase	VERB
ajmpe-90	167	24	risk.in	risk.in	PRON
ajmpe-90	167	25	this	this	DET
ajmpe-90	167	26	study	study	NOUN
ajmpe-90	167	27	,	,	PUNCT
ajmpe-90	167	28	most	most	ADJ
ajmpe-90	167	29	of	of	ADP
ajmpe-90	167	30	the	the	DET
ajmpe-90	167	31	patients	patient	NOUN
ajmpe-90	167	32	are	be	AUX
ajmpe-90	167	33	secondary	secondary	ADJ
ajmpe-90	167	34	hyperthyroidism	hyperthyroidism	NOUN
ajmpe-90	167	35	66	66	NUM
ajmpe-90	167	36	%	%	NOUN
ajmpe-90	167	37	this	this	DET
ajmpe-90	167	38	increase	increase	NOUN
ajmpe-90	167	39	the	the	DET
ajmpe-90	167	40	risk	risk	NOUN
ajmpe-90	167	41	of	of	ADP
ajmpe-90	167	42	diseases	disease	NOUN
ajmpe-90	167	43	.	.	PUNCT
ajmpe-90	168	1	conclusion	conclusion	NOUN
ajmpe-90	168	2	according	accord	VERB
ajmpe-90	168	3	to	to	ADP
ajmpe-90	168	4	our	our	PRON
ajmpe-90	168	5	findings	finding	NOUN
ajmpe-90	168	6	,	,	PUNCT
ajmpe-90	168	7	elevated	elevated	ADJ
ajmpe-90	168	8	serum	serum	NOUN
ajmpe-90	168	9	psa	psa	NOUN
ajmpe-90	168	10	levels	level	NOUN
ajmpe-90	168	11	were	be	AUX
ajmpe-90	168	12	linked	link	VERB
ajmpe-90	168	13	to	to	PART
ajmpe-90	168	14	decreased	decrease	VERB
ajmpe-90	168	15	serum	serum	NOUN
ajmpe-90	168	16	tsh	tsh	NOUN
ajmpe-90	168	17	and	and	CCONJ
ajmpe-90	168	18	elevated	elevated	ADJ
ajmpe-90	168	19	serum	serum	NOUN
ajmpe-90	168	20	t3	t3	PROPN
ajmpe-90	168	21	and	and	CCONJ
ajmpe-90	168	22	t4	t4	PROPN
ajmpe-90	168	23	levels	level	NOUN
ajmpe-90	168	24	.	.	PUNCT
ajmpe-90	169	1	although	although	SCONJ
ajmpe-90	169	2	the	the	DET
ajmpe-90	169	3	mechanism	mechanism	NOUN
ajmpe-90	169	4	of	of	ADP
ajmpe-90	169	5	how	how	SCONJ
ajmpe-90	169	6	thyroid	thyroid	NOUN
ajmpe-90	169	7	hormones	hormone	NOUN
ajmpe-90	169	8	affect	affect	VERB
ajmpe-90	169	9	patients	patient	NOUN
ajmpe-90	169	10	with	with	ADP
ajmpe-90	169	11	prostate	prostate	NOUN
ajmpe-90	169	12	cancer	cancer	NOUN
ajmpe-90	169	13	is	be	AUX
ajmpe-90	169	14	still	still	ADV
ajmpe-90	169	15	unknown	unknown	ADJ
ajmpe-90	169	16	,	,	PUNCT
ajmpe-90	169	17	further	further	ADJ
ajmpe-90	169	18	studies	study	NOUN
ajmpe-90	169	19	are	be	AUX
ajmpe-90	169	20	needed	need	VERB
ajmpe-90	169	21	to	to	PART
ajmpe-90	169	22	corroborate	corroborate	VERB
ajmpe-90	169	23	the	the	DET
ajmpe-90	169	24	results	result	NOUN
ajmpe-90	169	25	of	of	ADP
ajmpe-90	169	26	our	our	PRON
ajmpe-90	169	27	study	study	NOUN
ajmpe-90	169	28	.	.	PUNCT
ajmpe-90	170	1	hyperthyroidism	hyperthyroidism	NOUN
ajmpe-90	170	2	is	be	AUX
ajmpe-90	170	3	more	more	ADV
ajmpe-90	170	4	common	common	ADJ
ajmpe-90	170	5	than	than	ADP
ajmpe-90	170	6	hypothyroidism	hypothyroidism	NOUN
ajmpe-90	170	7	among	among	ADP
ajmpe-90	170	8	patients	patient	NOUN
ajmpe-90	170	9	with	with	ADP
ajmpe-90	170	10	prostate	prostate	NOUN
ajmpe-90	170	11	cancer	cancer	NOUN
ajmpe-90	170	12	.	.	PUNCT
ajmpe-90	171	1	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-90	171	2	american	american	PROPN
ajmpe-90	171	3	journal	journal	PROPN
ajmpe-90	171	4	of	of	ADP
ajmpe-90	171	5	medical	medical	ADJ
ajmpe-90	171	6	and	and	CCONJ
ajmpe-90	171	7	physical	physical	ADJ
ajmpe-90	171	8	education	education	NOUN
ajmpe-90	171	9	vol.1	vol.1	PROPN
ajmpe-90	171	10	,	,	PUNCT
ajmpe-90	171	11	issue	issue	NOUN
ajmpe-90	171	12	1	1	NUM
ajmpe-90	171	13	;	;	PUNCT
ajmpe-90	171	14	july	july	PROPN
ajmpe-90	171	15	2023	2023	NUM
ajmpe-90	171	16	;	;	PUNCT
ajmpe-90	171	17	1252	1252	NUM
ajmpe-90	171	18	columbia	columbia	PROPN
ajmpe-90	171	19	rd	rd	PROPN
ajmpe-90	171	20	nw	nw	PROPN
ajmpe-90	171	21	,	,	PUNCT
ajmpe-90	171	22	washington	washington	PROPN
ajmpe-90	171	23	dc	dc	PROPN
ajmpe-90	171	24	,	,	PUNCT
ajmpe-90	171	25	united	united	PROPN
ajmpe-90	171	26	states	states	PROPN
ajmpe-90	171	27	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-90	171	28	;	;	PUNCT
ajmpe-90	171	29	mail	mail	NOUN
ajmpe-90	171	30	:	:	PUNCT
ajmpe-90	171	31	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-90	172	1	32	32	NUM
ajmpe-90	173	1	|	|	ADV
ajmpe-90	173	2	a	a	DET
ajmpe-90	173	3	m	m	NOUN
ajmpe-90	173	4	e	e	NOUN
ajmpe-90	173	5	r	r	NOUN
ajmpe-90	174	1	i	i	NOUN
ajmpe-90	174	2	c	c	VERB
ajmpe-90	174	3	a	a	DET
ajmpe-90	174	4	n	n	NOUN
ajmpe-90	175	1	j	j	NOUN
ajmpe-90	175	2	o	o	X
ajmpe-90	175	3	u	u	NOUN
ajmpe-90	175	4	r	r	NOUN
ajmpe-90	175	5	n	n	NOUN
ajmpe-90	175	6	a	a	DET
ajmpe-90	175	7	l	l	NOUN
ajmpe-90	175	8	o	o	X
ajmpe-90	176	1	f	f	X
ajmpe-90	176	2	m	m	NOUN
ajmpe-90	176	3	e	e	NOUN
ajmpe-90	177	1	d	d	NOUN
ajmpe-90	177	2	i	i	PRON
ajmpe-90	177	3	c	c	VERB
ajmpe-90	177	4	a	a	DET
ajmpe-90	177	5	l	l	NOUN
ajmpe-90	177	6	a	a	X
ajmpe-90	177	7	n	n	NOUN
ajmpe-90	178	1	d	d	NOUN
ajmpe-90	178	2	p	p	NOUN
ajmpe-90	178	3	h	h	NOUN
ajmpe-90	178	4	y	y	NOUN
ajmpe-90	178	5	s	s	VERB
ajmpe-90	179	1	i	i	INTJ
ajmpe-90	179	2	c	c	VERB
ajmpe-90	179	3	a	a	DET
ajmpe-90	179	4	l	l	NOUN
ajmpe-90	179	5	e	e	NOUN
ajmpe-90	179	6	d	d	X
ajmpe-90	179	7	u	u	X
ajmpe-90	179	8	c	c	PROPN
ajmpe-90	180	1	a	a	DET
ajmpe-90	180	2	t	t	NOUN
ajmpe-90	181	1	i	i	PRON
ajmpe-90	181	2	o	o	VERB
ajmpe-90	181	3	n	n	CCONJ
ajmpe-90	181	4	|	|	ADV
ajmpe-90	181	5	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	NUM
ajmpe-90	181	6	ethics	ethic	NOUN
ajmpe-90	181	7	committee	committee	PROPN
ajmpe-90	181	8	approval	approval	NOUN
ajmpe-90	181	9	:	:	PUNCT
ajmpe-90	181	10	the	the	DET
ajmpe-90	181	11	study	study	NOUN
ajmpe-90	181	12	had	have	AUX
ajmpe-90	181	13	the	the	DET
ajmpe-90	181	14	approval	approval	NOUN
ajmpe-90	181	15	of	of	ADP
ajmpe-90	181	16	the	the	DET
ajmpe-90	181	17	institutional	institutional	ADJ
ajmpe-90	181	18	ethics	ethic	NOUN
ajmpe-90	181	19	committee	committee	PROPN
ajmpe-90	181	20	.	.	PUNCT
ajmpe-90	182	1	informed	informed	ADJ
ajmpe-90	182	2	consent	consent	NOUN
ajmpe-90	182	3	:	:	PUNCT
ajmpe-90	182	4	all	all	DET
ajmpe-90	182	5	participants	participant	NOUN
ajmpe-90	182	6	provided	provide	VERB
ajmpe-90	182	7	informed	informed	ADJ
ajmpe-90	182	8	consent	consent	NOUN
ajmpe-90	182	9	.	.	PUNCT
ajmpe-90	183	1	peer	peer	NOUN
ajmpe-90	183	2	-	-	PUNCT
ajmpe-90	183	3	review	review	NOUN
ajmpe-90	183	4	:	:	PUNCT
ajmpe-90	183	5	internally	internally	ADV
ajmpe-90	183	6	peer	peer	NOUN
ajmpe-90	183	7	-	-	PUNCT
ajmpe-90	183	8	reviewed	review	VERB
ajmpe-90	183	9	.	.	PUNCT
ajmpe-90	184	1	conflict	conflict	NOUN
ajmpe-90	184	2	of	of	ADP
ajmpe-90	184	3	interest	interest	NOUN
ajmpe-90	184	4	:	:	PUNCT
ajmpe-90	184	5	the	the	DET
ajmpe-90	184	6	authors	author	NOUN
ajmpe-90	184	7	declared	declare	VERB
ajmpe-90	184	8	no	no	DET
ajmpe-90	184	9	conflict	conflict	NOUN
ajmpe-90	184	10	of	of	ADP
ajmpe-90	184	11	interest	interest	NOUN
ajmpe-90	184	12	.	.	PUNCT
ajmpe-90	185	1	financial	financial	ADJ
ajmpe-90	185	2	disclosure	disclosure	NOUN
ajmpe-90	185	3	:	:	PUNCT
ajmpe-90	185	4	the	the	DET
ajmpe-90	185	5	authors	author	NOUN
ajmpe-90	185	6	declare	declare	VERB
ajmpe-90	185	7	that	that	SCONJ
ajmpe-90	185	8	they	they	PRON
ajmpe-90	185	9	have	have	VERB
ajmpe-90	185	10	no	no	DET
ajmpe-90	185	11	relevant	relevant	ADJ
ajmpe-90	185	12	financial	financial	NOUN
ajmpe-90	185	13	.	.	PUNCT
ajmpe-90	186	1	reference	reference	NOUN
ajmpe-90	186	2	1	1	NUM
ajmpe-90	186	3	.	.	PUNCT
ajmpe-90	186	4	jemal	jemal	PROPN
ajmpe-90	186	5	a	a	PRON
ajmpe-90	186	6	,	,	PUNCT
ajmpe-90	186	7	bray	bray	PROPN
ajmpe-90	186	8	f	f	PROPN
ajmpe-90	186	9	,	,	PUNCT
ajmpe-90	186	10	forman	forman	PROPN
ajmpe-90	186	11	d	d	PROPN
ajmpe-90	186	12	,	,	PUNCT
ajmpe-90	186	13	o'brien	o'brien	PROPN
ajmpe-90	186	14	m	m	PROPN
ajmpe-90	186	15	,	,	PUNCT
ajmpe-90	186	16	ferlay	ferlay	PROPN
ajmpe-90	186	17	j	j	PROPN
ajmpe-90	186	18	,	,	PUNCT
ajmpe-90	186	19	center	center	NOUN
ajmpe-90	186	20	m	m	PROPN
ajmpe-90	186	21	,	,	PUNCT
ajmpe-90	186	22	et	et	PROPN
ajmpe-90	186	23	al	al	PROPN
ajmpe-90	186	24	.	.	PUNCT
ajmpe-90	187	1	cancer	cancer	NOUN
ajmpe-90	187	2	burden	burden	NOUN
ajmpe-90	187	3	in	in	ADP
ajmpe-90	187	4	africa	africa	PROPN
ajmpe-90	187	5	and	and	CCONJ
ajmpe-90	187	6	opportunities	opportunity	NOUN
ajmpe-90	187	7	for	for	ADP
ajmpe-90	187	8	prevention	prevention	NOUN
ajmpe-90	187	9	.	.	PUNCT
ajmpe-90	188	1	cancer	cancer	NOUN
ajmpe-90	188	2	.	.	PUNCT
ajmpe-90	189	1	2012;118(18):4372–84	2012;118(18):4372–84	NUM
ajmpe-90	189	2	.	.	PUNCT
ajmpe-90	190	1	2	2	X
ajmpe-90	190	2	.	.	X
ajmpe-90	190	3	bray	bray	PROPN
ajmpe-90	190	4	f	f	PROPN
ajmpe-90	190	5	,	,	PUNCT
ajmpe-90	190	6	ferlay	ferlay	PROPN
ajmpe-90	190	7	j	j	PROPN
ajmpe-90	190	8	,	,	PUNCT
ajmpe-90	190	9	soerjomataram	soerjomataram	PROPN
ajmpe-90	190	10	i	i	PROPN
ajmpe-90	190	11	,	,	PUNCT
ajmpe-90	190	12	siegel	siegel	PROPN
ajmpe-90	190	13	rl	rl	PROPN
ajmpe-90	190	14	,	,	PUNCT
ajmpe-90	190	15	torre	torre	PROPN
ajmpe-90	190	16	la	la	PROPN
ajmpe-90	190	17	,	,	PUNCT
ajmpe-90	190	18	jemal	jemal	ADJ
ajmpe-90	190	19	a.	a.	PROPN
ajmpe-90	190	20	global	global	PROPN
ajmpe-90	190	21	cancer	cancer	PROPN
ajmpe-90	190	22	statistics	statistic	NOUN
ajmpe-90	190	23	2018	2018	NUM
ajmpe-90	190	24	:	:	PUNCT
ajmpe-90	190	25	globocan	globocan	PROPN
ajmpe-90	190	26	estimates	estimate	NOUN
ajmpe-90	190	27	of	of	ADP
ajmpe-90	190	28	incidence	incidence	NOUN
ajmpe-90	190	29	and	and	CCONJ
ajmpe-90	190	30	mortality	mortality	NOUN
ajmpe-90	190	31	worldwide	worldwide	ADV
ajmpe-90	190	32	for	for	ADP
ajmpe-90	190	33	36	36	NUM
ajmpe-90	190	34	cancers	cancer	NOUN
ajmpe-90	190	35	in	in	ADP
ajmpe-90	190	36	185	185	NUM
ajmpe-90	190	37	countries	country	NOUN
ajmpe-90	190	38	.	.	PUNCT
ajmpe-90	191	1	ca	can	AUX
ajmpe-90	191	2	cancer	cancer	PROPN
ajmpe-90	191	3	j	j	PROPN
ajmpe-90	191	4	clin	clin	PROPN
ajmpe-90	191	5	.	.	PUNCT
ajmpe-90	192	1	2018;68(6):394–424	2018;68(6):394–424	NUM
ajmpe-90	192	2	.	.	NOUN
ajmpe-90	193	1	3	3	X
ajmpe-90	193	2	.	.	X
ajmpe-90	193	3	ferlay	ferlay	PROPN
ajmpe-90	193	4	j	j	PROPN
ajmpe-90	193	5	em	em	PRON
ajmpe-90	193	6	,	,	PUNCT
ajmpe-90	193	7	lam	lam	PROPN
ajmpe-90	193	8	f	f	PROPN
ajmpe-90	193	9	,	,	PUNCT
ajmpe-90	193	10	colombet	colombet	PROPN
ajmpe-90	193	11	m	m	PROPN
ajmpe-90	193	12	,	,	PUNCT
ajmpe-90	193	13	mery	mery	PROPN
ajmpe-90	193	14	l	l	PROPN
ajmpe-90	193	15	,	,	PUNCT
ajmpe-90	193	16	pineros	pineros	PROPN
ajmpe-90	193	17	m	m	PROPN
ajmpe-90	193	18	,	,	PUNCT
ajmpe-90	193	19	znaor	znaor	PROPN
ajmpe-90	193	20	a	a	PRON
ajmpe-90	193	21	,	,	PUNCT
ajmpe-90	193	22	soerjomataram	soerjomataram	PROPN
ajmpe-90	193	23	i.	i.	NOUN
ajmpe-90	193	24	,	,	PUNCT
ajmpe-90	193	25	et	et	PROPN
ajmpe-90	193	26	al	al	PROPN
ajmpe-90	193	27	.	.	PUNCT
ajmpe-90	194	1	global	global	ADJ
ajmpe-90	194	2	cancer	cancer	NOUN
ajmpe-90	194	3	observatory	observatory	NOUN
ajmpe-90	194	4	:	:	PUNCT
ajmpe-90	194	5	cancer	cancer	NOUN
ajmpe-90	194	6	today	today	NOUN
ajmpe-90	194	7	.	.	PUNCT
ajmpe-90	195	1	lyon	lyon	PROPN
ajmpe-90	195	2	,	,	PUNCT
ajmpe-90	195	3	france	france	PROPN
ajmpe-90	195	4	:	:	PUNCT
ajmpe-90	195	5	international	international	ADJ
ajmpe-90	195	6	agency	agency	NOUN
ajmpe-90	195	7	for	for	ADP
ajmpe-90	195	8	research	research	NOUN
ajmpe-90	195	9	on	on	ADP
ajmpe-90	195	10	cancer	cancer	NOUN
ajmpe-90	195	11	.	.	PUNCT
ajmpe-90	195	12	accessed	access	VERB
ajmpe-90	195	13	02	02	NUM
ajmpe-90	195	14	february	february	NOUN
ajmpe-90	195	15	2019	2019	NUM
ajmpe-90	195	16	.	.	PUNCT
ajmpe-90	196	1	4	4	X
ajmpe-90	196	2	.	.	X
ajmpe-90	196	3	hercbergs	hercbergs	PROPN
ajmpe-90	196	4	a.	a.	NOUN
ajmpe-90	196	5	the	the	DET
ajmpe-90	196	6	thyroid	thyroid	NOUN
ajmpe-90	196	7	gland	gland	NOUN
ajmpe-90	196	8	as	as	ADP
ajmpe-90	196	9	an	an	DET
ajmpe-90	196	10	intrinsic	intrinsic	ADJ
ajmpe-90	196	11	biologic	biologic	NOUN
ajmpe-90	196	12	response	response	NOUN
ajmpe-90	196	13	-	-	PUNCT
ajmpe-90	196	14	modifier	modifier	NOUN
ajmpe-90	196	15	in	in	ADP
ajmpe-90	196	16	advanced	advanced	ADJ
ajmpe-90	196	17	neoplasia	neoplasia	NOUN
ajmpe-90	196	18	–	–	PUNCT
ajmpe-90	196	19	a	a	DET
ajmpe-90	196	20	novel	novel	ADJ
ajmpe-90	196	21	paradigm	paradigm	NOUN
ajmpe-90	196	22	.	.	PUNCT
ajmpe-90	197	1	in	in	ADP
ajmpe-90	197	2	vivo	vivo	NOUN
ajmpe-90	197	3	.	.	PUNCT
ajmpe-90	198	1	1996	1996	NUM
ajmpe-90	198	2	;	;	PUNCT
ajmpe-90	198	3	10	10	NUM
ajmpe-90	198	4	:	:	PUNCT
ajmpe-90	198	5	245–247	245–247	NUM
ajmpe-90	198	6	.	.	NOUN
ajmpe-90	199	1	5	5	NUM
ajmpe-90	199	2	.	.	X
ajmpe-90	199	3	pinto	pinto	NOUN
ajmpe-90	199	4	m	m	PROPN
ajmpe-90	199	5	,	,	PUNCT
ajmpe-90	199	6	soares	soar	VERB
ajmpe-90	199	7	p	p	PROPN
ajmpe-90	199	8	,	,	PUNCT
ajmpe-90	199	9	ribatti	ribatti	PROPN
ajmpe-90	199	10	d.	d.	PROPN
ajmpe-90	199	11	thyroid	thyroid	PROPN
ajmpe-90	199	12	hormone	hormone	NOUN
ajmpe-90	199	13	as	as	ADP
ajmpe-90	199	14	a	a	DET
ajmpe-90	199	15	regulator	regulator	NOUN
ajmpe-90	199	16	of	of	ADP
ajmpe-90	199	17	tumor	tumor	NOUN
ajmpe-90	199	18	-	-	PUNCT
ajmpe-90	199	19	induced	induce	VERB
ajmpe-90	199	20	angiogenesis	angiogenesis	NOUN
ajmpe-90	199	21	.	.	PUNCT
ajmpe-90	200	1	cancer	cancer	PROPN
ajmpe-90	200	2	lett	lett	PROPN
ajmpe-90	200	3	.	.	PUNCT
ajmpe-90	201	1	2011	2011	NUM
ajmpe-90	201	2	;	;	PUNCT
ajmpe-90	201	3	301	301	NUM
ajmpe-90	201	4	:	:	PUNCT
ajmpe-90	202	1	119–126	119–126	NUM
ajmpe-90	202	2	.	.	PUNCT
ajmpe-90	203	1	6	6	NUM
ajmpe-90	203	2	.	.	X
ajmpe-90	203	3	hsieh	hsieh	PROPN
ajmpe-90	203	4	ml	ml	PROPN
ajmpe-90	203	5	,	,	PUNCT
ajmpe-90	203	6	juang	juang	PROPN
ajmpe-90	203	7	hh	hh	PROPN
ajmpe-90	203	8	cell	cell	NOUN
ajmpe-90	203	9	growth	growth	NOUN
ajmpe-90	203	10	effects	effect	NOUN
ajmpe-90	203	11	of	of	ADP
ajmpe-90	203	12	triiodothyronine	triiodothyronine	NOUN
ajmpe-90	203	13	and	and	CCONJ
ajmpe-90	203	14	expression	expression	NOUN
ajmpe-90	203	15	of	of	ADP
ajmpe-90	203	16	thyroid	thyroid	NOUN
ajmpe-90	203	17	hormone	hormone	NOUN
ajmpe-90	203	18	receptor	receptor	NOUN
ajmpe-90	203	19	in	in	ADP
ajmpe-90	203	20	prostate	prostate	NOUN
ajmpe-90	203	21	carcinoma	carcinoma	NOUN
ajmpe-90	203	22	cells	cell	NOUN
ajmpe-90	203	23	.	.	PUNCT
ajmpe-90	204	1	j	j	PROPN
ajmpe-90	204	2	androl	androl	PROPN
ajmpe-90	204	3	.	.	PROPN
ajmpe-90	204	4	2005	2005	NUM
ajmpe-90	204	5	;	;	PUNCT
ajmpe-90	204	6	26	26	NUM
ajmpe-90	204	7	:	:	PUNCT
ajmpe-90	204	8	422–428	422–428	NUM
ajmpe-90	204	9	.	.	PUNCT
ajmpe-90	205	1	7	7	X
ajmpe-90	205	2	.	.	X
ajmpe-90	205	3	tsui	tsui	PROPN
ajmpe-90	205	4	kh	kh	PROPN
ajmpe-90	205	5	,	,	PUNCT
ajmpe-90	205	6	hsieh	hsieh	PROPN
ajmpe-90	205	7	wc	wc	PROPN
ajmpe-90	205	8	,	,	PUNCT
ajmpe-90	205	9	lin	lin	PROPN
ajmpe-90	205	10	mh	mh	PROPN
ajmpe-90	205	11	,	,	PUNCT
ajmpe-90	205	12	chang	chang	PROPN
ajmpe-90	205	13	pl	pl	PROPN
ajmpe-90	205	14	,	,	PUNCT
ajmpe-90	205	15	juang	juang	PROPN
ajmpe-90	205	16	hh	hh	PROPN
ajmpe-90	205	17	.triiodothyronine	.triiodothyronine	VERB
ajmpe-90	205	18	modulates	modulate	VERB
ajmpe-90	205	19	cell	cell	NOUN
ajmpe-90	205	20	proliferation	proliferation	NOUN
ajmpe-90	205	21	of	of	ADP
ajmpe-90	205	22	human	human	ADJ
ajmpe-90	205	23	prostatic	prostatic	ADJ
ajmpe-90	205	24	carcinoma	carcinoma	NOUN
ajmpe-90	205	25	cells	cell	NOUN
ajmpe-90	205	26	by	by	ADP
ajmpe-90	205	27	downregulation	downregulation	NOUN
ajmpe-90	205	28	of	of	ADP
ajmpe-90	205	29	the	the	DET
ajmpe-90	205	30	b	b	NOUN
ajmpe-90	205	31	-	-	PUNCT
ajmpe-90	205	32	cell	cell	NOUN
ajmpe-90	205	33	translocation	translocation	NOUN
ajmpe-90	205	34	gene	gene	NOUN
ajmpe-90	205	35	2	2	NUM
ajmpe-90	205	36	.	.	PUNCT
ajmpe-90	205	37	prostate	prostate	NOUN
ajmpe-90	205	38	2008	2008	NUM
ajmpe-90	205	39	;	;	PUNCT
ajmpe-90	205	40	68	68	NUM
ajmpe-90	205	41	:	:	PUNCT
ajmpe-90	205	42	610–619	610–619	NUM
ajmpe-90	205	43	.	.	X
ajmpe-90	206	1	8	8	NUM
ajmpe-90	206	2	.	.	X
ajmpe-90	206	3	yen	yen	NOUN
ajmpe-90	206	4	pm	pm	NOUN
ajmpe-90	206	5	.	.	PUNCT
ajmpe-90	207	1	physiological	physiological	ADJ
ajmpe-90	207	2	and	and	CCONJ
ajmpe-90	207	3	molecular	molecular	ADJ
ajmpe-90	207	4	basis	basis	NOUN
ajmpe-90	207	5	of	of	ADP
ajmpe-90	207	6	thyroid	thyroid	NOUN
ajmpe-90	207	7	hormone	hormone	NOUN
ajmpe-90	207	8	action	action	NOUN
ajmpe-90	207	9	.	.	PUNCT
ajmpe-90	208	1	physiol	physiol	PROPN
ajmpe-90	208	2	rev	rev	VERB
ajmpe-90	208	3	2001	2001	NUM
ajmpe-90	208	4	;	;	PUNCT
ajmpe-90	208	5	81	81	NUM
ajmpe-90	208	6	:	:	SYM
ajmpe-90	208	7	1097	1097	NUM
ajmpe-90	208	8	–	–	PUNCT
ajmpe-90	208	9	1142	1142	NUM
ajmpe-90	208	10	.	.	PUNCT
ajmpe-90	209	1	9	9	X
ajmpe-90	209	2	.	.	X
ajmpe-90	209	3	baskin	baskin	PROPN
ajmpe-90	209	4	hj	hj	PROPN
ajmpe-90	209	5	,	,	PUNCT
ajmpe-90	209	6	cobin	cobin	PROPN
ajmpe-90	209	7	rh	rh	PROPN
ajmpe-90	209	8	,	,	PUNCT
ajmpe-90	209	9	duick	duick	NOUN
ajmpe-90	209	10	ds	ds	PROPN
ajmpe-90	209	11	,	,	PUNCT
ajmpe-90	209	12	gharib	gharib	PROPN
ajmpe-90	209	13	h	h	NOUN
ajmpe-90	209	14	,	,	PUNCT
ajmpe-90	209	15	guttler	guttler	NOUN
ajmpe-90	209	16	rb	rb	PROPN
ajmpe-90	209	17	,	,	PUNCT
ajmpe-90	209	18	et	et	PROPN
ajmpe-90	209	19	al	al	PROPN
ajmpe-90	209	20	.	.	PROPN
ajmpe-90	209	21	american	american	PROPN
ajmpe-90	209	22	association	association	PROPN
ajmpe-90	209	23	of	of	ADP
ajmpe-90	209	24	clinical	clinical	ADJ
ajmpe-90	209	25	endocrinologists	endocrinologist	NOUN
ajmpe-90	209	26	medical	medical	ADJ
ajmpe-90	209	27	guidelines	guideline	NOUN
ajmpe-90	209	28	for	for	ADP
ajmpe-90	209	29	clinical	clinical	ADJ
ajmpe-90	209	30	practice	practice	NOUN
ajmpe-90	209	31	for	for	ADP
ajmpe-90	209	32	the	the	DET
ajmpe-90	209	33	evaluation	evaluation	NOUN
ajmpe-90	209	34	and	and	CCONJ
ajmpe-90	209	35	treatment	treatment	NOUN
ajmpe-90	209	36	of	of	ADP
ajmpe-90	209	37	hyperthyroidism	hyperthyroidism	NOUN
ajmpe-90	209	38	and	and	CCONJ
ajmpe-90	209	39	hypothyroidism	hypothyroidism	NOUN
ajmpe-90	209	40	.	.	PUNCT
ajmpe-90	210	1	endocr	endocr	PROPN
ajmpe-90	210	2	pract	pract	PROPN
ajmpe-90	210	3	.	.	PUNCT
ajmpe-90	211	1	2002	2002	NUM
ajmpe-90	211	2	;	;	PUNCT
ajmpe-90	211	3	8	8	NUM
ajmpe-90	211	4	:	:	PUNCT
ajmpe-90	211	5	457–469	457–469	NUM
ajmpe-90	211	6	.	.	NOUN
ajmpe-90	212	1	10	10	NUM
ajmpe-90	212	2	.	.	PUNCT
ajmpe-90	213	1	partin	partin	PROPN
ajmpe-90	213	2	aw	aw	INTJ
ajmpe-90	213	3	,	,	PUNCT
ajmpe-90	213	4	oesterling	oesterle	VERB
ajmpe-90	213	5	je	je	PROPN
ajmpe-90	213	6	.	.	PUNCT
ajmpe-90	214	1	the	the	DET
ajmpe-90	214	2	clinical	clinical	ADJ
ajmpe-90	214	3	usefulness	usefulness	NOUN
ajmpe-90	214	4	of	of	ADP
ajmpe-90	214	5	prostate	prostate	NOUN
ajmpe-90	214	6	-	-	PUNCT
ajmpe-90	214	7	specific	specific	ADJ
ajmpe-90	214	8	antigen	antigen	NOUN
ajmpe-90	214	9	:	:	PUNCT
ajmpe-90	214	10	update	update	NOUN
ajmpe-90	214	11	1994	1994	NUM
ajmpe-90	214	12	.	.	PUNCT
ajmpe-90	215	1	j	j	PROPN
ajmpe-90	215	2	urol	urol	PROPN
ajmpe-90	215	3	1994;152:1358	1994;152:1358	PROPN
ajmpe-90	215	4	-	-	SYM
ajmpe-90	215	5	1368	1368	NUM
ajmpe-90	215	6	.	.	PUNCT
ajmpe-90	216	1	11	11	NUM
ajmpe-90	216	2	.	.	PUNCT
ajmpe-90	217	1	panigrahi	panigrahi	PROPN
ajmpe-90	217	2	gk	gk	PROPN
ajmpe-90	217	3	,	,	PUNCT
ajmpe-90	217	4	praharaj	praharaj	VERB
ajmpe-90	217	5	pp	pp	ADP
ajmpe-90	217	6	,	,	PUNCT
ajmpe-90	217	7	kittaka	kittaka	PROPN
ajmpe-90	217	8	h	h	NOUN
ajmpe-90	217	9	,	,	PUNCT
ajmpe-90	217	10	mridha	mridha	PROPN
ajmpe-90	217	11	ar	ar	PROPN
ajmpe-90	217	12	,	,	PUNCT
ajmpe-90	217	13	black	black	ADJ
ajmpe-90	217	14	om	om	PROPN
ajmpe-90	217	15	,	,	PUNCT
ajmpe-90	217	16	singh	singh	PROPN
ajmpe-90	217	17	r	r	PROPN
ajmpe-90	217	18	,	,	PUNCT
ajmpe-90	217	19	mercer	mercer	PROPN
ajmpe-90	217	20	r.	r.	PROPN
ajmpe-90	217	21	,	,	PUNCT
ajmpe-90	217	22	et	et	PROPN
ajmpe-90	217	23	al	al	PROPN
ajmpe-90	217	24	.	.	PROPN
ajmpe-90	218	1	exosome	exosome	PROPN
ajmpe-90	218	2	proteomic	proteomic	ADJ
ajmpe-90	218	3	analyses	analysis	NOUN
ajmpe-90	218	4	identify	identify	VERB
ajmpe-90	218	5	inflammatory	inflammatory	ADJ
ajmpe-90	218	6	phenotype	phenotype	NOUN
ajmpe-90	218	7	and	and	CCONJ
ajmpe-90	218	8	novel	novel	ADJ
ajmpe-90	218	9	biomarkers	biomarker	NOUN
ajmpe-90	218	10	in	in	ADP
ajmpe-90	218	11	african	african	ADJ
ajmpe-90	218	12	american	american	ADJ
ajmpe-90	218	13	prostate	prostate	NOUN
ajmpe-90	218	14	cancer	cancer	NOUN
ajmpe-90	218	15	patients	patient	NOUN
ajmpe-90	218	16	.	.	PUNCT
ajmpe-90	219	1	cancer	cancer	NOUN
ajmpe-90	219	2	med	med	PROPN
ajmpe-90	219	3	.	.	PUNCT
ajmpe-90	219	4	2019	2019	NUM
ajmpe-90	219	5	.	.	PUNCT
ajmpe-90	220	1	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-90	220	2	american	american	PROPN
ajmpe-90	220	3	journal	journal	PROPN
ajmpe-90	220	4	of	of	ADP
ajmpe-90	220	5	medical	medical	ADJ
ajmpe-90	220	6	and	and	CCONJ
ajmpe-90	220	7	physical	physical	ADJ
ajmpe-90	220	8	education	education	NOUN
ajmpe-90	220	9	vol.1	vol.1	PROPN
ajmpe-90	220	10	,	,	PUNCT
ajmpe-90	220	11	issue	issue	NOUN
ajmpe-90	220	12	1	1	NUM
ajmpe-90	220	13	;	;	PUNCT
ajmpe-90	220	14	july	july	PROPN
ajmpe-90	220	15	2023	2023	NUM
ajmpe-90	220	16	;	;	PUNCT
ajmpe-90	220	17	1252	1252	NUM
ajmpe-90	220	18	columbia	columbia	PROPN
ajmpe-90	220	19	rd	rd	PROPN
ajmpe-90	220	20	nw	nw	PROPN
ajmpe-90	220	21	,	,	PUNCT
ajmpe-90	220	22	washington	washington	PROPN
ajmpe-90	220	23	dc	dc	PROPN
ajmpe-90	220	24	,	,	PUNCT
ajmpe-90	220	25	united	united	PROPN
ajmpe-90	220	26	states	states	PROPN
ajmpe-90	220	27	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-90	220	28	;	;	PUNCT
ajmpe-90	220	29	mail	mail	NOUN
ajmpe-90	220	30	:	:	PUNCT
ajmpe-90	220	31	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-90	221	1	33	33	NUM
ajmpe-90	222	1	|	|	ADV
ajmpe-90	222	2	a	a	DET
ajmpe-90	222	3	m	m	NOUN
ajmpe-90	222	4	e	e	NOUN
ajmpe-90	222	5	r	r	NOUN
ajmpe-90	223	1	i	i	NOUN
ajmpe-90	223	2	c	c	VERB
ajmpe-90	223	3	a	a	DET
ajmpe-90	223	4	n	n	NOUN
ajmpe-90	224	1	j	j	NOUN
ajmpe-90	224	2	o	o	X
ajmpe-90	224	3	u	u	NOUN
ajmpe-90	224	4	r	r	NOUN
ajmpe-90	224	5	n	n	NOUN
ajmpe-90	224	6	a	a	DET
ajmpe-90	224	7	l	l	NOUN
ajmpe-90	224	8	o	o	X
ajmpe-90	225	1	f	f	X
ajmpe-90	225	2	m	m	NOUN
ajmpe-90	225	3	e	e	NOUN
ajmpe-90	226	1	d	d	NOUN
ajmpe-90	226	2	i	i	PRON
ajmpe-90	226	3	c	c	VERB
ajmpe-90	226	4	a	a	DET
ajmpe-90	226	5	l	l	NOUN
ajmpe-90	226	6	a	a	X
ajmpe-90	226	7	n	n	NOUN
ajmpe-90	227	1	d	d	NOUN
ajmpe-90	227	2	p	p	NOUN
ajmpe-90	227	3	h	h	NOUN
ajmpe-90	227	4	y	y	NOUN
ajmpe-90	227	5	s	s	VERB
ajmpe-90	228	1	i	i	INTJ
ajmpe-90	228	2	c	c	VERB
ajmpe-90	228	3	a	a	DET
ajmpe-90	228	4	l	l	NOUN
ajmpe-90	228	5	e	e	NOUN
ajmpe-90	228	6	d	d	X
ajmpe-90	228	7	u	u	X
ajmpe-90	228	8	c	c	PROPN
ajmpe-90	229	1	a	a	DET
ajmpe-90	229	2	t	t	NOUN
ajmpe-90	230	1	i	i	PRON
ajmpe-90	230	2	o	o	VERB
ajmpe-90	231	1	n	n	CCONJ
ajmpe-90	232	1	|	|	ADV
ajmpe-90	232	2	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	NUM
ajmpe-90	232	3	12	12	NUM
ajmpe-90	232	4	.	.	PUNCT
ajmpe-90	233	1	claudio	claudio	PROPN
ajmpe-90	233	2	schneider	schneider	NOUN
ajmpe-90	233	3	,	,	PUNCT
ajmpe-90	233	4	martin	martin	PROPN
ajmpe-90	233	5	feller	feller	PROPN
ajmpe-90	233	6	,	,	PUNCT
ajmpe-90	233	7	et	et	PROPN
ajmpe-90	233	8	al	al	PROPN
ajmpe-90	233	9	.	.	PROPN
ajmpe-90	233	10	initial	initial	ADJ
ajmpe-90	233	11	evaluation	evaluation	NOUN
ajmpe-90	233	12	of	of	ADP
ajmpe-90	233	13	thyroid	thyroid	NOUN
ajmpe-90	233	14	dysfunction	dysfunction	NOUN
ajmpe-90	233	15	are	be	AUX
ajmpe-90	233	16	simultaneous	simultaneous	ADJ
ajmpe-90	233	17	tsh	tsh	NOUN
ajmpe-90	233	18	and	and	CCONJ
ajmpe-90	233	19	ft4	ft4	NOUN
ajmpe-90	233	20	tests	test	NOUN
ajmpe-90	233	21	necessary?plos	necessary?plos	PROPN
ajmpe-90	233	22	one	one	NUM
ajmpe-90	233	23	:	:	PUNCT
ajmpe-90	233	24	april	april	PROPN
ajmpe-90	233	25	30	30	NUM
ajmpe-90	233	26	,	,	PUNCT
ajmpe-90	233	27	2018	2018	NUM
ajmpe-90	233	28	13	13	NUM
ajmpe-90	233	29	.	.	PUNCT
ajmpe-90	234	1	goemann	goemann	PROPN
ajmpe-90	234	2	i	i	PRON
ajmpe-90	234	3	m	m	PROPN
ajmpe-90	234	4	,	,	PUNCT
ajmpe-90	234	5	romitti	romitti	VERB
ajmpe-90	234	6	m	m	PROPN
ajmpe-90	234	7	,	,	PUNCT
ajmpe-90	234	8	meyer	meyer	PROPN
ajmpe-90	234	9	els	els	PROPN
ajmpe-90	234	10	,	,	PUNCT
ajmpe-90	234	11	wajner	wajner	NOUN
ajmpe-90	234	12	sm	sm	PROPN
ajmpe-90	234	13	,	,	PUNCT
ajmpe-90	234	14	maia	maia	PROPN
ajmpe-90	234	15	al	al	PROPN
ajmpe-90	234	16	.	.	PROPN
ajmpe-90	234	17	role	role	NOUN
ajmpe-90	234	18	of	of	ADP
ajmpe-90	234	19	thyroid	thyroid	NOUN
ajmpe-90	234	20	hormones	hormone	NOUN
ajmpe-90	234	21	in	in	ADP
ajmpe-90	234	22	the	the	DET
ajmpe-90	234	23	neoplastic	neoplastic	ADJ
ajmpe-90	234	24	process	process	NOUN
ajmpe-90	234	25	:	:	PUNCT
ajmpe-90	234	26	an	an	DET
ajmpe-90	234	27	overview	overview	NOUN
ajmpe-90	234	28	.	.	PUNCT
ajmpe-90	235	1	endocr	endocr	PROPN
ajmpe-90	235	2	relat	relat	PROPN
ajmpe-90	235	3	cancer	cancer	NOUN
ajmpe-90	235	4	2017;24	2017;24	NUM
ajmpe-90	235	5	:	:	PUNCT
ajmpe-90	235	6	r367	r367	PROPN
ajmpe-90	235	7	-	-	PUNCT
ajmpe-90	235	8	r385	r385	PROPN
ajmpe-90	235	9	.	.	PUNCT
ajmpe-90	236	1	14	14	NUM
ajmpe-90	236	2	.	.	PUNCT
ajmpe-90	237	1	bilek	bilek	PROPN
ajmpe-90	237	2	r	r	NOUN
ajmpe-90	237	3	,	,	PUNCT
ajmpe-90	237	4	gkonos	gkonos	PROPN
ajmpe-90	237	5	pj	pj	PROPN
ajmpe-90	237	6	,	,	PUNCT
ajmpe-90	237	7	tavianini	tavianini	PROPN
ajmpe-90	237	8	ma	ma	PROPN
ajmpe-90	237	9	,	,	PUNCT
ajmpe-90	237	10	smyth	smyth	PROPN
ajmpe-90	237	11	dg	dg	PROPN
ajmpe-90	237	12	,	,	PUNCT
ajmpe-90	237	13	roos	roos	PROPN
ajmpe-90	237	14	ba	ba	PROPN
ajmpe-90	237	15	.	.	PUNCT
ajmpe-90	238	1	the	the	DET
ajmpe-90	238	2	thyrotrophin	thyrotrophin	ADV
ajmpe-90	238	3	-	-	PUNCT
ajmpe-90	238	4	releasing	release	VERB
ajmpe-90	238	5	hormone	hormone	NOUN
ajmpe-90	238	6	(	(	PUNCT
ajmpe-90	238	7	trh)like	trh)like	PROPN
ajmpe-90	238	8	peptides	peptide	NOUN
ajmpe-90	238	9	in	in	ADP
ajmpe-90	238	10	rat	rat	NOUN
ajmpe-90	238	11	prostate	prostate	NOUN
ajmpe-90	238	12	are	be	AUX
ajmpe-90	238	13	not	not	PART
ajmpe-90	238	14	formed	form	VERB
ajmpe-90	238	15	by	by	ADP
ajmpe-90	238	16	expression	expression	NOUN
ajmpe-90	238	17	of	of	ADP
ajmpe-90	238	18	the	the	DET
ajmpe-90	238	19	trh	trh	NOUN
ajmpe-90	238	20	gene	gene	NOUN
ajmpe-90	238	21	but	but	CCONJ
ajmpe-90	238	22	are	be	AUX
ajmpe-90	238	23	suppressed	suppress	VERB
ajmpe-90	238	24	by	by	ADP
ajmpe-90	238	25	thyroid	thyroid	NOUN
ajmpe-90	238	26	hormone	hormone	NOUN
ajmpe-90	238	27	.	.	PUNCT
ajmpe-90	239	1	j	j	PROPN
ajmpe-90	239	2	endocrinol	endocrinol	NOUN
ajmpe-90	239	3	1992;132:177	1992;132:177	NUM
ajmpe-90	239	4	-	-	SYM
ajmpe-90	239	5	184	184	NUM
ajmpe-90	239	6	.	.	NOUN
ajmpe-90	239	7	15	15	NUM
ajmpe-90	239	8	.	.	PUNCT
ajmpe-90	240	1	maran	maran	PROPN
ajmpe-90	240	2	rr	rr	PROPN
ajmpe-90	240	3	,	,	PUNCT
ajmpe-90	240	4	ravichandran	ravichandran	PROPN
ajmpe-90	240	5	k	k	PROPN
ajmpe-90	240	6	,	,	PUNCT
ajmpe-90	240	7	arunakaran	arunakaran	NOUN
ajmpe-90	240	8	j.	j.	PROPN
ajmpe-90	240	9	prostate	prostate	PROPN
ajmpe-90	240	10	-	-	PUNCT
ajmpe-90	240	11	thyroid	thyroid	NOUN
ajmpe-90	240	12	axis	axis	NOUN
ajmpe-90	240	13	:	:	PUNCT
ajmpe-90	240	14	prostatic	prostatic	ADJ
ajmpe-90	240	15	trh	trh	NOUN
ajmpe-90	240	16	is	be	AUX
ajmpe-90	240	17	one	one	NUM
ajmpe-90	240	18	of	of	ADP
ajmpe-90	240	19	the	the	DET
ajmpe-90	240	20	stimulators	stimulator	NOUN
ajmpe-90	240	21	of	of	ADP
ajmpe-90	240	22	thyroid	thyroid	NOUN
ajmpe-90	240	23	hormone	hormone	NOUN
ajmpe-90	240	24	.	.	PUNCT
ajmpe-90	241	1	endocr	endocr	PROPN
ajmpe-90	241	2	res	re	VERB
ajmpe-90	241	3	2001;27:14315	2001;27:14315	PROPN
ajmpe-90	241	4	.	.	PUNCT
ajmpe-90	242	1	16	16	NUM
ajmpe-90	242	2	.	.	PUNCT
ajmpe-90	243	1	lehrer	lehrer	PROPN
ajmpe-90	243	2	s	s	PART
ajmpe-90	243	3	,	,	PUNCT
ajmpe-90	243	4	diamond	diamond	PROPN
ajmpe-90	243	5	ej	ej	PROPN
ajmpe-90	243	6	,	,	PUNCT
ajmpe-90	243	7	bajwa	bajwa	PROPN
ajmpe-90	243	8	am	be	AUX
ajmpe-90	243	9	,	,	PUNCT
ajmpe-90	243	10	kornreich	kornreich	NOUN
ajmpe-90	243	11	r	r	NOUN
ajmpe-90	243	12	,	,	PUNCT
ajmpe-90	243	13	stagger	stagger	NOUN
ajmpe-90	243	14	s	s	NOUN
ajmpe-90	243	15	,	,	PUNCT
ajmpe-90	243	16	stone	stone	PROPN
ajmpe-90	243	17	nn	nn	PROPN
ajmpe-90	243	18	,	,	PUNCT
ajmpe-90	243	19	droller	droller	NOUN
ajmpe-90	243	20	mj	mj	PROPN
ajmpe-90	243	21	,	,	PUNCT
ajmpe-90	243	22	stock	stock	PROPN
ajmpe-90	243	23	rg	rg	PROPN
ajmpe-90	243	24	.	.	PROPN
ajmpe-90	243	25	association	association	PROPN
ajmpe-90	243	26	between	between	ADP
ajmpe-90	243	27	serum	serum	NOUN
ajmpe-90	243	28	triiodothyronine	triiodothyronine	NOUN
ajmpe-90	243	29	(	(	PUNCT
ajmpe-90	243	30	t3	t3	NOUN
ajmpe-90	243	31	)	)	PUNCT
ajmpe-90	243	32	level	level	NOUN
ajmpe-90	243	33	and	and	CCONJ
ajmpe-90	243	34	risk	risk	NOUN
ajmpe-90	243	35	of	of	ADP
ajmpe-90	243	36	disease	disease	NOUN
ajmpe-90	243	37	recurrence	recurrence	NOUN
ajmpe-90	243	38	in	in	ADP
ajmpe-90	243	39	men	man	NOUN
ajmpe-90	243	40	with	with	ADP
ajmpe-90	243	41	localized	localized	ADJ
ajmpe-90	243	42	prostate	prostate	NOUN
ajmpe-90	243	43	cancer	cancer	NOUN
ajmpe-90	243	44	.	.	PUNCT
ajmpe-90	244	1	prostate	prostate	NOUN
ajmpe-90	244	2	cancer	cancer	NOUN
ajmpe-90	244	3	prostatic	prostatic	ADJ
ajmpe-90	244	4	dis	dis	PROPN
ajmpe-90	244	5	2001;4:232	2001;4:232	PROPN
ajmpe-90	244	6	-	-	SYM
ajmpe-90	244	7	234	234	NUM
ajmpe-90	244	8	.	.	PUNCT
ajmpe-90	244	9	17	17	NUM
ajmpe-90	244	10	.	.	PUNCT
ajmpe-90	245	1	dogra	dogra	PROPN
ajmpe-90	245	2	p	p	X
ajmpe-90	245	3	,	,	PUNCT
ajmpe-90	245	4	paudel	paudel	NOUN
ajmpe-90	245	5	r	r	NOUN
ajmpe-90	245	6	,	,	PUNCT
ajmpe-90	245	7	panthi	panthi	PROPN
ajmpe-90	245	8	s	s	PROPN
ajmpe-90	245	9	,	,	PUNCT
ajmpe-90	245	10	cassity	cassity	NOUN
ajmpe-90	245	11	e	e	NOUN
ajmpe-90	245	12	,	,	PUNCT
ajmpe-90	245	13	tannock	tannock	NOUN
ajmpe-90	245	14	lr.low	lr.low	ADJ
ajmpe-90	245	15	yield	yield	NOUN
ajmpe-90	245	16	of	of	ADP
ajmpe-90	245	17	thyroid	thyroid	NOUN
ajmpe-90	245	18	-	-	PUNCT
ajmpe-90	245	19	function	function	NOUN
ajmpe-90	245	20	tests	test	NOUN
ajmpe-90	245	21	in	in	ADP
ajmpe-90	245	22	adult	adult	NOUN
ajmpe-90	245	23	hospitalized	hospitalize	VERB
ajmpe-90	245	24	patients	patient	NOUN
ajmpe-90	245	25	—	—	PUNCT
ajmpe-90	245	26	a	a	DET
ajmpe-90	245	27	retrospective	retrospective	ADJ
ajmpe-90	245	28	analysis	analysis	NOUN
ajmpe-90	245	29	.	.	PUNCT
ajmpe-90	246	1	dove	dove	NOUN
ajmpe-90	246	2	press	press	NOUN
ajmpe-90	246	3	:	:	PUNCT
ajmpe-90	246	4	6	6	NUM
ajmpe-90	246	5	july	july	PROPN
ajmpe-90	246	6	2020	2020	NUM
ajmpe-90	246	7	volume	volume	NOUN
ajmpe-90	246	8	2020:13	2020:13	NUM
ajmpe-90	246	9	pages	page	NOUN
ajmpe-90	246	10	343—349	343—349	PROPN
ajmpe-90	246	11	18	18	NUM
ajmpe-90	246	12	.	.	PUNCT
ajmpe-90	247	1	jun	jun	PROPN
ajmpe-90	247	2	ho	ho	PROPN
ajmpe-90	247	3	lee	lee	PROPN
ajmpe-90	247	4	,	,	PUNCT
ajmpe-90	247	5	yeon	yeon	PROPN
ajmpe-90	247	6	won	win	VERB
ajmpe-90	247	7	park	park	NOUN
ajmpe-90	247	8	,	,	PUNCT
ajmpe-90	247	9	and	and	CCONJ
ajmpe-90	247	10	sung	sung	PROPN
ajmpe-90	247	11	won	win	VERB
ajmpe-90	247	12	lee	lee	PROPN
ajmpe-90	247	13	.	.	PUNCT
ajmpe-90	248	1	the	the	DET
ajmpe-90	248	2	relationship	relationship	NOUN
ajmpe-90	248	3	between	between	ADP
ajmpe-90	248	4	thyroid	thyroid	NOUN
ajmpe-90	248	5	hormone	hormone	NOUN
ajmpe-90	248	6	levels	level	NOUN
ajmpe-90	248	7	and	and	CCONJ
ajmpe-90	248	8	lower	low	ADJ
ajmpe-90	248	9	urinary	urinary	ADJ
ajmpe-90	248	10	tract	tract	NOUN
ajmpe-90	248	11	symptoms	symptom	NOUN
ajmpe-90	248	12	/	/	SYM
ajmpe-90	248	13	benign	benign	ADJ
ajmpe-90	248	14	prostatic	prostatic	ADJ
ajmpe-90	248	15	hyperplasia	hyperplasia	NOUN
ajmpe-90	248	16	.	.	PUNCT
ajmpe-90	249	1	world	world	PROPN
ajmpe-90	249	2	j	j	PROPN
ajmpe-90	249	3	men	man	NOUN
ajmpe-90	249	4	's	's	PART
ajmpe-90	249	5	health	health	NOUN
ajmpe-90	249	6	.	.	PUNCT
ajmpe-90	250	1	2019	2019	NUM
ajmpe-90	250	2	sep;37(3):364371	sep;37(3):364371	PROPN
ajmpe-90	250	3	19.eilon	19.eilon	PROPN
ajmpe-90	250	4	krashin	krashin	PROPN
ajmpe-90	250	5	,	,	PUNCT
ajmpe-90	250	6	agnieszka	agnieszka	PROPN
ajmpe-90	250	7	piekiełko	piekiełko	PROPN
ajmpe-90	250	8	-	-	PUNCT
ajmpe-90	250	9	witkowska	witkowska	PROPN
ajmpe-90	250	10	,	,	PUNCT
ajmpe-90	250	11	martin	martin	PROPN
ajmpe-90	250	12	ellis	ellis	PROPN
ajmpe-90	250	13	,	,	PUNCT
ajmpe-90	250	14	and	and	CCONJ
ajmpe-90	250	15	osnat	osnat	ADJ
ajmpe-90	250	16	ashur-fabian.thyroid	ashur-fabian.thyroid	PROPN
ajmpe-90	250	17	hormones	hormone	NOUN
ajmpe-90	250	18	and	and	CCONJ
ajmpe-90	250	19	cancer	cancer	NOUN
ajmpe-90	250	20	:	:	PUNCT
ajmpe-90	250	21	a	a	DET
ajmpe-90	250	22	comprehensive	comprehensive	ADJ
ajmpe-90	250	23	review	review	NOUN
ajmpe-90	250	24	of	of	ADP
ajmpe-90	250	25	preclinical	preclinical	ADJ
ajmpe-90	250	26	and	and	CCONJ
ajmpe-90	250	27	clinical	clinical	ADJ
ajmpe-90	250	28	studies	study	NOUN
ajmpe-90	250	29	.	.	PUNCT
ajmpe-90	251	1	front	front	ADJ
ajmpe-90	251	2	endocrinol	endocrinol	NOUN
ajmpe-90	251	3	(	(	PUNCT
ajmpe-90	251	4	lausanne	lausanne	PROPN
ajmpe-90	251	5	)	)	PUNCT
ajmpe-90	251	6	.	.	PUNCT
ajmpe-90	252	1	2019	2019	NUM
ajmpe-90	252	2	;	;	PUNCT
ajmpe-90	252	3	10	10	NUM
ajmpe-90	252	4	:	:	SYM
ajmpe-90	252	5	59	59	NUM
ajmpe-90	252	6	.	.	NOUN
ajmpe-90	252	7	20	20	NUM
ajmpe-90	252	8	.	.	PUNCT
ajmpe-90	252	9	çağdaş	çağdaş	PROPN
ajmpe-90	252	10	şenel1	şenel1	PROPN
ajmpe-90	252	11	,	,	PUNCT
ajmpe-90	252	12	altuğ	altuğ	ADJ
ajmpe-90	252	13	tuncel1	tuncel1	PROPN
ajmpe-90	252	14	,	,	PUNCT
ajmpe-90	252	15	yılmaz	yılmaz	PROPN
ajmpe-90	252	16	aslan1	aslan1	PROPN
ajmpe-90	252	17	,	,	PUNCT
ajmpe-90	252	18	dilek	dilek	PROPN
ajmpe-90	252	19	berker2	berker2	VERB
ajmpe-90	252	20	,	,	PUNCT
ajmpe-90	252	21	merve	merve	NOUN
ajmpe-90	252	22	çatak2	çatak2	PROPN
ajmpe-90	252	23	,	,	PUNCT
ajmpe-90	252	24	serdar	serdar	PROPN
ajmpe-90	252	25	güler2	güler2	PROPN
ajmpe-90	252	26	,	,	PUNCT
ajmpe-90	252	27	melih	melih	ADJ
ajmpe-90	252	28	balcı1	balcı1	ADJ
ajmpe-90	252	29	mpact	mpact	PROPN
ajmpe-90	252	30	of	of	ADP
ajmpe-90	252	31	thyroid	thyroid	NOUN
ajmpe-90	252	32	hormones	hormone	NOUN
ajmpe-90	252	33	on	on	ADP
ajmpe-90	252	34	serum	serum	NOUN
ajmpe-90	252	35	prostate	prostate	NOUN
ajmpe-90	252	36	specific	specific	ADJ
ajmpe-90	252	37	antigen	antigen	ADJ
ajmpe-90	252	38	level	level	NOUN
ajmpe-90	252	39	in	in	ADP
ajmpe-90	252	40	patients	patient	NOUN
ajmpe-90	252	41	with	with	ADP
ajmpe-90	252	42	benign	benign	ADJ
ajmpe-90	252	43	thyroid	thyroid	NOUN
ajmpe-90	252	44	disorders	disorder	NOUN
ajmpe-90	252	45	journal	journal	NOUN
ajmpe-90	252	46	of	of	ADP
ajmpe-90	252	47	urological	urological	ADJ
ajmpe-90	252	48	surgery	surgery	NOUN
ajmpe-90	252	49	,	,	PUNCT
ajmpe-90	252	50	2020;7(4):290	2020;7(4):290	NUM
ajmpe-90	252	51	-	-	SYM
ajmpe-90	252	52	294	294	NUM
ajmpe-90	252	53	.	.	PUNCT
ajmpe-90	253	1	21	21	NUM
ajmpe-90	253	2	.	.	PUNCT
ajmpe-90	253	3	çağdaş	çağdaş	PROPN
ajmpe-90	253	4	şenel	şenel	PROPN
ajmpe-90	253	5	,	,	PUNCT
ajmpe-90	253	6	altuğ	altuğ	PROPN
ajmpe-90	253	7	tuncel	tuncel	PROPN
ajmpe-90	253	8	,	,	PUNCT
ajmpe-90	253	9	yılmaz	yılmaz	PROPN
ajmpe-90	253	10	aslan	aslan	PROPN
ajmpe-90	253	11	et	et	PROPN
ajmpe-90	253	12	ail	ail	PROPN
ajmpe-90	253	13	.	.	PUNCT
ajmpe-90	254	1	impact	impact	NOUN
ajmpe-90	254	2	of	of	ADP
ajmpe-90	254	3	thyroid	thyroid	NOUN
ajmpe-90	254	4	hormones	hormone	NOUN
ajmpe-90	254	5	on	on	ADP
ajmpe-90	254	6	serum	serum	NOUN
ajmpe-90	254	7	prostate	prostate	NOUN
ajmpe-90	254	8	specific	specific	ADJ
ajmpe-90	254	9	antigen	antigen	ADJ
ajmpe-90	254	10	level	level	NOUN
ajmpe-90	254	11	in	in	ADP
ajmpe-90	254	12	patients	patient	NOUN
ajmpe-90	254	13	with	with	ADP
ajmpe-90	254	14	benign	benign	ADJ
ajmpe-90	254	15	thyroid	thyroid	NOUN
ajmpe-90	254	16	disorder	disorder	NOUN
ajmpe-90	254	17	,	,	PUNCT
ajmpe-90	254	18	j	j	PROPN
ajmpe-90	254	19	urol	urol	PROPN
ajmpe-90	254	20	surg	surg	PROPN
ajmpe-90	254	21	2020;7(4):290	2020;7(4):290	NUM
ajmpe-90	254	22	-	-	SYM
ajmpe-90	254	23	294	294	NUM
ajmpe-90	254	24	22	22	NUM
ajmpe-90	254	25	.	.	PUNCT
ajmpe-90	255	1	petra	petra	PROPN
ajmpe-90	255	2	petranović	petranović	PROPN
ajmpe-90	255	3	ovčariček	ovčariček	PROPN
ajmpe-90	255	4	,	,	PUNCT
ajmpe-90	255	5	ana	ana	PROPN
ajmpe-90	255	6	fröbe	fröbe	PROPN
ajmpe-90	255	7	,	,	PUNCT
ajmpe-90	255	8	frederik	frederik	PROPN
ajmpe-90	255	9	anton	anton	PROPN
ajmpe-90	255	10	verburg	verburg	PROPN
ajmpe-90	255	11	,	,	PUNCT
ajmpe-90	255	12	et	et	PROPN
ajmpe-90	255	13	al	al	PROPN
ajmpe-90	255	14	.	.	PROPN
ajmpe-90	255	15	association	association	PROPN
ajmpe-90	255	16	of	of	ADP
ajmpe-90	255	17	triiodothyronine	triiodothyronine	ADJ
ajmpe-90	255	18	levels	level	NOUN
ajmpe-90	255	19	with	with	ADP
ajmpe-90	255	20	prostate	prostate	NOUN
ajmpe-90	255	21	cancer	cancer	NOUN
ajmpe-90	255	22	histopathological	histopathological	ADJ
ajmpe-90	255	23	differentiation	differentiation	NOUN
ajmpe-90	255	24	and	and	CCONJ
ajmpe-90	255	25	tumor	tumor	NOUN
ajmpe-90	255	26	stage	stage	NOUN
ajmpe-90	255	27	.	.	PUNCT
ajmpe-90	256	1	anticancer	anticancer	NOUN
ajmpe-90	256	2	research	research	PROPN
ajmpe-90	256	3	april	april	PROPN
ajmpe-90	256	4	2020	2020	NUM
ajmpe-90	256	5	,	,	PUNCT
ajmpe-90	256	6	40	40	NUM
ajmpe-90	256	7	(	(	PUNCT
ajmpe-90	256	8	4	4	NUM
ajmpe-90	256	9	)	)	PUNCT
ajmpe-90	256	10	2323	2323	NUM
ajmpe-90	256	11	-	-	SYM
ajmpe-90	256	12	2329	2329	NUM
ajmpe-90	256	13	;	;	PUNCT
ajmpe-90	256	14	doi	doi	NOUN
ajmpe-90	256	15	:	:	PUNCT
ajmpe-90	256	16	https://doi.org/10.21873/anticanres.14199	https://doi.org/10.21873/anticanres.14199	NOUN
ajmpe-90	256	17	23	23	NUM
ajmpe-90	256	18	.	.	PUNCT
ajmpe-90	257	1	baskin	baskin	PROPN
ajmpe-90	257	2	hj	hj	PROPN
ajmpe-90	257	3	,	,	PUNCT
ajmpe-90	257	4	cobin	cobin	PROPN
ajmpe-90	257	5	rh	rh	PROPN
ajmpe-90	257	6	,	,	PUNCT
ajmpe-90	257	7	duick	duick	NOUN
ajmpe-90	257	8	ds	ds	PROPN
ajmpe-90	257	9	,	,	PUNCT
ajmpe-90	257	10	gharib	gharib	PROPN
ajmpe-90	257	11	h	h	NOUN
ajmpe-90	257	12	,	,	PUNCT
ajmpe-90	257	13	guttler	guttler	NOUN
ajmpe-90	257	14	rb	rb	PROPN
ajmpe-90	257	15	,	,	PUNCT
ajmpe-90	257	16	et	et	PROPN
ajmpe-90	257	17	al	al	PROPN
ajmpe-90	257	18	.	.	PROPN
ajmpe-90	258	1	american	american	PROPN
ajmpe-90	258	2	association	association	PROPN
ajmpe-90	258	3	of	of	ADP
ajmpe-90	258	4	clinical	clinical	ADJ
ajmpe-90	258	5	endocrinologists	endocrinologist	NOUN
ajmpe-90	258	6	medical	medical	ADJ
ajmpe-90	258	7	guidelines	guideline	NOUN
ajmpe-90	258	8	for	for	ADP
ajmpe-90	258	9	clinical	clinical	ADJ
ajmpe-90	258	10	practice	practice	NOUN
ajmpe-90	258	11	for	for	ADP
ajmpe-90	258	12	the	the	DET
ajmpe-90	258	13	evaluation	evaluation	NOUN
ajmpe-90	258	14	and	and	CCONJ
ajmpe-90	258	15	treatment	treatment	NOUN
ajmpe-90	258	16	of	of	ADP
ajmpe-90	258	17	hyperthyroidism	hyperthyroidism	NOUN
ajmpe-90	258	18	and	and	CCONJ
ajmpe-90	258	19	hypothyroidism	hypothyroidism	NOUN
ajmpe-90	258	20	.	.	PUNCT
ajmpe-90	259	1	endocr	endocr	PROPN
ajmpe-90	259	2	pract	pract	PROPN
ajmpe-90	259	3	.	.	PUNCT
ajmpe-90	260	1	2002	2002	NUM
ajmpe-90	260	2	;	;	PUNCT
ajmpe-90	260	3	8	8	NUM
ajmpe-90	260	4	:	:	PUNCT
ajmpe-90	260	5	457–469	457–469	NUM
ajmpe-90	260	6	.	.	PUNCT
ajmpe-90	261	1	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-90	261	2	https://doi.org/10.21873/anticanres.14199	https://doi.org/10.21873/anticanres.14199	NOUN
ajmpe-90	261	3	https://doi.org/10.21873/anticanres.14199	https://doi.org/10.21873/anticanres.14199	NOUN
ajmpe-90	261	4	american	american	PROPN
ajmpe-90	261	5	journal	journal	PROPN
ajmpe-90	261	6	of	of	ADP
ajmpe-90	261	7	medical	medical	ADJ
ajmpe-90	261	8	and	and	CCONJ
ajmpe-90	261	9	physical	physical	ADJ
ajmpe-90	261	10	education	education	NOUN
ajmpe-90	261	11	vol.1	vol.1	PROPN
ajmpe-90	261	12	,	,	PUNCT
ajmpe-90	261	13	issue	issue	NOUN
ajmpe-90	261	14	1	1	NUM
ajmpe-90	261	15	;	;	PUNCT
ajmpe-90	261	16	july	july	PROPN
ajmpe-90	261	17	2023	2023	NUM
ajmpe-90	261	18	;	;	PUNCT
ajmpe-90	261	19	1252	1252	NUM
ajmpe-90	261	20	columbia	columbia	PROPN
ajmpe-90	261	21	rd	rd	PROPN
ajmpe-90	261	22	nw	nw	PROPN
ajmpe-90	261	23	,	,	PUNCT
ajmpe-90	261	24	washington	washington	PROPN
ajmpe-90	261	25	dc	dc	PROPN
ajmpe-90	261	26	,	,	PUNCT
ajmpe-90	261	27	united	united	PROPN
ajmpe-90	261	28	states	states	PROPN
ajmpe-90	261	29	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-90	261	30	;	;	PUNCT
ajmpe-90	261	31	mail	mail	NOUN
ajmpe-90	261	32	:	:	PUNCT
ajmpe-90	261	33	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-90	262	1	34	34	NUM
ajmpe-90	263	1	|	|	ADV
ajmpe-90	263	2	a	a	DET
ajmpe-90	263	3	m	m	NOUN
ajmpe-90	263	4	e	e	NOUN
ajmpe-90	263	5	r	r	NOUN
ajmpe-90	264	1	i	i	NOUN
ajmpe-90	264	2	c	c	VERB
ajmpe-90	264	3	a	a	DET
ajmpe-90	264	4	n	n	NOUN
ajmpe-90	265	1	j	j	NOUN
ajmpe-90	265	2	o	o	X
ajmpe-90	265	3	u	u	NOUN
ajmpe-90	265	4	r	r	NOUN
ajmpe-90	265	5	n	n	NOUN
ajmpe-90	265	6	a	a	DET
ajmpe-90	265	7	l	l	NOUN
ajmpe-90	265	8	o	o	X
ajmpe-90	266	1	f	f	X
ajmpe-90	266	2	m	m	NOUN
ajmpe-90	266	3	e	e	NOUN
ajmpe-90	267	1	d	d	NOUN
ajmpe-90	267	2	i	i	PRON
ajmpe-90	267	3	c	c	VERB
ajmpe-90	267	4	a	a	DET
ajmpe-90	267	5	l	l	NOUN
ajmpe-90	267	6	a	a	X
ajmpe-90	267	7	n	n	NOUN
ajmpe-90	268	1	d	d	NOUN
ajmpe-90	268	2	p	p	NOUN
ajmpe-90	268	3	h	h	NOUN
ajmpe-90	268	4	y	y	NOUN
ajmpe-90	268	5	s	s	VERB
ajmpe-90	269	1	i	i	INTJ
ajmpe-90	269	2	c	c	VERB
ajmpe-90	269	3	a	a	DET
ajmpe-90	269	4	l	l	NOUN
ajmpe-90	269	5	e	e	NOUN
ajmpe-90	269	6	d	d	X
ajmpe-90	269	7	u	u	X
ajmpe-90	269	8	c	c	PROPN
ajmpe-90	270	1	a	a	DET
ajmpe-90	270	2	t	t	NOUN
ajmpe-90	271	1	i	i	PRON
ajmpe-90	271	2	o	o	VERB
ajmpe-90	272	1	n	n	CCONJ
ajmpe-90	272	2	|	|	ADV
ajmpe-90	272	3	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	NOUN
ajmpe-90	272	4	24	24	NUM
ajmpe-90	272	5	.	.	PUNCT
ajmpe-90	273	1	hsieh	hsieh	PROPN
ajmpe-90	273	2	ml	ml	PROPN
ajmpe-90	273	3	,	,	PUNCT
ajmpe-90	273	4	juang	juang	PROPN
ajmpe-90	273	5	hh	hh	PROPN
ajmpe-90	273	6	.	.	PUNCT
ajmpe-90	274	1	cell	cell	NOUN
ajmpe-90	274	2	growth	growth	NOUN
ajmpe-90	274	3	effects	effect	NOUN
ajmpe-90	274	4	of	of	ADP
ajmpe-90	274	5	triiodothyronine	triiodothyronine	NOUN
ajmpe-90	274	6	and	and	CCONJ
ajmpe-90	274	7	expression	expression	NOUN
ajmpe-90	274	8	of	of	ADP
ajmpe-90	274	9	thyroid	thyroid	NOUN
ajmpe-90	274	10	hormone	hormone	NOUN
ajmpe-90	274	11	receptor	receptor	NOUN
ajmpe-90	274	12	in	in	ADP
ajmpe-90	274	13	prostate	prostate	NOUN
ajmpe-90	274	14	carcinoma	carcinoma	NOUN
ajmpe-90	274	15	cells	cell	NOUN
ajmpe-90	274	16	.	.	PUNCT
ajmpe-90	275	1	j	j	PROPN
ajmpe-90	275	2	androl	androl	PROPN
ajmpe-90	275	3	2005;26	2005;26	NOUN
ajmpe-90	275	4	:	:	PUNCT
ajmpe-90	275	5	422–428	422–428	NUM
ajmpe-90	275	6	.	.	PUNCT
ajmpe-90	275	7	25	25	NUM
ajmpe-90	275	8	.	.	PUNCT
ajmpe-90	276	1	tsui	tsui	PROPN
ajmpe-90	276	2	kh	kh	PROPN
ajmpe-90	276	3	,	,	PUNCT
ajmpe-90	276	4	hsieh	hsieh	PROPN
ajmpe-90	276	5	wc	wc	PROPN
ajmpe-90	276	6	,	,	PUNCT
ajmpe-90	276	7	lin	lin	PROPN
ajmpe-90	276	8	mh	mh	PROPN
ajmpe-90	276	9	,	,	PUNCT
ajmpe-90	276	10	chang	chang	PROPN
ajmpe-90	276	11	pl	pl	PROPN
ajmpe-90	276	12	,	,	PUNCT
ajmpe-90	276	13	juang	juang	PROPN
ajmpe-90	276	14	hh	hh	PROPN
ajmpe-90	276	15	.	.	PUNCT
ajmpe-90	277	1	triiodothyronine	triiodothyronine	ADJ
ajmpe-90	277	2	modulates	modulate	NOUN
ajmpe-90	277	3	cell	cell	NOUN
ajmpe-90	277	4	proliferation	proliferation	NOUN
ajmpe-90	277	5	of	of	ADP
ajmpe-90	277	6	human	human	ADJ
ajmpe-90	277	7	prostatic	prostatic	ADJ
ajmpe-90	277	8	carcinoma	carcinoma	NOUN
ajmpe-90	277	9	cells	cell	NOUN
ajmpe-90	277	10	by	by	ADP
ajmpe-90	277	11	downregulation	downregulation	NOUN
ajmpe-90	277	12	of	of	ADP
ajmpe-90	277	13	the	the	DET
ajmpe-90	277	14	b	b	NOUN
ajmpe-90	277	15	-	-	PUNCT
ajmpe-90	277	16	cell	cell	NOUN
ajmpe-90	277	17	translocation	translocation	NOUN
ajmpe-90	277	18	gene	gene	NOUN
ajmpe-90	277	19	2	2	NUM
ajmpe-90	277	20	.	.	PUNCT
ajmpe-90	277	21	prostate	prostate	NOUN
ajmpe-90	277	22	2008	2008	NUM
ajmpe-90	277	23	;	;	PUNCT
ajmpe-90	277	24	68	68	NUM
ajmpe-90	277	25	:	:	PUNCT
ajmpe-90	277	26	610–619	610–619	NUM
ajmpe-90	277	27	.	.	PUNCT
ajmpe-90	278	1	26	26	NUM
ajmpe-90	278	2	.	.	PUNCT
ajmpe-90	278	3	lehrer	lehrer	PROPN
ajmpe-90	278	4	s	s	PROPN
ajmpe-90	278	5	,	,	PUNCT
ajmpe-90	278	6	diamond	diamond	PROPN
ajmpe-90	278	7	ej	ej	PROPN
ajmpe-90	278	8	,	,	PUNCT
ajmpe-90	278	9	stone	stone	PROPN
ajmpe-90	278	10	nn	nn	PROPN
ajmpe-90	278	11	,	,	PUNCT
ajmpe-90	278	12	stock	stock	NOUN
ajmpe-90	278	13	rg	rg	PROPN
ajmpe-90	278	14	.serum	.serum	ADV
ajmpe-90	278	15	thyroid	thyroid	NOUN
ajmpe-90	278	16	-	-	PUNCT
ajmpe-90	278	17	stimulating	stimulate	VERB
ajmpe-90	278	18	hormone	hormone	NOUN
ajmpe-90	278	19	is	be	AUX
ajmpe-90	278	20	elevated	elevate	VERB
ajmpe-90	278	21	in	in	ADP
ajmpe-90	278	22	men	man	NOUN
ajmpe-90	278	23	with	with	ADP
ajmpe-90	278	24	gleason	gleason	PROPN
ajmpe-90	278	25	8	8	NUM
ajmpe-90	278	26	prostate	prostate	NOUN
ajmpe-90	278	27	cancer	cancer	NOUN
ajmpe-90	278	28	.	.	PUNCT
ajmpe-90	279	1	bju	bju	NOUN
ajmpe-90	279	2	int	int	PROPN
ajmpe-90	279	3	.	.	PUNCT
ajmpe-90	280	1	2005	2005	NUM
ajmpe-90	280	2	;	;	PUNCT
ajmpe-90	280	3	96	96	NUM
ajmpe-90	280	4	:	:	SYM
ajmpe-90	280	5	328	328	NUM
ajmpe-90	280	6	–	–	PUNCT
ajmpe-90	280	7	329	329	NUM
ajmpe-90	280	8	.	.	PUNCT
ajmpe-90	280	9	27	27	NUM
ajmpe-90	280	10	.	.	PUNCT
ajmpe-90	281	1	lehrer	lehrer	PROPN
ajmpe-90	281	2	s	s	PROPN
ajmpe-90	281	3	,	,	PUNCT
ajmpe-90	281	4	diamond	diamond	PROPN
ajmpe-90	281	5	ej	ej	PROPN
ajmpe-90	281	6	,	,	PUNCT
ajmpe-90	281	7	stone	stone	PROPN
ajmpe-90	281	8	nn	nn	PROPN
ajmpe-90	281	9	,	,	PUNCT
ajmpe-90	281	10	droller	droller	NOUN
ajmpe-90	281	11	mj	mj	PROPN
ajmpe-90	281	12	,	,	PUNCT
ajmpe-90	281	13	stock	stock	NOUN
ajmpe-90	281	14	rg	rg	PROPN
ajmpe-90	281	15	.	.	PUNCT
ajmpe-90	282	1	serum	serum	PROPN
ajmpe-90	282	2	triiodothyronine	triiodothyronine	PROPN
ajmpe-90	282	3	is	be	AUX
ajmpe-90	282	4	increased	increase	VERB
ajmpe-90	282	5	in	in	ADP
ajmpe-90	282	6	men	man	NOUN
ajmpe-90	282	7	with	with	ADP
ajmpe-90	282	8	prostate	prostate	NOUN
ajmpe-90	282	9	cancer	cancer	NOUN
ajmpe-90	282	10	and	and	CCONJ
ajmpe-90	282	11	benign	benign	ADJ
ajmpe-90	282	12	prostatic	prostatic	ADJ
ajmpe-90	282	13	hyperplasia	hyperplasia	NOUN
ajmpe-90	282	14	.	.	PUNCT
ajmpe-90	283	1	j	j	PROPN
ajmpe-90	283	2	urol	urol	PROPN
ajmpe-90	283	3	2002	2002	NUM
ajmpe-90	283	4	;	;	PUNCT
ajmpe-90	283	5	168	168	NUM
ajmpe-90	283	6	:	:	SYM
ajmpe-90	283	7	2431–2433	2431–2433	NUM
ajmpe-90	283	8	.	.	PUNCT
ajmpe-90	284	1	28	28	NUM
ajmpe-90	284	2	.	.	PUNCT
ajmpe-90	285	1	hoption	hoption	PROPN
ajmpe-90	285	2	cann	cann	PROPN
ajmpe-90	285	3	sa	sa	PROPN
ajmpe-90	285	4	,	,	PUNCT
ajmpe-90	285	5	qiu	qiu	PROPN
ajmpe-90	285	6	z	z	PROPN
ajmpe-90	285	7	,	,	PUNCT
ajmpe-90	285	8	van	van	PROPN
ajmpe-90	285	9	netten	netten	PROPN
ajmpe-90	285	10	c	c	PROPN
ajmpe-90	285	11	.a	.a	PROPN
ajmpe-90	285	12	prospective	prospective	ADJ
ajmpe-90	285	13	study	study	NOUN
ajmpe-90	285	14	of	of	ADP
ajmpe-90	285	15	iodine	iodine	NOUN
ajmpe-90	285	16	status	status	NOUN
ajmpe-90	285	17	,	,	PUNCT
ajmpe-90	285	18	thyroid	thyroid	NOUN
ajmpe-90	285	19	function	function	NOUN
ajmpe-90	285	20	,	,	PUNCT
ajmpe-90	285	21	and	and	CCONJ
ajmpe-90	285	22	prostate	prostate	NOUN
ajmpe-90	285	23	cancer	cancer	NOUN
ajmpe-90	285	24	risk	risk	NOUN
ajmpe-90	285	25	:	:	PUNCT
ajmpe-90	285	26	follow	follow	VERB
ajmpe-90	285	27	-	-	PUNCT
ajmpe-90	285	28	up	up	NOUN
ajmpe-90	285	29	of	of	ADP
ajmpe-90	285	30	the	the	DET
ajmpe-90	285	31	first	first	ADJ
ajmpe-90	285	32	national	national	PROPN
ajmpe-90	285	33	health	health	NOUN
ajmpe-90	285	34	and	and	CCONJ
ajmpe-90	285	35	nutrition	nutrition	NOUN
ajmpe-90	285	36	examination	examination	NOUN
ajmpe-90	285	37	survey	survey	NOUN
ajmpe-90	285	38	.	.	PUNCT
ajmpe-90	286	1	nutr	nutr	NOUN
ajmpe-90	286	2	cancer	cancer	NOUN
ajmpe-90	286	3	2007	2007	NUM
ajmpe-90	286	4	;	;	PUNCT
ajmpe-90	286	5	58	58	NUM
ajmpe-90	286	6	:	:	PUNCT
ajmpe-90	286	7	28–34	28–34	NUM
ajmpe-90	286	8	.	.	NOUN
ajmpe-90	286	9	29	29	NUM
ajmpe-90	286	10	.	.	PUNCT
ajmpe-90	287	1	hellevik	hellevik	PROPN
ajmpe-90	287	2	ai	ai	VERB
ajmpe-90	287	3	,	,	PUNCT
ajmpe-90	287	4	asvold	asvold	PROPN
ajmpe-90	287	5	bo	bo	PROPN
ajmpe-90	287	6	,	,	PUNCT
ajmpe-90	287	7	bjoro	bjoro	PROPN
ajmpe-90	287	8	t	t	PROPN
ajmpe-90	287	9	,	,	PUNCT
ajmpe-90	287	10	romundstad	romundstad	NOUN
ajmpe-90	287	11	pr	pr	PROPN
ajmpe-90	287	12	,	,	PUNCT
ajmpe-90	287	13	nilsen	nilsen	PROPN
ajmpe-90	287	14	ti	ti	PROPN
ajmpe-90	287	15	,	,	PUNCT
ajmpe-90	287	16	et	et	PROPN
ajmpe-90	287	17	al	al	PROPN
ajmpe-90	287	18	.	.	PROPN
ajmpe-90	287	19	thyroid	thyroid	PROPN
ajmpe-90	287	20	function	function	NOUN
ajmpe-90	287	21	and	and	CCONJ
ajmpe-90	287	22	cancer	cancer	NOUN
ajmpe-90	287	23	risk	risk	NOUN
ajmpe-90	287	24	:	:	PUNCT
ajmpe-90	287	25	a	a	DET
ajmpe-90	287	26	prospective	prospective	ADJ
ajmpe-90	287	27	population	population	NOUN
ajmpe-90	287	28	study	study	NOUN
ajmpe-90	287	29	.	.	PUNCT
ajmpe-90	288	1	cancer	cancer	NOUN
ajmpe-90	288	2	epidemiol	epidemiol	PROPN
ajmpe-90	288	3	biomarkers	biomarkers	PROPN
ajmpe-90	288	4	prev	prev	X
ajmpe-90	288	5	2009	2009	NUM
ajmpe-90	288	6	;	;	PUNCT
ajmpe-90	288	7	18	18	NUM
ajmpe-90	288	8	:	:	PUNCT
ajmpe-90	288	9	570–574	570–574	NUM
ajmpe-90	288	10	.	.	NOUN
ajmpe-90	288	11	30	30	NUM
ajmpe-90	288	12	.	.	PUNCT
ajmpe-90	289	1	kumar	kumar	PROPN
ajmpe-90	289	2	cc	cc	PROPN
ajmpe-90	289	3	.integrin	.integrin	PROPN
ajmpe-90	289	4	alpha	alpha	NOUN
ajmpe-90	289	5	v	v	ADP
ajmpe-90	289	6	beta	beta	NOUN
ajmpe-90	289	7	3	3	NUM
ajmpe-90	289	8	as	as	ADP
ajmpe-90	289	9	a	a	DET
ajmpe-90	289	10	therapeutic	therapeutic	ADJ
ajmpe-90	289	11	target	target	NOUN
ajmpe-90	289	12	for	for	ADP
ajmpe-90	289	13	blocking	block	VERB
ajmpe-90	289	14	tumor	tumor	NOUN
ajmpe-90	289	15	-	-	PUNCT
ajmpe-90	289	16	induced	induce	VERB
ajmpe-90	289	17	angiogenesis	angiogenesis	NOUN
ajmpe-90	289	18	.	.	PUNCT
ajmpe-90	290	1	curr	curr	PROPN
ajmpe-90	290	2	drug	drug	NOUN
ajmpe-90	290	3	targets	target	NOUN
ajmpe-90	290	4	2003	2003	NUM
ajmpe-90	290	5	;	;	PUNCT
ajmpe-90	290	6	4	4	NUM
ajmpe-90	290	7	:	:	SYM
ajmpe-90	290	8	123–131	123–131	NUM
ajmpe-90	290	9	.	.	PUNCT
ajmpe-90	291	1	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	X